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Polycystic ovary syndrome (PCOS) is a complex endocrinopathy associated with adverse 
cardio-metabolic, reproductive, and quality of life outcomes. Controversy surrounds the optimal 
diet composition to mediate favourable health-related outcomes for women with PCOS. The 
main hypothesis of the present work was that a nutritionally balanced, low-glycemic index, 
pulse-based diet containing lentils, beans, split peas, and chickpeas would increase insulin 
sensitivity; thereby, improving multiple health-related outcomes of PCOS. The objectives of the 
present work were 1) to examine the prevalence and characteristics of metabolic syndrome 
(MetS), glucoregulation, type 2 diabetes, and risk factors for cardiovascular disease in women 
with PCOS, and 2) to compare the effect of a pulse-based diet to the National Cholesterol 
Education Program’s Therapeutic Lifestyle Changes (TLC) diet on reproductive health 
measures, cardio-metabolic risk profile, health-related quality of life (HRQoL) indices, dietary 
intakes, and pulse consumption behaviours in women with PCOS. 
To examine the study Objective 1, data were pooled from 2 prospective and cross-
sectional studies on 237 women with PCOS and 42 (non-PCOS) controls (18-36y; Chapter 3). 
The prevalence of metabolic syndrome was 29.5% in the PCOS group, approximately 6-fold 
higher than age-matched controls (P<0.001), with worse glucose control, acanthosis nigricans, 
body mass index (BMI), systolic blood pressure (SBP), triglyceride (TG), high- (HDL-C) and 
low- (LDL-C) density lipoprotein cholesterol, total cholesterol to HDL-C (TC/HDL-C), and 
highly sensitive C-reactive protein levels (P<0.001 to P=0.03). Women with PCOS and MetS 
exhibited exacerbated levels of insulin and glucose responses to an oral glucose tolerance test 
(OGTT), TC, TC/HDL-C ratio, hirsutism, and acanthosis nigricans than BMI-matched 
counterparts without MetS (P<0.001 to P=0.05). Our observations support the opinion that MetS 
exacerbates hyperandrogenism, dyslipidemia, and glucose control in PCOS, possibly by 
aggravating inherent insulin resistance. 
To address the main goal of the study, Objective 2, 95 women with PCOS (18-35y) were 
randomized to receive either the pulse-based diet or the TLC diet, without purposefully inducing 
calorie restriction, for 16 weeks. All women participated in an aerobic exercise program and 





pulse-based diet and 31 in TLC diet group completed the study. Chapter 4 represents the 
reproductive outcome results of Objective 2. Bilateral antral follicle count, ovarian volume, total 
testosterone (TT) levels, average and longest intervals between menses decreased over time in 
both groups (P≤0.05). Sex-hormone binding globulin levels increased (P<0.01) in both groups 
with a tendency for a greater increase in the pulse-based diet group (P=0.07). In Chapter 5, 
cardio-metabolic outcomes of Objective 2 are addressed. The pulse-based diet group had a 
greater reduction in total area under the curve (AUC) for insulin response to an OGTT than the 
TLC diet group (P=0.05). Following the intervention, the pulse-based diet group exhibited lower 
diastolic BP, TG, LDL-C, and TC/HDL-C, as well as a greater increase in HDL-C when 
compared to the TLC diet group (P≤0.05). Body weight, waist circumference, percent body fat, 
SBP, homeostatic model assessment of insulin resistance, glucose AUC, and TC decreased in 
both groups (P≤0.03). Both groups maintained some of the improvements in cardio-metabolic 
and endocrine measures after 16 and 12 months post-intervention, including TT, HDL-C, and 
TC/HDL-C levels (P≥0.05); however, contrary to our hypothesis, groups had a tendency to revert 
to the baseline measures for certain cardio-metabolic and endocrine measures including fasting 
insulin and TC levels 6 and 12 months after the completion of the intervention (P≤0.05). 
Following the 16-week intervention, the HRQoL scores of both groups increased in the 
domains of knowledge, concerns about PCOS, healthcare satisfaction, and lifestyle practices 
comprised of physical activity and healthy diets (P<0.05; Chapter 6). The dietary component of 
Objective 2 is addressed in Chapter 7. Both intervention groups voluntarily reduced their average 
daily energy intake from baseline (P<0.001). Dietary intakes increased for fiber, folate, 
magnesium, iron, and decreased for cholesterol in the pulse-based diet group compared to the 
TLC diet group (P<0.05). Women in the pulse-based diet group exhibited higher scores in the 
domain of knowledge about the nutritional composition of pulses, recommended servings of 
legumes based on Canada’s Food Guide, environmental, and economic benefits of pulse 
consumption when compared with the TLC diet group (P<0.05). Both groups exhibited increased 
scores in the domain of attitudes about the palatability, accessibility, preparation, and 





Supported by the favourable health outcomes from the present intervention, an evidence-
based pulse-based recipe resource guide has been developed for use by allied healthcare 
professionals and their clients (Appendix C). 
In conclusion, both dietary interventions, without calorie restriction, in combination with 
aerobic exercise, education, and healthcare counselling yielded substantial improvements in 
multiple PCOS-specific health outcomes. The pulse-based diet was more effective than the TLC 
diet in decreasing insulin response to OGTT, improving many key risk factors for cardio-
metabolic disease, and the overall dietary intakes in women with PCOS. In general, women did 
not maintain the reproductive and metabolic improvements. Further research is required to 
promote the consumption of nutrient-rich pulse foods and sustainable adherence to healthy 
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1.1. Background Information and Rationale 
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy and a leading 
cause of anovulatory infertility, affecting up to one in five women of reproductive age 
worldwide in all ethnic groups (Carmina & Lobo, 1999; Knochenhauer, 1998; March et al., 
2010; Teede et al., 2010). The PCOS is a complex multifactorial disorder, influenced by genetic 
and environmental factors contributing to its development. 
The PCOS is classically characterized by hyperandrogenism, menstrual irregularity and 
polycystic appearing ovaries. The condition is associated with several reproductive features 
(i.e., hirsutism, acne, alopecia, ovulatory and menstrual dysfunction, infertility, pregnancy 
complications, miscarriage, endometrial hyperplasia, and endometrial adenoma) and 
substantial psychological distress (i.e., anxiety, depression, poor self-esteem, reduced quality 
of life, negative body image, psychosexual dysfunction, and eating disorders) (Azziz et al., 
2006; "The revised Rotterdam ESHRE/ASRM criteria ", 2004). 
Aside from the reproductive and psychologic burden, PCOS is associated with profound 
metabolic complications (Carmina & Lobo, 1999; A Dunaif, 1997). A majority (50-70%) of 
women with PCOS demonstrate significant peripheral insulin resistance (IR) and compensatory 
hyperinsulinemia, with higher rates compared to women without PCOS, matched by age, 
ethnicity and body mass index (BMI) (Diamanti-Kandarakis et al., 2008; Diamanti-Kandarakis 
& Papavassiliou, 2006). Women with PCOS exhibit other metabolic disturbances, including 
more dyslipidemia and impaired glucose metabolism compared with women without PCOS. A 
chronic inflammatory state and hypertension have been observed in PCOS, which can be 
attributed to high rates of obesity (Palomba et al., 2015). Thirty to 50% of women with PCOS 
are obese and overweight (A Dunaif, 1997; Gambineri et al., 2002; Norman et al., 2002). 
Obesity negatively affects metabolic abnormalities and complicates the management of the 
PCOS (Lau, 2007). Therapeutic modalities for PCOS have been shown to be less effective in 
women who are obese (Palomba et al., 2008). Impaired glucose metabolism, dyslipidemia, 
hypertension and abdominal obesity are key components of metabolic syndrome (MetS), a 




(DM2). The presence of MetS exacerbates the clinical and endocrine manifestations of PCOS 
(Apridonidze et al., 2005; Carmina et al., 2006; Glueck et al., 2003). The MetS is a major 
contributor to CVD and DM2 (Brien & Katzmarzyk, 2006; Cameron et al., 2008). With MetS, 
the risk of CVD doubles (Grundy, 2008). Women with PCOS have a 5-fold increased risk for 
DM2 (Alberti et al., 2006). Compared to other clinical presentations associated with PCOS, 
metabolic aberrations appear to be relatively more important contributors to increased morbidity 
and mortality rates in long term (Carmina & Lobo, 1999; Diamanti- Kandarakis & Dunaif, 
2012; Wild, 2012; Wild et al., 2010). 
Management of PCOS should focus on support and education, addressing psychological 
factors and strongly emphasizing healthy lifestyle with targeted medical therapy, as required 
(Teede et al., 2010). Lifestyle modification (comprising dietary, exercise and behavioural 
therapy), represents the first-line approach and the most effective strategy to manage PCOS. 
Lifestyle modification can positively impact the spectrum of morbidity associated with this 
disorder and reduce the risk of developing CVD and DM2 (Bruner et al., 2006; Marsh et al., 
2010; Sweatt et al., 2015). 
Adherence to lifestyle change is challenging and difficult for women with PCOS to 
maintain. While there is a general agreement on prioritizing body weight control, maintaining 
regular physical activity and acquiring cognitive behavioural skills for the management of 
syndrome, there is much debate about the optimal balance of dietary composition and exercise 
dose, type, intensity and frequency that would be uniformly beneficial for women with PCOS. 
There is limited evidence for the long-term effects of combined lifestyle interventions on 
PCOS health outcomes. Long-term therapeutic strategies are crucial to prevent or delay the 
occurrence of comorbidities and improve the overall prognosis associated with PCOS (Marsh 
& Brand-Miller, 2005).  
Dietary pulses have received insufficient attention in the dietary management of PCOS. 
A pulse-rich diet has the potential to improve reproductive and metabolic aberrations 
associated with PCOS. Pulses, that is, split-peas, beans, lentils, and chickpeas, are high in 
fiber, contain complex carbohydrates with a low glycemic index (GI), are low in fat, contain 
high-quality protein, have low sodium content, and are a significant source of vitamins and 
minerals, such as iron, zinc, folate, calcium, and potassium (Mudryj et al., 2014). Chronic 




blood glucose and insulin concentrations, hypercholesterolemia, and obesity (Ha et al., 2014; 
McCrory et al., 2010; Sievenpiper et al., 2009). 
 
1.2. Significance of the Study 
Previous research has been limited in terms of reporting the degree of metabolic 
derangements in women with PCOS and the effects of MetS on PCOS prognosis. Previous 
studies suffered from several methodological limitations, including small sample size, marked 
heterogeneity in techniques employed, and the fact that older or less accurate criteria were 
used to diagnose PCOS, PCOM, and MetS. Unlike previous investigations, in the present 
study, we used a rigorous and comprehensive approach to diagnose PCOS and MetS to 
determine the prevalence of MetS in reproductive-age women with PCOS and the effect of 
MetS on many clinical and biochemical outcomes associated with PCOS. 
Potential benefits of pulse consumption in women with PCOS has not been evaluated 
in available literature. The proposed study will examine a pulse-based diet as a nutrition 
intervention for a population of women exhibiting PCOS. The rationale for this intervention is 
supported by the association of improved glycemic control following consumption of pulse-
rich diets by non-PCOS populations who similarly exhibit adverse cardio-metabolic DM2 risk 
profiles (Sievenpiper et al., 2009). It is proposed that a pulse-based diet can improve the 
metabolic and reproductive features of the syndrome, and the lifestyle intervention can 
enhance the overall quality of life and maintain lifestyle changes in women with PCOS. As 
complementary components of a comprehensive multidimensional lifestyle intervention 
program, the proposed intervention will profit from the additional benefits of exercise, 
education and healthcare counselling about PCOS and lifestyle modification. To isolate the 
effect of diet and healthcare counselling, exercise was prescribed as a portion of ethical Good 
Clinical Practice Guidelines. Extended follow-up times will be used in the study, in order to 
better explore the long-term effects of the nutritional intervention in women with PCOS. This 
research can provide insight on how a pulse-based diet may affect short-term and long-term 
outcomes for women with PCOS. 
 
1.3. Main Research Hypotheses 




Program (NCEP) Therapeutic Lifestyle Changes (TLC) diet to reduce cardio-metabolic risk 
profile, improve reproductive outcomes, the overall quality of life, dietary intakes, and 
pulse consumption behaviours in women with PCOS. 
 
1.3.1. Primary Hypothesis 
A 16-week pulse-based diet is more effective compared to the TLC diet to 
improve reproductive outcomes and reduce cardio-metabolic risk in women with 
PCOS, when the diet is combined with aerobic exercise and healthcare counselling. 
 
1.3.2. Secondary Hypotheses 
i. The prevalence of MetS is high in reproductive-age women with PCOS 
and MetS would exacerbate clinical and biochemical outcomes 
associated with PCOS. 
ii. A 16-week pulse-based diet is more effective compared to the TLC diet 
to improve the quality of life of women with PCOS when combined with 
aerobic exercise and healthcare counselling. 
iii. A 16-week pulse-based diet is more effective compared to the TLC diet 
to improve dietary intakes and pulse consumption behaviours in women 
with PCOS when combined with aerobic exercise and healthcare 
counselling. 
iv. A 16-week pulse-based diet is more effective compared to the TLC diet 
after 6 and 12 months post-intervention to maintain improvements in 
cardio-metabolic and reproductive outcome measures. 
 
1.4. Research Objectives 
i. To characterize the prevalence rate and individual components of MetS, impaired glucose 
control, DM2, and risk factors for CVD in women with PCOS. 
ii. To determine whether the pulse-based diet is more effective compared to the TLC diet on the 
multiple reproductive health measures of PCOS, cardio-metabolic risk profile, dietary 
intakes, and quality of life after a 16-weeks intervention when the diets are combined with 





The outcome variables are as follows: 
 
 Measures of reproductive health related to PCOS, which include a) PCOM 
(i.e., antral follicle count [AFC], and ovarian volume [OV]); b) intervals 
between menstrual bleeds; and c) endocrine measures (i.e., ratio of 
luteinizing hormone [LH] to follicle stimulating hormone [FSH] and free 
androgen index [ratio of total testosterone {TT} to sex-hormone binding 
globulin {SHBG}]). 
 Anthropometric measures, which include weight, BMI and waist 
circumference (WC). 
 Measures of body composition, which include total body mass, fat mass, 
trunk fat mass, and muscle mass. 
 Physiological measures, which include blood pressure (BP) and pulse rate. 
 Measures of glucose control, which include fasting plasma glucose (FPG), 
2-hour standard oral glucose tolerance test (OGTT), glycated hemoglobin 
(HbA1c), and insulin. 
 Measures of blood lipids, which include total cholesterol (TC), low-
density lipoprotein cholesterol (LDL-C), HDL-C, and TG. 
 A measure of inflammation, which includes highly-sensitive C-reactive 
protein (hsCRP). 
 Measures related to the quality of life, using a researcher-devised PCOS-
specific health-related quality of life (HRQoL) survey (Appendix A).  
 Dietary intake factors, using serial 24-hour dietary recalls and pulse 
consumption behavious using a researcher-devised Pulse Consumption 
Survey (Appendix B). 
iii. To monitor women with PCOS 6 and 12 months after the completion of the intervention to 
determine long-term effects of the intervention on cardio-metabolic and endocrine outcome 
measures, as described in objective іі. 






1.5. Thesis Outline 
In the next chapter, recent advances in understanding the PCOS paradigm and the 
syndrome-associated comorbidities were examined. Dietary and exercise interventions, which 
have been shown to possess important clinical implications on PCOS outcomes, were the focus 
of the review.  
Findings of the research project have been presented in Chapters 3 to 7. Research 
Objective і has been addressed in Chapter 3. Various components of research Objective іі have 
been addressed in Chapter 4: the reproductive health outcomes; Chapter 5: cardio-metabolic risk, 
Chapter 6: the HRQoL indices, and Chapter 7: changes in dietary intakes and pulse consumption 
behaviours in women with PCOS following the 16-week lifestyle change intervention. Our 
observations about research Objective ііі have been presented in relevant sections of Chapters 4 
and 5. The last chapter, Chapter 8, discusses the findings of the research project while linking the 
findings to each other and to findings from previous studies. In Chapter 8, research gaps, 
limitations and future directions have been addressed. Overall conclusions have been established 
at the end of Chapter 8.  
To address objective іv, a pulsed-based food recipe booklet has been developed. The 
booklet has been developed to promote pulse consumption and provide researchers and the general 
population with insight about preparation and consumption of pulse-based meals. The pulse-









 LITERATURE REVIEW 
 
2.1. Overview of Polycystic Ovary Syndrome 
 
2.1.1. Definition and Epidemiology 
“The PCOS is a syndrome of ovarian dysfunction along with the cardinal features of 
hyperandrogenism and polycystic ovary morphology in the absence of other explanatory 
endocrinopathies” (Fauser et al., 2012). Considered the most common endocrinopathy and the 
primary cause of anovulatory infertility amongst reproductive-age women worldwide, the 
prevalence of PCOS is up to 18% (Carmina & Lobo, 1999; Knochenhauer, 1998; March et al., 
2010). The PCOS affects approximately 105 million women worldwide (Azziz et al., 2005), 
including an estimated 1.4 million women in Canada (Lujan et al., 2008). Determination of the 
exact prevalence of PCOS is challenging, owing to heterogeneity in employing the current 
diagnostic criteria, regional, lifestyle, and ethnic variations of women, as well as variability in 
clinical symptoms, laboratory values, and imaging studies across populations (Wild et al., 2005). 
A drastic increase in the prevalence of PCOS in recent years has accrued because of revisions in 
the PCOS diagnostic criteria, improved sonographic imaging and increased interest by 
researchers and clinicians. The global obesity epidemic, concomitant with a sedentary lifestyle 
has also contributed to an increased likelihood of recognizing PCOS. The PCOS represents an 
exasperating experience for affected women and has been a complicated scientific challenge for 
clinicians and researchers (Teede et al., 2010). 
2.1.2. Etiology 
The etiology of PCOS is multifactorial and still unclear. Compelling evidence exists to 
attribute genetic inheritance as a significant contributor to the origins of the syndrome (S. Franks 
et al., 2008; Legro et al., 1998). PCOS appears to be inherited as a common polygenic trait, with 
multiple susceptibility loci (Brower et al., 2015; Zhao et al., 2015); however, the available 
literature is not conclusive. More genome-wide association studies are required to identify the 
list of susceptibility genes contributing to PCOS risk, and potentially explain developmental 




While PCOS was initially considered a reproductive condition arising from a genetic 
predisposition, emerging evidence has highlighted the role of environmental determinants, 
including lifestyle factors (i.e., diet and physical activity), environmental toxins and 
socioeconomic status as contributing components to the development of the syndrome (E 
Diamanti-Kandarakis & A Dunaif, 2012; Dunaif & Fauser, 2013; Legro et al., 2013; Lim et al., 
2013; Moran et al., 2011; Palomba et al., 2015). Obesity and poor dietary practices adversely 
affect symptoms and signs that lead to a diagnosis of PCOS, in part, by aggravating the 
syndrome associated metabolic abnormalities, including chronic low-grade inflammation, 
glucose intolerance, and IR. Obesity induces abnormal ovarian steroidogenesis, steatohepatitis, 
and neuroendocrine abnormalities, all of which can negatively influence women with PCOS  
(Dewailly et al., 2006; Kuchenbecker et al., 2011; Motta, 2012; Welt, 2006; Yildiz et al., 2008). 
Obesity increases the risk of developing DM2, CVD, dyslipidemia, and infertility in women with 
PCOS (Benson, 2008; Carmina, 2006; Diamanti-Kandarakis et al., 2006; Kiddy et al., 1990). 
Environmental toxins are defined as “chemical pollutants in the environment, which 
negatively affect biological organisms” (Diamanti-Kandarakis et al., 2009). Examples of 
environmental pollutants include tobacco smoke, lead, pesticides, bisphenol A, and mercury. 
These pollutants have been hypothesized to act as endocrine-disrupting agents, with the potential 
to alter sex-steroids in women and sperm counts in men. Endocrine disruptors can alter sex 
hormone steroidogenesis to deteriorate human reproductive health in general, and enhance the 
development of PCOS symptoms in particular (Environmental impacts on reproductive health 
and fertility 2010, 2010; Kandaraki et al., 2010).  There is limited research about how toxins may 
contribute to the development of PCOS, or possibly trigger or exacerbate symptoms of the 
syndrome.  
There is limited research linking the relationship between socioeconomic status and 
PCOS. Low socioeconomic status and adverse health behaviours can influence an increase in the 
rate of obesity. An association between socioeconomic status and PCOS appears to be more 
pronounced among obese women; the relationship between socioeconomic status and obesity 
should be considered when examining the etiological origins and the threshold for the 
recognition of PCOS  (Lim et al., 2013; Wang & Beydoun, 2007). Low socioeconomic status can 
indirectly and adversely influence hormonal reactions and unmask PCOS in predisposed women. 




and utilization for the onset of and treatment of obesity (Escobar-Morreale et al., 2005; Norman 
et al., 2007; Wang & Beydoun, 2007). Limited studies indicate some association between the 
exposure to low socioeconomic status, and the early development of PCOS in adolescents, as 
well as PCOS-related metabolic dysfunction and IR (E Diamanti-Kandarakis & A Dunaif, 2012; 
Lawlor et al., 2002).  
Explaining the environmental factors related to PCOS allows us to understand the presentation, 
etiology and pathophysiology of the syndrome, and to improve the health status of the affected 
women. 
2.1.3 Pathophysiology 
A number of overlapping and interrelated processes underlie the pathophysiology of 
PCOS. IR and consequent hyperinsulinemia, androgen excess, and abnormal dynamics of FSH 
and LH secretion are key interdependent contributors to the pathophysiology of PCOS (Goodarzi 
et al., 2011). Due to the variability in degrees of insulin resistance, androgen excess and other 
complex, interrelated and interdependent contributors to the pathophysiology of PCOS, the 
clinical presentation of PCOS can be highly variable. These factors make it difficult to recognize 
and manage women with PCOS. 
Elevated levels of androgens (mainly testosterone and androstenedione) and insulin in 
serum are the most consistently elevated biochemical abnormalities in PCOS (Franks, 1991). 
Overproduction of androgens occurs because of an intrinsic abnormality of ovarian theca cell 
function which is highly sensitive to insulin and leads to the pathology of PCOS (Figure 1). The 
hypothalamic-pituitary-ovarian (HPO) axis responds to changes in androgens and estrogens and 
contribute to the pathogenesis of ovulatory dysfunction in PCOS. Gonadotropin secretion 
changes, to include an elevated level of LH when compared to FSH and an elevated LH to FSH 
ratio during the follicular phase, which is longstanding when women do not grow follicles or 
ovulate. Hyperandrogenemia and hyperinsulinemia are important underpinnings to the ovulatory 
dysfunction in PCOS, acting to perpetuate a dysregulation of the HPO axis and stimulate further 
hyperandrogenism. Local production of androgens, in turn, contributes to ovarian follicular 
arrest, anovulation, and the morphologic hallmark of the syndrome–polycystic ovaries on 
ultrasound. Hyperandrogenism, in combination with an increase in the frequency and amplitude 
of gonadotropin-releasing hormone (GnRH) pulses from the hypothalamus, leads to 




amplitude, in turn, contributes to the mechanisms of anovulation (Brown, 1978; Pardridge, 
1981). Additionally, PCOS is associated with lower follicular phase FSH levels when compared 
to the follicular phase levels of FSH in women with regular menstrual cycles (Chavez-Ross et 
al., 1997; Stephen Franks et al., 2008). The suboptimal level of FSH in women with PCOS 
contributes to impaired follicular development and anovulation (Baird et al., 1977; Rebar et al., 
1976). Together, impaired follicle growth and anovulation result in infrequent and unpredictable 
menstrual bleeding, a heightened risk of infertility and an increase in the incidence of abnormal 
bleeding. 
Insulin resistance and subsequent hyperinsulinemia are found in 50–70% of women with 
PCOS (Dunaif et al., 1989). Hyperinsulinemia stimulated ovarian-induced hyperandrogenemia 
via its own theca cells receptors interact with gonadotrophins to modulate steroidogenesis. In 
women with PCOS, the metabolic pathway of insulin activity is defective both at the cell 
receptors and at the post-receptor level in peripheral target tissues (myocytes and adipocytes), as 
well as in the ovarian tissue (Diamanti-Kandarakis et al., 2008). On the other hand, insulin 
sensitivity is negatively affected by central adiposity, and in part, by hyperandrogenism, both of 
which may exacerbate the mechanisms of anovulation (E Diamanti-Kandarakis & A Dunaif, 
2012). Once established, both LH secretion and hyperinsulinemia exacerbate excess androgen 
production by ovarian theca cells (Franks, 2008; Franks et al., 2006). Hyperinsulinemia in 
women with PCOS suppresses the hepatic secretion of SHBG. Recognized as a modulator of 
circulating levels of free androgens, the hepatic SHBG is a glycoprotein recognized as the 
dominant carrier protein that binds circulating androgens, including testosterone, 
androstenedione, and dihydrotestosterone, with high affinity and minimizes the percentage of 
free androgen available to act at the target tissues. Sex-hormone binding globulin transports the 
sex-steroids within the bloodstream and to extravascular target tissues. Hepatic synthesis of 
SHBG is regulated by several metabolic and hormonal factors including insulin. The decline in 
SHBG levels, as seen in states of IR and hyperinsulinemia, is associated with an increase in 
circulating unbound sex-steroids. Down-regulation of SHBG levels, as seen in states of IR, is 
associated with an increase in the bioavailability of free androgen levels;  hence, androgen-





Vitamin D deficiency has been described in women with PCOS (He et al., 2015). A 
growing body of evidence indicates a relevance of vitamin D deficiency in the pathophysiology 
of PCOS, through its association with obesity, IR, hyperandrogenemia, dyslipidemia, ovulation 
dysfunction, and inflammation (Balen et al., 2005; A Dunaif, 1997; S Hahn et al., 2006; H. W. R. 
Li et al., 2011; Yasuda et al., 1975; Yildiz et al., 2008). Insulin secretion is a calcium-dependent 
process (Gedik & Zileli, 1977; Yasuda et al., 1975); IR and compensatory hyperinsulinemia are 
well described in the setting of PCOS. Vitamin D deficiency compromises the physiological 
mechanisms associated with insulin synthesis and release, downregulates insulin receptor 
expression, and upregulates the synthesis of proinflammatory cytokines that are recognized to 
play a role in the pathogenesis of IR (Chiu et al., 2004; Wang et al., 2008). Regulation of gene 
expression that is critical for glucose and lipid metabolism and is recognized to be downstream 
targets of vitamin D signalling, can be impaired by vitamin D deficiency (Chiu et al., 2004; 
Holick, 2007; Pittas et al., 2007). Vitamin D plays a vital role in oocyte activation, maturation, 
and eventually ovulation, through regulating calcium homeostasis (Kaufman & Homa, 1993; 
Steinhardt et al., 1974). Vitamin D deficiency has been hypothesized to increase free levels of 
androgens in the PCOS setting, with mechanisms associated with decreased SHBG, and 
increased parathyroid hormone (PTH) levels (Balen et al., 2005).  
Despite great strides, our knowledge of the pathophysiology of PCOS is still evolving. 
The existing literature is limited predominantly to observational designs and small study 
samples. Sufficiently powered, well-designed studies can help to clarify the physiological 
mechanisms underlying the development of PCOS; therapeutic strategies can be developed once 
“cause and effect” mechanisms are clarified and linked with the many associated signs and 





Starting from top left going in a clockwise direction: Genetic predisposition and environmental 
factors (i.e., diet and physical activity) stimulate ovarian theca cells steroidogenesis. An increase 
in GnRH secretion leads to abnormalities in the dynamics of FSH and LH, which can be 
aggravated by hyperandrogenism, mainly increased levels of total testosterone. Once established, 
hypersecretion of LH, sub-optimal secretion of FSH, and hyperinsulinemia further exacerbate 
ovarian theca cell androgen production. Central abnormalities in the pathogenesis of PCOS are 
IR, hyperinsulinemia and ovarian-induced hyperandrogenism, which may contribute to the 
mechanisms of anovulation. Vitamin D deficiency contributes to the pathogenesis of PCOS 
through mechanisms associated with IR, and SHBG and PTH secretion. IR and hyperinsulinemia 
suppress the hepatic synthesis of SHBG, resulting in increased mfree circulating bioactive 
testosterone and increased hyperandrogenemia, which can aggravate abnormal secretion of sex-
hormones in PCOS. (Abbott et al., 2002; E Diamanti-Kandarakis & A Dunaif, 2012; Franks et 
al., 2006; S. Franks et al., 2008; Nelson et al., 1999; Pardridge, 1981). Abbreviations: PCOS, 
Polycystic ovary syndrome; LH, luteinizing hormone; FSH, follicle stimulating hormone; GnRH, 
gonadotropin-resealing hormone; PTH, parathyroid hormone; SHBG, sex hormone-binding 
globulin.  





PCOS was first established by Stein and Leventhal in 1935 to describe women who 
presented with obesity, hirsutism, and chronic anovulation, with enlarged cystic ovaries post-
mortem (Stein & Leventhal, 1935). With the emergence of new evidence, the original 
characterization of the syndrome has been modified to include physical symptoms, biochemical 
profiles and ovarian ultrasonographic morphology. Subsequently, the PCOS diagnostic criteria 
have undergone multiple iterations in an attempt to refine and standardize the identification of 
this complex entity. Three iterations of the diagnostic criteria for PCOS have been established 
over time: the National Institutes of Health (NIH) criteria, the Rotterdam criteria, and the 
Androgen Excess and Polycystic Ovary Syndrome Society (AE-PCOS) criteria. 
The NIH guidelines were outlined in 1990 in the first international expert workshop on 
PCOS and were based upon a consensus of the expert opinion of the attendees, without 
substantial research-based evidence. The criteria set forth included chronic anovulation with 
clinical and biochemical signs of hyperandrogenism (i.e., hirsutism and hyperandrogenemia). 
PCOS was classified as a disorder of exclusion; the diagnosis of PCOS was based on the 
exclusion of other endocrinopathies that mimicked the characteristics of PCOS, including 
adrenal dysfunction, Cushing’s syndrome, congenital adrenal hyperplasia, androgen-secreting 
neoplasms, pituitary tumours, hyperprolactinemia, and thyroid dysfunction. The NIH criteria 
encompassed the strictest set of diagnostics to standardize research populations; however, 
because the clinical manifestations of PCOS appeared broader than that defined by the NIH 
criteria, newer criteria were adopted ("The revised Rotterdam ESHRE/ASRM criteria ", 2004; 
Zawadzki & Dunaif, 1992).  
At a joint workshop meeting in the Netherlands between the European Society of Human 
Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine 
(ASRM), the NIH criteria were amended in favour of the Rotterdam consensus in 2003. The 
PCOS diagnostic consensus revised the criteria to include oligo-or anovulation, clinical and/or 
biochemical signs of hyperandrogenism, and polycystic appearing ovaries on imaging. The 
Rotterdam diagnosis of PCOS was defined by the presence of at least two of the three criteria;  
other conditions mimicking PCOS must be excluded similar to the NIH criteria ("The ACOG 
practice bulletin on PCOS," 2009). The Rotterdam criteria have been the most inclusive criteria. 




associated with PCOS would not be overlooked ("The revised Rotterdam ESHRE/ASRM criteria 
", 2004). 
In 2006, the AE-PCOS Society proposed a further modification of PCOS diagnostic 
criteria to emphasize that PCOS was an androgenic condition; The criteria included 
hyperandrogenism and ovarian dysfunction (where dysfunction was defined as oligo-anovulation 
and/or polycystic appearing ovaries). The AE-PCOS society also acknowledged that exclusion of 
other androgen excess or related disorders had been an essential element of the PCOS diagnosis 
(Azziz et al., 2006). Although the PCOS diagnostic criteria have not “officially” changed since 
2006, in 2014, the AE-PCOS Society modified the diagnostic criteria for the polycystic ovary 
(PCO). The newest PCO criteria have refined the diagnosis of PCOS, by excluding women with 
a normal ovarian morphology, and has narrowed the population of women diagnosed with 
PCOS. The PCO criteria were defined as ≥ 25 antral follicles per ovary (Dewailly et al., 2014).  
There continues to be controversy about which elements constitute the optimal criteria for 
the diagnosis of PCOS, partly because the various sets of criteria place different degrees of 
emphasis on specific phenotypes. Clinicians need discreet categorical criteria for ease of 
diagnosis. Because many features of PCOS overlap with multiple other endocrine disorders and 
clinical conditions, the diagnosis of PCOS is a “diagnosis of exclusion”; systemic evaluation is 
aimed at excluding conditions that could masquerade as PCOS (Dunaif & Fauser, 2013; 
Michelmore et al., 1999).  
2.1.5. Clinical Manifestations and Associated Comorbidities 
Clinically, PCOS is characterized by its heterogeneous presentation, including 
reproductive (e.g., hyperandrogenism, polycystic ovaries, and ovarian dysfunction), metabolic 
(e.g., impaired glucose tolerance [IGT], IR, dyslipidemia), and psychological (e.g., depression 
and anxiety) features (Barry et al., 2011; Deeks et al., 2011; Ehrmann, 2005; Ehrmann, 2006; 
Ehrmann et al., 1999; Kjerulff et al., 2011; Moran et al., 2010; Toulis et al., 2011; Weiner et al., 
2004). Further, PCOS is associated with several medical comorbidities (i.e., type 2 diabetes and 
cardiovascular disease), that can negatively affect the quality of life and increase the risk of 
mortality in women with PCOS. ("The ACOG practice bulletin on PCOS," 2009; Azziz, 2004; 
Bethea & Nestler, 2008; Ehrmann, 2005; Elsenbruch et al., 2003; Hardiman et al., 2003a; Legro 




comorbidities that develop in women with PCOS, to improve the management and prognosis of 
women with the syndrome. 
2.1.5.1. Reproductive Features  
Reproductive presentations of PCOS are heterogeneous. Reproductive features of the 
syndrome include clinical and biochemical hyperandrogenism, polycystic appearing ovaries, and 
ovarian dysfunction. Associated clinical manifestations include abnormal uterine bleeding, 
amenorrhea, hirsutism, alopecia, and acne (Azziz et al., 2006; "The revised Rotterdam 
ESHRE/ASRM criteria ", 2004).  
2.1.5.2. Hyperandrogenism 
Hyperandrogenemia, defined as elevated blood levels of androgens (i.e., testosterone, 
androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone-sulfate), is observed in 
60-80% of women with PCOS (Teede et al., 2010). Clinical presentations of hyperandrogenism 
are phenotypically identified as hirsutism, acne, and alopecia (Azziz et al., 2004). 
Hirsutism is defined as “excessive terminal hair growth that follows a male pattern hair 
distribution” (Musrap & Diamandis, 2016). Development of hirsutism can be attributed to higher 
hair follicle sensitivity to androgenemia. Increased sensitivity to androgens leads to the 
overproduction of 5a-dihydrotestosterone in hair follicles, conversion of vellus hair to terminal 
hair, prolonged anagen phase of hair follicles sensitive to androgens and results in longer thicker 
terminal hairs (Archer & Chang, 2004). The most common, and recommended method used to 
score hirsutism is the Ferriman-Gallwey score. Twelve body areas (upper lip, chin, sideburns, 
neck, chest, upper back, lower back, upper and lower abdomen, upper arm, thigh, and perineum) 
are assigned a score from 0 to 4 depending on the position and density of hair growth. The 
clinical evaluation of hirsutism is subjective and prone to inter-observer variability. The requisite 
diagnostic threshold score for hirsutism has varied from 6 to 8 for Caucasian women (Ferriman 
& Gallwey, 1961). Is it important to note that the severity of hirsutism varies across ethnicities. 
There are racial variations in hair growth patterns with a lower prevalence of male pattern hair 
growth in women of East Asian descent, and a higher prevalence is seen in women of East Indian 
descent (Azziz et al., 2004). Assessment of hirsutism may be underestimated in women who 
have received therapies that suppress androgenemia when women receive contraceptive hormone 
therapies. Hirsutism may also be underestimated following electrolysis, depilatory therapies and 




Acne vulgaris is another cutaneous manifestation of hyperandrogenism that may be 
associated with PCOS (Panidis et al., 1995). Androgens form acne by increasing sebum 
production and follicular epithelial cell desquamation of sebaceous glands (Archer & Chang, 
2004). Acne vulgaris affects approximately 12-14% of Caucasian women with PCOS. It is 
difficult to ascertain a causal relationship for acne in PCOS because acne vulgaris is also widely 
prevalent in the healthy non-PCOS population. There is also a paucity of evidence for women 
with PCOS who present with acne vulgaris but do not exhibit hirsutism (Azziz et al., 2009). 
Alopecia is the loss of hair from the head or the body. Male pattern hair loss (androgenic 
alopecia) is another feature of hyperandrogenism and is a typical pattern of hair loss in women 
with PCOS. Androgenic alopecia involves thinning of hair at the crown with preservation of the 
anterior hairline (17). It is unclear whether the development of androgenic alopecia is correlated 
with hyperandrogenism or is independent of it. Androgenic alopecia typically has a genetic 
predisposition. (Azziz et al., 2009). As the relationship between PCOS and alopecia is unclear, 
studies are required to confirm the hypothesis that alopecia is a single dermatological sign of 
PCOS (O'Driscoll et al., 1994). While 75-80% of women with hirsutism have PCOS and 20-40% 
of women who exclusively present with acne vulgaris have PCOS, only 10% of women who 
present with alopecia will have a positive diagnosis of PCOS (Azziz et al., 2009).  
Hyperandrogenism remains the main feature of PCOS because up to 80% of women 
diagnosed with the syndrome exhibit clinical manifestations of hyperandrogenism (Diamanti-
Kandarakis et al., 2007). Ultrasonographic evidence of polycystic appearing ovaries is 
considered the third diagnostic criterion for PCOS (Lujan et al., 2013). 
2.1.5.3. Polycystic Ovaries 
The PCO is another reproductive marker for PCOS. The PCO can be determined by 
ultrasonographical examination of the ovaries. Non-PCO ovaries differ from the PCO by the 
distribution pattern and the number of ovarian follicles. The 2003 Rotterdam consensus defined 
the PCO by the appearance of a follicle count of ≥ 12 peripheral follicles measuring 2-9 mm in 
diameter in at least one ovary or an ovarian volume of at least 10 mL with follicles less than 10 
mm diameter("The revised Rotterdam ESHRE/ASRM criteria ", 2004). Most recently, a higher 
threshold for follicle number (antral follicle count [AFC] ≥ 25) has been recommended to define 
PCO. The higher threshold for follicle number obviates the growing misconception that 




have PCOS (Dewailly et al., 2014). Decreased follicle atresia appears to underlie the increased 
follicle numbers in PCO. Morphological studies have demonstrated an increased density of 
follicles in the ovarian cortex predominantly at the primordial (resting) and primary stages 
(growing). It has been suggested that there may be an increased initiation of growth of follicles 
from the resting pool regardless of ovulatory status in women with PCOS compared with the 
non-PCO population. This observation has been suggested to occur via: an excessive 
transformation of the primordial germ cells in the fetal ovary and more mitotic divisions of the 
oogonia in the fetal ovary; enhanced assembly of somatic cells around the naked oocytes during 
follicle formation around the twelfth week of gestation; or a decreased rate of loss (atresia) of 
germ cells and the surrounding somatic cells in the PCO compared to non-PCO. Women with 
PCOS who are not ovulating have exhibited abnormalities in the later stages of antral follicle 
growth, including an arrest of follicular growth, typically at a diameter of approximately 5-8 
mm. A trend toward a higher proportion of atretic follicles is seen in women with PCOS, 
compared with a non-PCOS group (Webber et al., 2003). Further, histologic features of atretic 
ovarian follicles have included a degenerated oocyte nucleus, uneven or folded nuclear 
membranes, vacuoles in the oocyte, and pyknotic nuclei in the granulosa cells (Hovatta et al., 
1997; Webber et al., 2003). Women with PCOS have a lower proportion of healthy primordial 
cells, a higher proportion of early primary follicles, and a reciprocal decrease in primordial 
follicles when compared with non-PCOS counterparts (Webber et al., 2003). 
2.1.5.4. Ovarian Dysfunction and Infertility 
Women who ovulate regularly typically have regular menstrual cycles between 26-35 
days (18). Ovarian dysfunction usually manifests as oligomenorrhoea/amenorrhoea resulting 
from chronic oligo-ovulation/anovulation, defined as  ≤ 8 menstrual cycles per year or intervals 
of  ≥ 35 days between menstrual cycles (Brassard et al., 2008). A study of menstrual cyclicity in 
873 women aged 15-46 years revealed that 18% of the women had menstrual dysfunction and 
approximately 27% of women with menstruation dysfunction had PCOS. It has been suggested 
that approximately 25-33% of women who present with menstrual dysfunction have PCOS  
(Azziz et al., 2004). Of note, tracking reproductive cycles using the observation of bleeding 
patterns, which typically reflects a progression of follicle growth to ovulation to corpus luteum 




ovulate have irregular, non-cyclic bleeding patterns. When estrogen-stimulated endometrial 
growth is not suppressed and controlled by progesterone, irregular bleeding occurs. 
Androgens synthesized in excessive amounts in ovarian stromal tissue are aromatized to 
estrogen in peripheral tissues (adipose, muscle, and liver). Peripheral estrogen synthesis in the 
absence of ovulation is available to stimulate endometrial growth and enable irregular bleeding. 
Thus, women with PCOS who do not ovulate have variable endometrial bleeding episodes (Baird 
et al., 1977; DeVane et al., 1975; MacDonald et al., 1967). 
In women, 7% of menstrual cycles of normal length are anovulatory (Harlow & 
Campbell, 2000). The length of each menstrual cycle is highly variable in ovulatory women 
without PCOS.  Because of newer diagnostic criteria for PCOS, women with regular menstrual 
cycles may be diagnosed with PCOS (Azziz et al., 2006). 
The most prevalent cause of anovulatory infertility is PCOS. Approximately 90-95% of 
women with anovulation attending infertility clinics had PCOS (Teede et al., 2010). At least 40% 
of women with PCOS are infertile, defined as the lack of ability to conceive within 12 months. 
Obesity is a strong risk factor that can exacerbate anovulation and cause infertility. Obesity is 
highly prevalent in women with PCOS, affecting over 90% of women with PCOS who have 
infertility (Brassard et al., 2008). Ideally, optimizing weight, and planning to conceive early in 
reproductive life are important factors not only in the treatment of infertility but also in the 
reduction of pregnancy complications and the risk of miscarriage in women with PCOS (Teede 
et al., 2010).  
2.1.5.5. Endometrial Pathologies 
Women with PCOS are predisposed to endometrial pathologies, including endometrial 
polyps, hyperplasia and endometrial adenocarcinoma (Azziz et al., 2006). Endometrial 
hyperplasia occurs in 35% of women with PCOS who do not have regular bleeding intervals. 
Endometrial adenocarcinoma represents 8% of all cancers occurring in women, and the highest 
risk populations are women who are obese, have hyperinsulinemia, DM2 and PCOS. 
Anovulation and abnormal uterine bleeding occur in women with PCOS, as ovarian androgens 
are aromatized to estradiol in peripheral tissues (i.e., adipose, muscle, and liver) (Hardiman et al., 
2003b). Estradiol mediates endometrial growth, which is “unopposed” in the absence of 
ovulation. Irregular bleeding is common following anovulation because continuous estrogen-




following ovulation. Hyperinsulinemia plays a role in the etiology of endometrial pathology. 
With PCOS, hyperinsulinemia promotes androgen synthesis in ovarian theca cells and increases 
vascular unbound androgens by downregulating hepatic SHBG synthesis. Hyperinsulinemia 
accelerates cell proliferation, promotes tumour angiogenesis and has been implicated in 
endometrial proliferation, hyperplasia and carcinoma (González et al., 2006; Ortega et al., 2014; 
Piotrowski et al., 2005). Chronic systemic inflammation may increase the risk of endometrial 
hyperplasia and metabolic changes in women with PCOS (Hardiman et al., 2003b). Exposure to 
progesterone, either as replacement therapy or via spontaneous ovulation, more than 4 times per 
year may decrease neoplastic changes in endometrial tissue. Menstrual cyclicity following 
ovulation is associated with a lower risk of neoplastic change in endometrial tissue (Azziz et al., 
2006). 
2.1.5.6. Psychological Features 
Most research has focused on the biological and physiological aspects of PCOS, and little 
attention has been focused on psychological features of the syndrome. Women with PCOS 
experience high rates of anxiety and depression. Physical challenges, such as acne vulgaris, 
alopecia, hirsutism, acanthosis nigricans (i.e., a striking cutaneous marker for tissue resistance to 
insulin (Goldenberg & Punthakee, 2013)), obesity, and alterations in voice, as well as long-term 
health-related comorbidities, such as diabetes, metabolic syndrome, heart disease, and infertility 
compromise quality of life and adversely impact mood and thr psychological well-being of 
affected women (Coffey et al., 2006; Deeks et al., 2010a; Dunaif et al., 1987). Women with 
PCOS are more prone to poor body image, psychosexual dysfunction, bipolar spectrum disorder, 
depression, anxiety, and eating disorders compared to counterparts without PCOS (Coffey & 
Mason, 2003; Deeks et al., 2010a).  
No causal relationship between psychological, sexual, body image issues and PCOS have 
been established. However, psychological issues have been shown to adversely affect the levels 
of adherence of women with PCOS to therapeutic modalities. Negative impacts of mood 
disturbance, poor self-esteem, and reduced psychological well-being have been documented 
alongside the levels of motivation of women with PCOS to adopt healthy lifestyle options. 
Further, psychological issues associated with PCOS have been reported to reduce the ability of 
women with PCOS to implement and sustain successful long-term lifestyle change   (Himelein & 




with PCOS be explored and addressed as part of routine PCOS assessment and management 
(Himelein & Thatcher, 2006). 
2.1.5.7. Metabolic Features and Associated Long-Term Comorbidities  
Polycystic ovary syndrome is associated with substantial metabolic derangements, 
including IR and compensatory hyperinsulinemia, glucose intolerance, and dyslipidemia. 
Women with PCOS are at increased risk for developing long-term comorbidities including DM2, 
and CVD, which can negatively impact the overall prognosis and increase all-cause mortality 
rates of women with PCOS (Moran et al., 2010; Teede et al., 2006).  
2.1.5.8. Insulin Resistance and Abnormal Glucose Metabolism 
Insulin stimulates glucose uptake in tissues such as skeletal myocytes, adipocytes, and 
cardiac myocytes, and suppresses hepatic gluconeogenesis, glycogenolysis, proteolysis, and 
lipolysis (DeFronzo, 1988; Saltiel & Kahn, 2001). Insulin resistance is defined by a decreased 
ability of a certain amount of insulin to efficiently mediate glucose uptake, glucose production, 
and lipolysis; IR is characterized by an increased amount of circulating insulin (Bergman et al., 
1985). A majority (50-70%) of women with PCOS demonstrate significant peripheral 
hyperinsulinemia and IR, with significantly higher prevalence rates compared to women without 
PCOS, matched by age, ethnicity, and BMI (A Dunaif, 1997; Gambineri et al., 2002).  
Mechanisms involved in the development of IR are complex, with genetic and 
environmental contributors. Specific abnormalities of insulin metabolism identified in PCOS 
include reduced pancreatic secretion, reduced hepatic extraction, impaired hepatic 
gluconeogenesis suppression, defects in peripheral insulin receptor signalling, and impaired 
insulin-mediated glucose transport pathways (A Dunaif, 1997; Dunaif & Finegood, 1996; Dunaif 
et al., 1989; O'Meara et al., 1993). Further, obesity can contribute to the development of PCOS, 
via endocrine pathways of IR that are mechanistically distinct from the IR present in lean women 
with PCOS (Corbould et al., 2005; Corbould et al., 2006; E Diamanti-Kandarakis & A Dunaif, 
2012; Andrea Dunaif, 1997; Skov et al., 2007). Thirty-five to 50% of women with PCOS have 
abdominal obesity and an increased waist circumference (WC) (Norman et al., 2002). Up to 95% 
of obese (BMI ≥ 30 kg/m2) women with PCOS  have some degree of IR (DeUgarte et al., 2005; 
Legro et al., 1999) compared with 20–25% of lean counterparts (BMI <  25 kg/m2) (Ovesen et 
al., 1993). In the state of obesity, adipose tissue releases excessive amounts of proinflammatory 




glycerol, leptin, resistin, and other factors (e.g., retinol-binding protein-4) that are involved in the 
development of IR. Further, in obesity, A reduction of adiponectin secretion by adipose tissue 
has been linked to the development of IR and atherosclerosis (Kern et al., 2003). The distribution 
of body fat is a critical determinant of insulin sensitivity. Individuals with a more peripheral 
accumulation of fat are generally more insulin sensitive when compared to individuals with 
central fat accumulation in abdominal and chest areas (Kahn et al., 2006). 
Insulin resistance and consequent hyperinsulinemia can aggravate PCOS symptoms and 
unmask PCOS in predisposed women, by inducing hyperandrogenemia, oligo-anovulation, and 
infertility (E Diamanti-Kandarakis & A Dunaif, 2012). Impaired insulin function can dysregulate 
lipid and protein metabolism and contribute to the development of the long-term comorbidities 
associated with PCOS, including atherosclerotic CVD, DM2, and MetS. Hyperinsulinemia and 
IR act in concert to cause dysfunction and apoptosis of insulin-releasing pancreatic islet β-cells; 
impaired glycemic control, glucose intolerance, and ultimately DM2 subsequently develop in 
women with PCOS. Women with PCOS are at an increased risk of developing IGT and DM2 
with prevalence rates of 31.3% and 7.5% respectively, compared to 14% for IGT and 0% for 
DM2 in age-matched and weight-matched women without PCOS (Legro et al., 1999). Abnormal 
glucose metabolism develops in women with PCOS at a younger age compared with non-PCOS 
counterparts. Further, women with PCOS and impaired glucose tolerance have a tendency 
toward an increased rate of developing DM2 when compared with non-PCOS counterparts 
(Ehrmann et al., 1999). Women with PCOS are at higher risk of developing gestational diabetes 
when compared with women without PCOS. The development of gestational diabetes is 
independent of obesity, but can be exacerbated by obesity (Boudreaux et al., 2006; Legro et al., 
1999). Acanthosis nigricans is an important cutaneous manifestation of IR, which is frequently 
observed in women with PCOS. The altered insulin signalling in PCOS accelerates the growth of 
keratinocytes and dermal fibroblasts and leads to the development of acanthosis nigricans 
(Panidis et al., 1995).  
Few adequately powered studies have examined the evolution of IGT, DM2, and CVD in 
PCOS. Nevertheless, the International Diabetes Federation has identified PCOS as a significant 
and modifiable risk factor associated with DM2 (Alberti et al., 2007). Given the high prevalence 
rates and the clinical significance of the metabolic complications associated with IR and IGT in 




recommended routine clinical screening for IGT and DM2 for all women with PCOS, using a 
standard 2-hour 75-g OGTT. The OGTT is a sensitive and relatively specific test, recommended 
as the gold standard screening tool for the diagnosis of IGT and DM2 in women with PCOS. The 
OGTT cannot be replaced by simpler alternatives, such as fasting plasma insulin levels, HbA1C, 
fasting plasma glucose (FPG) levels, homeostatic model assessment score, fasting glucose to 
insulin ratio, and quantitative insulin index test. For example, the FPG test fails to diagnose 
women with IGT in PCOS population, as a majority of women with IGT have normal FPG 
(Legro et al., 1999). The OGTT can provide information about peripheral insulin action and 
pancreatic β-cell function and can be performed in office laboratory settings. The reproducibility 
of the test can be enhanced by the standardizing of the carbohydrate content of the prior days’ 
meals and ensuring the blood samples will be collected within a 2-hour limit (Legro et al., 2004; 
Salley et al., 2007). 
2.1.5.9. Dyslipidemia 
Dyslipidemia is a frequent metabolic abnormality in women with PCOS. Dyslipidemia is 
characterised by elevations of TG, very low-density lipoprotein cholesterol (VLDL-C), and total 
cholesterol, as well as reduced HDL-C levels. Approximately 70% of women with PCOS exhibit 
abnormal serum lipid levels ("The NCEP ATP III final report," 2002). Depressed HDL-C and 
elevated TG are the most frequent lipid abnormalities observed in women with PCOS (Legro et 
al., 1999; Talbott et al., 1998; Wild et al., 1985). Dyslipidemia is one of the most perplexing 
metabolic complications associated with PCOS which can increase the risk of DM2 and CVD in 
the affected women, in a complex interplay with IR. 
Hyperinsulinemia can exacerbate the lipidemic aberrations of PCOS, in part, by 
stimulating lipogenesis and altering the expression of lipase enzymes which regulate lipid 
metabolism (E Diamanti-Kandarakis & A Dunaif, 2012; Victor et al., 2009; Wild et al., 1985). 
Hyperinsulinemia induces the hepatic overproduction of apo-B-containing VLDL-C and 
upregulates the expression of proteins involved in the VLDL-C production, thereby, significantly 
increasing VLDL-C levels (Au et al., 2003; Taghibiglou et al., 2000). Hyperinsulinemia has been 
reported to suppress the clearance of TG-rich proteins during the postprandial period, which may 
be another possible mechanism of dyslipidemia in PCOS (Harbis et al., 2001).  
Dyslipidemia in PCOS has frequently been reported independent of BMI (Wild & 




effects on the development of dyslipidemia in PCOS (Wild et al., 1985). Accumulation of intra-
abdominal visceral fat alters lipid metabolism and accelerates lipolysis, mainly because of the 
upregulation of hormone-sensitive lipases. Insulin resistance and consequent hyperinsulinemia 
are the primary pathological contributors to the development of dyslipidemia in PCOS.  
Hyperandrogenemia may contribute to the development of dyslipidemia (von 
Eckardstein, 1998; Whitsel et al., 2001). Hyperandrogenemia, specifically increased testosterone, 
induces androgen receptor-mediated IR, a mechanism for further potentiation of IR. Interactions 
between androgens and androgen receptors decrease the catabolic clearance and increase the 
circulating levels of LDL-C (Croston et al., 1997). Elevated levels of sex-steroids alter 
lipoprotein lipase activity through regulations that occur at the transcriptional and post-
transcriptional levels and lead to the development of dyslipidemia (Enerbäck & Gimble, 1993). 
Androgens have been shown to impair HDL-C metabolism and lead to depressed levels of HDL-
C, by altering enzymes involved in HDL-C remodeling, lipid transfer, and cell surface receptors. 
Additionally, hyperandrogenemia may induce the expression of genes involved in the catabolism 
of HDL-C (Arai et al., 1999; Kozarsky et al., 2000). To better understand the mechanistic 
interplay between metabolic and hormonal abnormalities in PCOS and dyslipidemia, more 
research is required. 
2.1.5.10. Cardiovascular Disease  
Women with PCOS are at high risk of developing CVD. In addition to the classical risk 
determinants for CVD such as obesity, dyslipidemia, MetS, IGT, DM2, and IR, (Wild et al., 
2010), women with PCOS are predisposed to novel CVD risk factors, including inflammation, 
oxidative stress, and impaired fibrinolysis and coagulation (Mannerås-Holm et al., 2011; Moran 
& Teede, 2009). Results of a systematic review and meta-analysis of studies evaluating 
circulating markers of oxidative stress in women with PCOS showed a: 23% increase in 
homocysteine concentration with a 0.6 standardized mean difference (SMD; a measure of effect 
size) (95% CI, 0.4-0.8); 47% increase in malondialdehyde levels, 1.9 SMD (95% CI 1.2-2.6); 
36% increase in asymmetric dimethylarginine levels, 1.1 SMD (95% CI 0.6-1.6); 34% increase 
in superoxide dismutase activity, 1.0 SMD (95% CI 0.5-1.4); 50% decrease in glutathione 
concentration, −3.7 SMD (95% CI −6.2 to −1.2); and 32% decrease in paraoxonase-1 activity 
−0.9 SMD (95% CI −1.3 to −0.4) when compared with control subjects without PCOS (Murri et 




and fibrinogen when compared with controls. Differences between groups remained significant 
after adjustments for age and BMI. An impaired prothrombotic state also contributes to the 
increased risk of CVD in women with PCOS (Mannerås-Holm et al., 2011). An elevated CRP 
level has frequently been observed in PCOS. Elevation of CRP has been an indicator of low-
grade chronic inflammation. Increased CRP level has also been a reliable and independent 
predictor of CVD (Duleba & Dokras, 2012). 
Women with PCOS are at high risk for IGT and DM2 (Moran et al., 2010), which can 
increase the risk of developing premature CVD. The risk of CVD mortality was estimated to be 
up to 60% among PCOS population with impaired glucose metabolism (Barr et al., 2007). 
Obesity is a common comorbidity present in PCOS (A Dunaif, 1997; Gambineri et al., 
2002). Obesity can induce chronic systemic inflammation. Obesity can exacerbate the 
development of early clinical indicators of atherosclerosis in PCOS, including endothelial 
dysfunction, pulse wave velocity, carotid intima-media wall thickness, presence of carotid 
plaques, and coronary artery calcification in women with PCOS (Legro et al., 1999; Legro et al., 
2001; C Meyer et al., 2005; C. Meyer et al., 2005).  
While evidence from retrospective studies is limited, it has been suggested that there is an 
increased risk of CVD with PCOS (Shaw et al., 2008). Evidence from well-conducted 
longitudinal studies to address CVD in the PCOS population from different age and race groups 
is not available. There is still a paucity of appropriate methods to evaluate or predict the risk of 
CVD in women with PCOS, particularly in reproductive-age women, and further research is 
required. 
2.1.5.11. Metabolic Syndrome 
The MetS is a complex clustering of five interrelated risk factors for CVD and DM2, 
including elevated FPG, BP and TG levels, central adiposity, and low HDL-C levels (Alberti et 
al., 2009). The prevalence of MetS is high in women with PCOS and varies depending upon the 
chosen diagnostic criteria, and regional, lifestyle, and ethnic variations (Apridonidze et al., 2005; 
Carmina et al., 2006; Glueck et al., 2003). Metabolic syndrome affects 47-53% of women with 
PCOS (Apridonidze et al., 2005; Ehrmann et al., 1999). The MetS is a significant contributor to 
CVD and DM2 (Brien & Katzmarzyk, 2006; Cameron et al., 2008). With MetS, the risk of CVD 




There are several definitions for MetS based on central features, including IR, visceral 
adiposity, atherogenic dyslipidemia, and endothelial dysfunction. The 1998 World Health 
Organization (WHO) criteria, the 1999 European Group for the Study of Insulin Resistance 
(EGIR) criteria, the 2005 (revised) NCEP Adult Treatment Panel (ATP) III criteria, and the 2005 
International Diabetes Federation and American Heart Association/National Heart, Lung, and 
Blood Institute (IDF and AHA/NHLBI) criteria are amongst the most widely recognized criteria 
for diagnosing MetS (Alberti et al., 2006; Alberti & Zimmet, 1998; Huang, 2009; "The NCEP 
ATP III final report," 2002; Takamiya et al., 2004). The revised NCEP ATP III, the IDF and the 
AHA/NHLBI criteria are the most widely used to characterize MetS in PCOS research 
(Apridonidze et al., 2005; Carmina et al., 2006; Glueck et al., 2003; Teede et al., 2006). 
According to the modified NCEP ATP III criteria, MetS is diagnosed in women with PCOS if  ≥ 
3 of the following is satisfied: FPG ≥ 100 mg/dl (≥ 5.6 mmol/L) or a positive diagnosis of DM2, 
WC ≥ 88 cm, BP ≥ 130/85 mmHg or the use of medication for the control of hypertension, TG ≥ 
150 mg/dl (≥ 1.7 mmol/L) or the use of medication for elevated TG levels, and reduced HDL-C 
≤ 50 mg/dl (≤ 1.3 mmol/L) or the use of medication for reduced HDL-C levels. The IDF 2005 
criteria use similar cut-points for FPG, TG, HDL-C, and BP. However, the IDF and 
AHA/NHLBI recommend using race-specific WC cut-points to determine abdominal obesity. 
The present recommendation accounts for the fact that different populations, ethnicities, and 
nationalities have different distributions of normative values for body weight and WC. The 2005 
IDF criteria reflect that there is a relationship between the proposed WC cut-points and the risk 
for DM2 or CVD which varies in different populations (Alberti et al., 2006). For example, South 
Asian populations have an increased risk for DM2 and CVD at a WC that is smaller than the 
criteria for MetS in Western populations. The variability in MetS criteria may explain the 
observed disparities in the prevalence rates of MetS among different populations. Table 1 shows 
the 2005 IDF and AHA/NHLBI thresholds for abdominal obesity in females, which are currently 






Table 1. Recommended population and country-specific waist circumference thresholds for 
abdominal obesity (K. G. M. M. Alberti et al., 2006) 
Population Waist circumference thresholds 
Canada, United States, and Europe ≥88 cm 
Middle East, Mediterranean, Sub-Saharan African, 
and West Asian 
≥80 cm 
Asian, Latin American, Ethnic Central and South 
American 
≥80 cm 
Chinese ≥80 cm 
 
The pathophysiology of MetS is complex and is not fully understood. However, the 
pathophysiology of MetS appears to run in parallel to the pathophysiology of PCOS in many 
ways. Two features appear to stand out as potential shared contributing factors: IR and abnormal 
fat distribution, predominantly central obesity. Other factors have also been implicated in the 
development of MetS, including genetic profile, physical inactivity, ageing, a chronic 
proinflammatory state, and hormonal aberrations. The role and influence of the proposed factors 
may vary depending on ethnic variations (Anderson et al., 2001; Saad et al., 1991).  
Many (42-74%) women with PCOS are obese or overweight, and lead a sedentary 
lifestyle, both of which contribute to the development of MetS (Corbould et al., 2005; Corbould 
et al., 2006; E Diamanti-Kandarakis & A Dunaif, 2012; Andrea Dunaif, 1997; Skov et al., 2007). 
Accumulation of excess adipose tissue that culminates in obesity, especially visceral fat 
interferes with normal adipose tissue function as a metabolically active endocrine and 
immunological organ and impairs adipose tissue metabolism (Legro et al., 1999). Obesity can 
impair immunity, induce inflammation, and lead to metabolic derangements and endocrine 
imbalance. Obesity is a proinflammatory state that induces oxidative stress (Vendrell et al., 2004; 
Vincent & Taylor, 2005). Obesity-induced inflammation and oxidative stress are pronounced 
more in the setting of MetS, rather than in PCOS per se, and may stand out as a distinguishing 
factor in the pathophysiology of MetS (Boulman et al., 2004; Tarkun et al., 2004). Inflammation 
can trigger a cascade of molecular events that lead to metabolic aberrations in PCOS. Also, 
inflammation can directly induce excess ovarian hyperandrogenism in PCOS (Ortega et al., 
2014; Piotrowski et al., 2005). Diet-induced inflammation and oxidative stress have been 
proposed to aggravate proinflammatory signalling in PCOS, independent of obesity. Dietary 




hyperandrogenism, atherogenesis, and ovarian dysfunction in PCOS (Abdelhadi et al., 2013; 
González, 2015; González et al., 2013; González et al., 2012).  
The PCOS and MetS share overlapping pathophysiological mechanisms. Aside from the 
pathophysiological pathways, many of the anthropometric and metabolic features of PCOS 
overlap with the characteristics of MetS, including increased WC, hypertriglyceridemia, low 
levels of HDL-C, hypertension, and elevated FPG levels. Many women with PCOS have MetS, 
and almost all women with PCOS present with least one adverse CVD risk factor, suggesting an 
increased risk of developing CVD and DM2 with PCOS. In a retrospective chart review of 
women with PCOS, Apridonidze et al. reported a 43% prevalence rate of MetS in women with 
PCOS, using the revised NCEP ATP III criteria, compared with 24% in age-adjusted controls 
obtained from the Third National Health and Nutrition Examination Survey (Apridonidze et al., 
2005). The differences remained significant after adjustments for age and BMI differences 
between groups. The researchers concluded that the prevalence rate of MetS and its risk factors, 
particularly abdominal obesity and reduced HDL-C levels, were high in women with PCOS and 
may increase the risk of premature CVD and DM2. Increased age and obesity can aggravate the 
development of CVD and DM2 in post-menopausal age in women with PCOS, mainly due to a 
progressive shift toward androgen dominance in the hormonal profile and estrogen deficiency 
(Burger et al., 2000; Carr, 2003; Lasley et al., 2002).  
Given the high prevalence and staggering morbidity burden of the above metabolic 
abnormalities, it is no longer feasible to consider PCOS a purely gynaecological disorder. 
Instead, PCOS is a systemic metabolic endocrinopathy. Early recognition of PCOS metabolic 
sequelae, including IR, IGT, DM2, dyslipidemia, and CVD seems to be crucial in the 
management of women with PCOS. Identification of metabolic abnormalities associated with 
PCOS may assist healthcare professionals and the affected women to adopt available therapeutic 
modalities for the management of PCOS and prevent or improve the risk of CVD and DM2 in 
the long-term. 
2.1.6. Management 
2.1.6.1. Pharmaceutical, Surgical, and Cosmetic Management 
The complex pathophysiological mechanisms that underlie PCOS and extensive clinical 
manifestations of the syndrome require multidisciplinary medical management. Aside from 




cosmetic therapeutic approaches, tailored to the individual needs of each patient. In the present 
section, current medical, surgical, and cosmetic approaches for the management of PCOS were 
examined.  
In general, most PCOS pharmacological therapeutic modalities have targeted excess 
ovarian androgen production, androgen action at the receptor level, insulin sensitization and 
menstrual control (Badawy & Elnashar, 2011; Ganie et al., 2015). Combined hormonal 
contraceptives (CHC), containing ethinyl estradiol and progestin, indirectly inhibit intra-ovarian 
androgen production by suppressing GnRH release. The CHC is a conventional method for the 
management of menstrual abnormalities, hirsutism, and acne in women with PCOS (Legro et al., 
2013). The CHC increase circulating levels of SHBG. As indicated previously, SHBG plays a 
vital role in regulating bioavailable sex-steroid concentrations and decreases free sex steroids 
levels in women with PCOS. Decreased level of SHBG has been associated with androgenization 
in women with PCOS. The CHC might also inhibit binding of dihydrotestosterone to the 
androgen receptors (Eli & Edelson, 1984; Givens et al., 1974; Wild et al., 1982).  
Antiandrogens (e.g., cyproterone acetate, flutamide, and spironolactone), and 5-α 
reductase inhibitors (e.g., finasteride) act as competitive antagonists, by competing for binding 
sites at the receptor level on the normally androgen-sensitive tissues in the body. Thus, 
antiandrogens inhibit androgen activity. Antiandrogens have been combined with ethinyl 
estradiol to manage hirsutism and menstrual irregularity (Azziz et al., 2009). 
IR is a significant abnormality in PCOS, leading to metabolic and reproductive 
complications for women with PCOS. Efforts have been made to use medications that improve 
insulin sensitivity and modulate IR (E Diamanti-Kandarakis & A Dunaif, 2012). There are two 
main groups of insulin-sensitising agents: biguanides, with metformin as the principal agent, and 
thiazolidinediones (TZDs; also known as glitazones) (Baillargeon et al., 2003; Legro et al., 
2013). Metformin is the most widely used insulin reducing agent, which improves metabolic and 
glycemic abnormalities and decreases menstrual irregularities in women with PCOS. Metformin 
exerts its beneficial effects through decreasing intestinal glucose uptake, reducing IR by 
inhibition of hepatic gluconeogenesis, and improving peripheral insulin sensitivity (Diamanti-
Kandarakis et al., 2010; Palomba et al., 2009). TZD improve insulin signalling, enhance insulin-
mediated glucose uptake and utilization in adipose tissue and muscle, and confer multiple effects 




peripheral glucose uptake, metformin was found to be more efficient in decreasing hepatic 
glucose production (Dunaif, 2008). However, the use of TZDs have been discouraged in women 
with PCOS, because of the safety concerns associated with it, such as increased risk of CVD, 
hepatotoxicity, bladder cancer, and drug-induced weight gain (Baillargeon et al., 2003; Dunaif, 
2008; Lago et al., 2007; Lewis et al., 2011).  
Many medications are available to induce ovulation for anovulatory women who desire 
pregnancy. Clomiphene citrate is an estrogen receptor antagonist; the negative feedback exerted 
by estradiol on gonadotropin secretion is inhibited by clomiphene. Thus, FSH secretion 
increases, which in turn, increases follicle growth and improves the chance of ovulation. The 
medication was recommended as the first-line drug therapy for infertility treatment for women 
with PCOS ("The ESHRE/ASRM PCOS Consensus on infertility," 2008). Recent off-label use 
of aromatase inhibitors, such as letrozole, has been recommended to increase FSH secretion, 
follicle growth and ovulation. Letrozole suppresses the activity of aromatase enzyme and 
prevents the aromatase from converting androgens to estrogens by competitive, reversible 
binding to the heme of its cytochrome P450 unit (Franik et al., 2015; Palomba, 2015). Roque et 
al. performed a meta-analysis on seven RCTs (n=1833) comparing the effects of letrozole with 
clomiphene citrate on ovulation induction in women with PCOS. The letrozole treatment 
appeared to be superior to the clomiphene citrate treatment in increasing live birth and pregnancy 
rates in women with PCOS (relative risk = 1.55, 95% CI: 1.26–1.90, and 1.38, 1.05–1.83, 
respectively). Groups were not different in their rates of multiple pregnancy, miscarriage and 
ovulation (Roque et al., 2015). 
Orlistat (tetrahydrolipstatin), a semisynthetic derivative of lipstatin, inhibits the 
absorption of fat from the gut by binding irreversibly to gastric and pancreatic lipases. Orlistat is 
considered a safe alternative in the management of obesity for women with PCOS. Orlistat is 
used alone, or in combination with appetite regulator agents, such as sibutramine.  
Bariatric surgical procedures are effective at reducing weight in overweight or obese 
women with PCOS and are used as adjuvant therapies within a weight management program 
(Panidis et al., 2014; Rubio et al., 2007). Many women are able to discontinue medications for 
the control of DM2 and HTN following bariatric surgical weight loss (Ikramuddin et al., 2013; 
Sjöström et al., 1999).  Significant weight regains, and micronutrient (iron, vitamin B12, folate, 




bariatric surgery. Therefore regular monitoring, follow up visits, and interventions are 
recommended to maintain weight loss (Rashti et al., 2015; Shah et al., 2006). 
Numerous therapies for hirsutism exist, but most therapies are temporary. Cosmetic 
treatments for hirsutism include temporary hair removal methods such as waxing, shaving, 
threading, and bleaching. Eflornithine and spironolactone are antiandrogens that are used as 
pharmacological agents to slow male-pattern hair growth for the treatment of hirsutism. Long-
term hair removal procedures include laser therapy and electrolysis. Each therapy is effective for 
variable duration and serves to reduce the discomfort, improve hair removal, increase the self-
image of PCOS women with hirsutism (Balfour & McClellan, 2001; Legro et al., 2013; Trueb, 
2002). Hair regrowth recurs most quickly when other therapies aimed at decreasing androgen 
production are not used on a long-term basis (O'Driscoll et al., 1994).  
Surgical procedures have been developed to induce ovulation and achieve pregnancy in 
infertile women with PCOS. Two primary surgical methods have been used for those who desire 
pregnancy: ovarian wedge resection and ovarian drilling (ovarian diathermy) completed at 
laparotomy or laparoscopy) (Adashi et al., 1981; Buttram & Vaquero, 1975). Ovarian wedge 
resection at laparotomy, performed by taking multiple biopsies or a single larger ovarian biopsy, 
became obsolete after the introduction of the minimally invasive surgical techniques, because of 
the frequent rates of complications such as, premature ovarian failure and periovarian adhesions 
(Adashi et al., 1981; Buttram & Vaquero, 1975). Ovarian drilling involves destroying multiple 
small areas of ovarian tissue by creating a variable number of holes (drilling) in the ovarian 
capsule and subcapsular stroma in anovulatory women with PCOS. The drilling procedure is also 
associated with periovarian adhesion and may provide only temporary induction of ovulation. 
The destruction of the ovarian stroma is believed to decrease androgen synthesis and therefore 
decrease peripheral conversion of androgen to estrogen, thereby allowing a decline in estrogen 
and spontaneous GnRH release. Surgical procedures are considered as the second-line alternative 
after the failure of or lack of supply of conventional medical treatment, such as treatment with 
clomiphene citrate and gonadotropins (Vause et al., 2010). In vitro fertilization and 
intracytoplasmic sperm injection cycles have been proposed as the third line therapy for infertile 
women suffering from PCOS ("The ESHRE/ASRM PCOS Consensus on infertility," 2008). In 
vitro fertilization has been adopted when women with PCOS are at greater risk of multiple 




transfer, cryopreservation, and delayed embryo transfer have decreased the risk of multiple 
gestations and ovarian hyperstimulation syndrome in vitro fertilization (Smith et al., 2015; 
Tiitinen et al., 2001). However, some women with PCOS who complete IVF have poor rates of 
conception due to unexplained poor-quality oocyte fertilization and embryonic development. 
The medical management of women with PCOS remains a very complicated issue. No 
single therapy has been established to address all aspects of the syndrome simultaneously. 
However, any clinical intervention in the management of PCOS should be an adjuvant treatment 
to lifestyle modification.  
2.1.6.2. Lifestyle Interventions  
Lifestyle modification, comprising dietary, exercise, and behavioural therapies, is, 
without question, the most important and first-line therapy in the management of PCOS. Diet and 
exercise interventions have been demonstrated to improve insulin sensitivity, reduce insulin 
levels, modify glucose metabolism, improve lipid profiles, and improve the overall physical and 
mental health of women with PCOS (Domecq et al., 2013; Harris-Glocker et al., 2010; Moran et 
al., 2011; Norman et al., 2002). Adopting healthy lifestyle behaviours have been recommended 
to improve the prognosis for women affected by PCOS. 
2.1.6.2.1. Dietary Interventions  
Dietary modification is an integral part of therapeutic strategies for the management of 
PCOS. However, the optimal dietary composition that will mediate reproductive, metabolic, and 
psychological improvements in women with PCOS has yet to be determined (Moran, Ko, et al., 
2013). This section will focus on the available literature regarding the dietary interventions to 
improve PCOS outcomes.  
There is much debate concerning the overall diet quality and dietary intake of women 
with PCOS compared to counterparts without PCOS, mainly due to regional, ethnic, life stage, 
and lifestyle variations in PCOS populations (S Barr et al., 2011; Crystal C. Douglas et al., 2006; 
Graff et al., 2013; Moran, Ko, et al., 2013; Tsai et al., 2013; Wright et al., 2004). However, there 
is a general agreement that women with PCOS have higher intakes of energy (mainly from foods 
with high GI) and saturated fat (SFA), as well as insufficient fiber intake, specifically from 
pulses and vegetables, when compared to women without PCOS (Crystal C Douglas et al., 2006; 
Eslamian et al., 2016; Lin & Lujan, 2014; Shishehgar et al., 2016b). Positive energy balance is a 




risk of chronic disease in women with PCOS. Targeting weight loss in overweight and obese 
PCOS populations and maintaining long-term healthy weight should be a priority in the 
management of the syndrome. A modest weight loss (5-10%) has been shown to improve CVD 
risk factors, including abdominal obesity and lipid profile, modulate blood glucose, increase 
insulin sensitivity, attenuate hyperandrogenemia, regulate menstrual cyclicity, restore ovulation, 
enhance fertility, and improve overall psychological well-being and quality of life of women 
with PCOS, irrespective of dietary composition (Badawy & Elnashar, 2011; Crosignani et al., 
2003; Elsenbruch et al., 2003; Gronbaek et al., 2012; M.-M. Huber-Buchholz et al., 1999; 
Moran, Ko, et al., 2013; Sweatt et al., 2015). Moran et al. (2013) conducted a systematic review 
to assess the favourable dietary composition that can uniformly improve the features of PCOS. 
Dietary interventions showed subtle differences in multiple outcomes. There was a lack of 
conclusive evidence for the optimal dietary composition that may confer benefit over caloric 
restriction in PCOS. Instead, the positive effects of weight loss per se were highlighted in 
overweight and obese women through short-term calorie restriction. The proposed hypocaloric 
dietary interventions have had a minimal emphasis on optimizing dietary composition for women 
with PCOS. A low GI and low carbohydrate diet was reported to result in higher improvements 
in IR, fibrinogen, total cholesterol, HDL-C, and quality of life; a high protein diet was shown to 
improve depression and self-esteem; a monounsaturated fat-enriched diet was reported to 
enhanced weight loss, and a high-carbohydrate diet was shown to increase free androgen index 
(Moran, Ko, et al., 2013). Asemi and colleagues (2014) examined the effects of a calorie-
restricted Dietary Approaches to Stop Hypertension (DASH) diet on lipid profile and the 
biomarkers of oxidative stress in overweight and obese women with PCOS (Asemi et al., 2014). 
The DASH diet is a diet rich in fruits, vegetables, whole grains, and low-fat dairy products and 
low in SFA, total cholesterol, and refined grains (Sacks et al., 2001a). The DASH diet combined 
with calorie restriction for 8 weeks was reported to improve insulin, TG and VLDL-C levels, and 
increased plasma total antioxidant capacity and total glutathione levels (Asemi et al., 2014). 
However, the dietary intervention was on a background of a calorie restriction; thus, the isolated 
benefits of the DASH eating plan on PCOS metabolic and oxidative stress outcomes are difficult 
to extrapolate. 
Studies comparing the benefits of one diet over another are scarce. Conventional healthy 




specifically from whole grains, fruits, and vegetables, are most commonly recommended for 
women with PCOS. It has been proposed that insulin sensitivity, glucose tolerance, lipid profile, 
body fat distribution, and visceral fat content improve following the adherence to conventional 
healthy diets (Barr et al., 2013; Crystal C. Douglas et al., 2006; Goss et al., 2014; Gower et al., 
2013; Marsh & Brand-Miller, 2005; Marsh et al., 2010; Stamets et al., 2004; Sweatt et al., 2015; 
Turner-McGrievy et al., 2014a). 
Emerging evidence supports the use of dietary supplements, to modulate hyperglycemia 
and dyslipidemia, and to alleviate the manifestations of hyperandrogenemia in PCOS. Omega-3 
fatty acids have been shown to improve glucose metabolism. Results of three 8-week RCTs, 
which were conducted separately, have shown improvements in fasting glucose and insulin 
levels in women with PCOS following dietary supplementation therapy. A dose of 1200 mg/d 
omega-3 long-chain polyunsaturated fatty acids (Rafraf et al., 2012) and selenium 
supplementation with a dose of 200 µg/d (Jamilian et al., 2015) have been reported to decrease 
insulin, TG, and VLDL-C levels. Zinc supplementation at a dose of 220 mg/d has resulted in 
modified insulin, glucose, and TG levels in women with PCOS (Foroozanfard et al., 2015).  
Inositol supplementation has been proposed as a safe therapy to improve insulin 
sensitivity in PCOS (Dinicola et al., 2014; Unfer et al., 2016). Inositols are 6-carbon compounds 
found in many foods, including fruits, beans, cereals, and nuts (Dinicola et al., 2014). Inositol 
isomers, myo-inositol and D-chiro-inositol, were shown to improve IR, glucose uptake, 
hyperandrogenemia, FSH signalling, and dyslipidemia in PCOS. A 40:1 ratio of myo-inositol to 
D-chiro-inositol has been proposed to be optimal to both reproduce the physiological plasma 
ratio, and to improve insulin sensitivity in PCOS (Dinicola et al., 2014; Unfer et al., 2016). 
Results of a systematic review and meta-analysis of 12 RCTs indicated supplementation with 
myo-inositol, alone, or in combination with D-chiro-inositol, can restore spontaneous ovulation, 
improve fertility, and modify hormonal and reproductive alterations in women with PCOS 
(Unfer et al., 2016). 
The efficacy of vitamin D3 supplementation on various features of PCOS is still 
controversial. Vitamin D3 deficiency appears to exacerbate IR and increase FPG in women with 
PCOS (He et al., 2015). Supplementation with 20,000-50,000 IU vitamin D3 weekly for 8 weeks 
has been reported to improve FPG, TG, and menstrual cyclicity in 30-50% of vitamin D-




Additionally, vitamin D3 supplementation with a dose of 50,000 IU weekly for 8 weeks appears 
to decrease the intervals between menstrual bleedings, hirsutism, acne, and TG levels in women 
with PCOS with vitamin D3 deficiency. Vitamin D3 replenishment has been proposed to 
regulate the bioavailability of transforming growth factor (TGF)-β1, a cytokine with essential 
roles in immunity and modulation of many cellular functions, including the control of cell 
growth, cell proliferation, cell differentiation and apoptosis (Irani et al., 2015).  
The available literature on the effects of various nutritional supplementation on PCOS is 
limited by sample size, supplementation duration, supplementation dosage, and study design. 
Further adequately powered, well-designed RCTs are needed to confirm the safety and 
effectiveness of dietary supplementation on multiple PCOS outcomes. 
2.1.6.2.2. Proposed Dietary Interventions with Potential to Improve PCOS Outcomes 
2.1.6.2.2.1. The Therapeutic Lifestyle Changes Diet 
The TLC diet is an integral component of nonpharmacologic healthy lifestyle habits 
program, recommended by the NCEP ATP III, to lower LDL-C and reduce CVD risk. In the 
TLC program, ATP III endorses a multifactorial lifestyle approach: Reducing high-saturated fat 
atherogenic diet; optimizing body weight; increasing physical activity; and smoking cessation 
("The NCEP ATP III final report," 2002). Many women with PCOS present with obesity, 
dyslipidemia, and adverse lifestyle habits. The TLC diet appears to be appropriate for women 
with PCOS. The TLC diet encourages a nutritionally balanced diet focusing on improving CVD 
risk and reducing LDL-C levels by diminishing fat intake and increasing fiber consumption. 
Hence, the TLC diet, as a component of the TLC program that promotes healthy changes in 
lifestyle, can be considered a standard conventional healthy diet, with the potential to improve 
PCOS outcomes.  
The TLC program has been designed according to a number of factors: 1) the benefits of 
keeping cholesterol and trans fatty acid intake low and the addition of LDL-C lowering dietary 
options (i.e., viscous, soluble fiber and plant stanol/sterol esters); 2) the encouragement of 
health-promoting aspects of the diet that include, among other things, fish and omega-3 fatty 
acids; and 3) the endorsement of regular physical activity, weight loss, and smoking cessation as 





The general approach to a TLC diet involves reduced intake of saturated fats and 
cholesterol and incorporating other therapeutic dietary options, such as increased consumption of 
viscous fiber to reduce LDL-C. The major LDL-C-raising dietary constituents are saturated fat 
and cholesterol. There is a dose-response relationship between saturated fatty acids and LDL-C 
levels ("The NCEP ATP III final report," 2002). For every 1% increase in calories from saturated 
fatty acids, as a percent of total energy, the serum LDL-C rises about 2% (Ginsberg et al., 1998). 
The primary sources of saturated fatty acids in the diet are high-fat dairy products (e.g., whole 
milk, cheese, butter, and cream), high-fat meats, and tropical oils (e.g., palm oil, coconut oil, and 
baked products containing dairy fats, tropical oils, and shortening oils). Trans fatty acids (fatty 
acids in which double-bonds are in the trans configuration) have a dose-response effect on 
lowering HDL-C, and thus, are associated with increased risk of CVD. Significant sources of 
trans fatty acids in the diet include products made from partially hydrogenated oils, such as 
baked products, including cookies and doughnuts, French fries, or chicken fried in partially 
hydrogenated shortening. Animal sources of trans fatty acids include dairy products, which 
contain a relatively smaller amount of trans fatty acids. Other major nutrients, such as 
unsaturated fats, proteins, and carbohydrates, do not raise cholesterol levels significantly 
compared to saturated fats and trans fatty acids. The TLC diet recommends to minimize the 
intake of trans fatty acids, and reduce the intake of saturated fatty acids to less than 7% of total 
calorie intake. Moreover, intake of cholesterol is recommended to be confined to less than 200 
mg per day, to maximize the amount of LDL-C lowering that can be achieved through a 
reduction in dietary cholesterol. Substitution of mono- and polyunsaturated fats for saturated fats, 
and limiting total caloric fat intake up to 10% and 20% respectively can cause a reduction in 
LDL-C levels ("The NCEP ATP III final report," 2002).  
Based on the TLC diet recommendations, carbohydrate intake should be limited to 60% 
of total calories, with focus on the dietary sources from grain products, especially whole grains, 
vegetables, fruits, and fat-free and low-fat dairy products ("The NCEP ATP III final report," 
2002). Consumption of complex carbohydrates along with high fiber diets modifies the rise in 
TG and fall in the HDL-C concentration (Jenkins et al., 1993; Turley et al., 1998; Vuksan et al., 
2000), which were reported in diets when carbohydrates are substituted for high saturated fatty 




The TLC diet recommends receiving 15% of daily calories from proteins. Dietary 
protein, in general, has little effect on serum LDL-C level or other lipoprotein functions. 
However, substituting soy protein for animal protein has been reported to reduce LDL-C 
concentrations ("The NCEP ATP III final report," 2002). Plant sources of protein include 
soybeans, pulses, nuts, grain products and vegetables, which tend to be low in saturated fats and 
cholesterol. Animal sources of protein should be consumed in moderation; the recommended 
animal protein sources which contain lower amounts of saturated fat and cholesterol include low-
fat dairy products, egg whites, fish, skinless poultry, and lean meats. Choosing lean forms of 
animal protein and plants sources of protein are encouraged in the TLC diet guideline ("The 
NCEP ATP III final report," 2002). 
On average, the dietary increase of 5-10 g viscous soluble fiber per day is accompanied 
by an approximately 5% reduction in LDL-C. Accordingly, the ATP III panel recommended the 
enrichment of the Therapeutic Diet by foods that provide a total of at least 5-10 g of viscous 
soluble fiber daily. Even higher intakes of 10-25 g per day can be beneficial. Soluble fiber can be 
increased by emphasizing intake of certain foods, including cereal grains, fruits, vegetables, 
dried beans, peas, and lentils ("The NCEP ATP III final report," 2002). 
Plant sterols and stanols are phytosterols and are essential components of plant 
membranes that “resemble the chemical structure of animal cholesterol and carry out similar 
cellular functions in plants” ("Functional foods fact sheet: Plant stanols and sterols," 2003). Plant 
sterols and stanols are effective and safe cholesterol-lowering functional food ingredients, which 
are naturally present in small quantities in many fruits, vegetables, nuts, seeds, cereals, legumes, 
vegetable. Intestinal cholesterol absorption is reduced by the consumption of plant sterols and 
stanols. Subsequently, LDL-C is reduced when plant sterols & stanols mimick LDL-C and 
compete with cholesterol for intestinal absorption, influence cellular LDL-C metabolism within 
intestinal enterocytes, and enhance, receptor-mediated lipoprotein cholesterol uptake (Plat & 
Mensink, 2005). Plant-derived stanols/sterol esters at dosages of a 2-3 g per day lower LDL-C 
levels by 6-15%, with no or little change in HDL-C or TG levels (Brown et al., 1999). However, 
dietary intake of the recommended dosage of stanols/sterols to improve LDL-C may be 
challenging in conventional dietary regimens. Most diets provide a few plant sterols and stanols. 
Vegetarian diets may contain more plant sterols and stanols; however, the amount of diet-derived 




supplements or foods fortified with sterols and stanols may be an option for patients with 
hypercholesterolemia. Further research is required to clarify the applicability, efficacy, safety, 
and generalizability of fortification and supplementation with plant-derived sterols and sterols to 
lower LDL-C cholesterol. 
After TLC dietary therapy achieved a maximum reduction of LDL-C, emphasis on ways 
to reduce other lipid risk factors associated with MetS, such as elevated TG and low HDL-C 
were addressed within the TLC program. Weight reduction therapy in combination with 
increased regular physical activity is recommended by the TLC program, to obtain further CVD 
risk reduction beyond LDL-C lowering achieved through dietary changes. At all stages of diet 
therapy, healthcare professionals are encouraged to refer clients to registered dietitians for 
dietary counselling and nutritional education. The ATP III essential components of the TLC 
program and recommendations for ranges of macronutrients are described in Tables 2 and 3 
("The NCEP ATP III final report," 2002). Please see Tables 2 and 3, below. 
 
Table 2. Essential components of the Therapeutic Lifestyle Changes program ("The NCEP ATP 
III final report," 2002) 
Component of the TLC program Recommendations 
LDL-C-raising nutrients 
 Saturated fats and trans fatty acids
 Dietary cholesterol 
 
Less than 7% of total calories 
Less than 200 mg/d 
Therapeutic options for LDL-C lowering  
 Plant stanols/sterols 
 Increased viscous (soluble) fiber 
 
2 g per day 
10-25 g per day 
Total calories (energy) Adjust total caloric intake to maintain desirable 
body weight/prevent weight gain 
Physical activity Include moderate exercise to expend at least 200 
kcal/d
 







Table 3. Macronutrient recommendations for the Therapeutic Lifestyle Changes diet ("The 
NCEP ATP III final report," 2002) 
Nutrient  Recommended intake 
Polyunsaturated fat Up to 10% of total calories 
Monounsaturated fat Up to 20% of total calories 
Total fat 25-35% of total calories* 
Carbohydrate† 50-60% of total calories* 
Dietary fiber 20-30 g/d
Protein Approximately 15% of total calories
 
*ATP III recommends an increase of total fat to 35% of total calories and a reduction in 
carbohydrate to 50% for individuals with MetS. Any increase in fat intake should be in the form 
of either polyunsaturated or monounsaturated fat. †Carbohydrates should be derived 
predominantly from foods rich in complex carbohydrates including grains (especially whole 
grains), fruits, and vegetables. 
2.1.6.2.2.2. Dietary Pulses and their Health Benefits  
Pulse consumption has received insufficient attention in PCOS research. Pulses have a 
favourable nutritional composition, which includes an exceptionally low-glycemic index (GI; 
i.e., “a ranking of carbohydrates in foods, based on their effects on blood glucose levels”) 
(Jenkins et al., 1981). Further, pulses have high fibre, are low in fat, and are an excellent source 
of starch and vegetable protein (Hanefeld et al., 2004). Chronic consumption of pulses has been 
associated with several favourable effects, including reduced postprandial blood glucose, lower 
insulin levels, and enhanced lipid profile (Abeysekara et al., 2012). Consuming pulses can be 
beneficial in the dietary management of PCOS. The health benefits of pulse consumption are 
addressed in the present section. 
According to the Food and Agriculture Organization of the United Nations (FAO), pulses 
are a type of annual leguminous crop yielding from one to 12 grains or seeds of variable size, 
shape and colour within a pod. The term pulse is limited to leguminous crops that are exclusively 
harvested for the dry grain, including dry beans, dry broad beans, dry peas, chickpeas, cow peas, 
pigeon peas, lentils, Bambara beans, vetches and lupins. Therefore, the term “pulse” excludes 




harvested green for food (green peas and green beans), and leguminous crops used for forage 
(e.g. seeds of clover and alfalfa) (FAO, 2014). Pulses are also referred to as pulse grains or grain 
legumes. Legumes are the pods or fruits of plants in the botanical family Fabaceae or 
Leguminosae. Legumes include dry beans, chickpeas, lentils, alfalfa, clover, lupin, green beans, 
and peas, peanuts, and soybean (McCrory et al., 2010).  
Canada has emerged as the world’s largest producer and exporter of dry peas and lentils 
("Saskatchewan Pulse Growers," 2016a). Saskatchewan is “at the heart of the Canadian pulse 
industry”. Saskatchewan grows 99% of Canada’s chickpeas, 96% of lentils, and 60% of dry peas 
(Farm and Food Care, 2016), while most beans are grown in Alberta, Manitoba, Ontario, and 
Quebec. Over 80% of pulse crops are sold to international markets ("Saskatchewan Pulse 
Growers," 2016b). Peas are mainly exported to India, Spain, and China; a large percentage of 
beans are exported to the US and UK; and chickpeas are exported to Pakistan, India, Jordan, and 
other countries ("Pulse facts," 2016). Pulses are Canada’s fifth largest crop, after wheat, canola, 
corn, and barley ("Saskatchewan Pulse Growers," 2016a).  
Consumption of pulses is low in Canada, and the Canadian consumption reports indicate 
that domestic consumers do not eat pulse foods on a regular basis ("Pulse facts," 2016). For 
example, Canada’s pea consumption is estimated at 1% of its total production ("Pulse facts," 
2016). The median intake level of pulses in the US is 0.2 servings daily, and only 7.9% of 
American adults consume pulses on a given day (Guenther et al., 2006; Mitchell et al., 2009). In 
Canada only 13% consume dietary pulses on a given day, with a median intake of only about 0.5 
serving daily (Ha et al., 2014). A recent analysis of data from the Food Habits of Canadians 
study demonstrated that energy in the diet of Canadian adults was derived mainly from bread, 
pasta, rice, grains, and fluid milk. Protein intake was primarily derived from meat and dairy 
products, while legumes, nuts, seeds, and eggs were not significant sources of protein (Johnson-
Down et al., 2006). 
Pulse producers seek potential domestic markets. An opportunity exists for Canadians to 
consume more pulses, given the availability of the food supply and that Canadians currently have 
low consumption rates. Pulse producers invest in research to examine opportunities to increase 
pulse consumption locally, including the adaptation of pulses into Canadian daily eating patterns 
and advertising the nutritional benefits of pulses ("Saskatchewan Pulse Growers," 2016c). The 




IYP 2016 was recommended to increase public awareness of the nutritional benefits of pulses, as 
part of sustainable food production to improve global food security and nutrition. A second goal 
of the nomination was to help the UN implement its 2030 Agenda for Sustainable Development, 
which aims to eliminate global poverty and hunger (FAO, 2016). 
A growing body of evidence supports the positive effects of pulses on diet quality. Pulses 
are the leading source of dry vegetable protein, an excellent source of fiber, and a significant 
source of vitamins and minerals, such as iron, zinc, folate, calcium, and magnesium. Pulses 
contain approximately double the protein content of some grains, and double the amount found 
in whole grain cereals, such as wheat, and three times the protein content of rice. Pulses are a 
good source of potassium and have a low sodium content. Pulses are gluten-free, cholesterol-
free, low in fat, have a low GI, and high protein quality, which can considerably fulfil the 
essential amino acid requirement of human diet (Iqbal et al., 2006; Mudryj et al., 2014). 
Consuming half a cup of pulses has been shown to enhance the overall diet quality (Mudryj et 
al., 2014). Consumption of pulses has been shown to increase the intake of fiber, protein, 
carbohydrate, folate, magnesium, iron and zinc (Mitchell et al., 2009). Pulses can mediate satiety 
and weight management, due to high fiber content, moderate energy density, and complex and 
slowly digestible carbohydrates (McCrory et al., 2010). Pulses have the potential to improve diet 
quality as indicated by the Healthy Eating Index, a numerical scale to assess diet quality of 
specific populations on a scale of 1 to 100) (Garriguet, 2009). In Health Canada’s resource: 
Eating Well with Canada’s Food Guide (EWCFG), pulses are considered nutritious foods and are 
recommended as a part of a healthy diet. The EWCFG classified pulses as a meat alternative 
(Health Canada, 2007). Interestingly, the United States Department of Agriculture’s MyPyramid 
food guidance system includes pulses in both the Meat and Beans group as well as the Vegetable 
group (USDA Center for Nutrition and Policy Promotion, 2016). Contrary to the United States 
Department of Agriculture 2005 Dietary Guidelines, which recommends consumption of 3 cups 
of legumes per week for most adults (USDA Center for Nutrition and Policy Promotion, 2016), 
Health Canada does not have a recommended amount of legume or pulse consumption for adults. 
Rather, Health Canada recommends “having meat alternatives such as beans, lentils…often”. 
The EWCFG defines one serving of pulses as 175 ml (3/4 cup) (Health Canada, 2007). See Table 
4 for some nutrient values of common pulses (Health Canada. Nutrient Value of Some Common 




Table 4. Nutrients per 175ml (3/4 cup) of pulses (Health Canada. Nutrient Value of Some 
Common Foods, 2008) 
Measure White beans (Canned) Chickpeas (Canned) Lentils (Boiled) Split peas (Boiled) 
Weight (g) 194 178 146 145 
Energy (kcal) 227 211 170 171 
Protein (g) 14 9 13 12 
Carbohydrate (g) 43 40 29 31 
Dietary fiber (g) 9.3 7.8 6.2 4.2 
Total fat (g) 1 2 1 1 
Iron (mg) 5.8 2.4 4.9 1.9 
 
The favourable nutrient profile of pulse foods has led to research findings related to their 
potential health benefits in the dietary management of chronic diseases. Specifically, pulses have 
demonstrated health benefits in CVD, DM2, weight maintenance, and cancer prevention 
(Abeysekara et al., 2012; Ha et al., 2014; McCrory et al., 2010; Mudryj et al., 2014). Pulses have 
received particular attention for their ability to reduce the risk of CVD (Ha et al., 2014). Pulse 
consumption improves serum lipid profiles and positively affects some CVD risk factors, such as 
BP, LDL-C, platelet activity, and inflammation (Ha et al., 2014; Jenkins et al., 2003). These 
observations may be, in part, due to the remarkable antioxidant capacity of pulses, attributed to 
tannins, flavonoids, polyphenols, phytates, and saponins. Pulses may inhibit the oxidation of 
LDL-C and modulate total cholesterol levels, and thus, improve arterial health and reduce 
cardiometabolic risk factors. Approximately 60% of the fiber in pulses is insoluble, and 31% is 
soluble, both of which can bind to, and prevent the reabsorption of bile acids in the intestine 
(Abeysekara et al., 2012). Also, fermentation of fiber in the colon can produce short-chain fatty 
acids and improve in the gut microbiota composition, which contributes to the decreased hepatic 
synthesis of cholesterol and glucose (Chibbar et al., 2010; Kishimoto et al., 1995; van Bennekum 
et al., 2005). Results of a meta-analysis of eleven clinical trials evaluating effects of non-soy 
legume interventions with serum lipids revealed that regular pulse consumption lowered LDL-C, 
with no significant effects on HDL-C levels (Anderson & Major, 2002). Researchers attributed 
the hypocholesterolemic effects of pulses to be multi-factorial but ranked their soluble fiber 
content, vegetable protein and oligosaccharides as the top three important traits. The positive 
effects of pulse consumption on total cholesterol and LDL-C in individuals at risk for MetS are 




(i.e., 2 servings per day of pulses, or 150 g/d dry weight) reduced total cholesterol and LDL-C-
cholesterol by 8%, and improved body composition (i.e., reduced body fat%) in men and women 
at risk for MetS of 50 years of age and older, which is an age-group with an increased risk of 
CVD (Abeysekara et al., 2012). Results of a recent systematic review and meta-analysis on 26 
RCTs showed a modest reduction, −0.17 mmol/L (95% CI, −0.25 to −0.09) of LDL-C 
concentration following the consumption of a median dose (130 g/d dry weight) of pulses (Ha et 
al., 2014). Similarly, results of a meta-analysis of 10 RCTs showed −0.2 mmol/L (95% CI, −0.3 
to −1.2) decrease in LDL-C levels following the consumption of legume-rich diets (Bazzano et 
al., 2011). However, the assessed RCTs were limited by methodological and intervention 
duration heterogeneity. Large-scale, long-term RCTs are required to confirm LDL-C lowering 
findings. In addition to improving blood lipid concentrations, pulses have been shown to 
improve BP. Jayalath et al. performed a meta-analysis on 8 isocaloric trials (n=554 participants) 
and showed pulse consumption (~162 gram/day) over 10 weeks reduced mean arterial BP by -
0.75 mmHg in middle-aged subjects with or without hypertension (Jayalath et al., 2014). Pulses 
can confer BP-lowering effects by increasing dietary intakes of low-GI foods, dietary fiber, plant 
protein, potassium, and magnesium, as well as decreasing sodium intake through pre-established 
mechanisms (Aburto et al., 2013; Altorf–van der Kuil et al., 2010; Jee et al., 2002; Mudryj et al., 
2014; Tielemans et al., 2013). 
Pulse consumption has positive effects on the control of IGT and DM2. Most pulses have 
an exceptionally low GI, which is approximately half of that reported for commonly eaten 
carbohydrate-rich foods. For example, using a reference value of GI = 100 for 50 g glucose, the 
GIs of 150 g green lentils, chickpeas, and kidney beans are 30±4, 28±6, and 28±4 respectively, 
compared to weight-matched long-grain white rice with a GI of 56±2 (Health Canada. Nutrient 
Value of Some Common Foods, 2008). Chronic consumption of pulses has been shown to 
modulate glucose and insulin responses of patients with DM2 and improve weight control, by 
reducing appetite and energy intake (McCrory et al., 2010). However, the isolated effect of 
pulses on glycemic response in diabetes is less clear. Many trials have classified pulses as a 
whole grain, and thus, interpretation of the isolated positive effects of pulses is difficult to 
ascertain (Jacobs et al., 1998; Jang et al., 2001). Further, the reported low intake and the duration 
of pulse consumption were likely too small to claim pulse consumption reflected a genuine effect 




grains and legumes is beneficial in the treatment and management of diabetes” (Venn & Mann, 
2004). Theoretically, some unprocessed whole grains share the nutritional profile of pulses 
including a high fiber content and lower GI. However, it is important to investigate the isolated 
effects of pulses on diabetes management. Results of a systematic review and meta-analysis of 
41 RCTs on the effects of pulse interventions on glycemic control in adults with and without 
DM2, were in favour of pulse consumption (Sievenpiper et al., 2009). Results of the meta-
analysis were stratified according to the effects of pulses alone, pulses as a component of low-GI 
diets, or as a component of high-fibre diets on glycemic control measures. Eleven trials from the 
meta-analysis revealed that pulses alone lowered the FPG −0.82 SMD (95%CI −1.36 to −0.27) 
and fasting insulin −0.49 SMD (95% CI −0.93 to −0.04). Nineteen trials showed that pulses as a 
component of low-GI diets lowered blood glycosylated proteins, measured as HbA1c or 
fructosamine −0.28 SMD (95% CI −0.42 to −0.14). The remaining eleven trials examined pulses 
as a component of high-fibre diets and showed lowered FPG −0.32 SMD (95% CI −0.49 to 
−0.15) and glycosylated proteins −0.27 SMD (95%CI −0.45 to −0.09). However, there was high 
heterogeneity in results, and researchers were unable to conclude the optimal type and dose of 
pulses that would improve DM2 outcomes (Sievenpiper et al., 2009). 
Pulses are rich sources of dietary fiber. Fermentation of non-digestible dietary fiber in 
cecum and colon leads to the exogenous synthesis of short-chain fatty acids (SCFA) and branch-
chain amino acids (valine, isoleucine, leucine) derivatives of gut microbiota. The microbial 
conversion of fiber into functionally relevant metabolites has been proposed to improve host gut 
microbiota composition, immunity, and metabolism, protect against metabolic diseases and 
improve IR. SCFAs, in particular, acetate, propionate, and butyrate, are critical bacterial 
metabolites which can promote host-microbial symbiosis as effective prebiotics. SCFAs are 
minor energy and essential signalling molecules, which are implicated in improving insulin 
sensitivity, glucose tolerance, and lipid metabolism; regulation of blood-brain barrier 
permeability; regulation of satiety; regulation of hepatic and intestinal gluconeogenesis; 
regulation of cytokines expression; regulation of vaginal physiological environment; and 
potential improvement of mood, depression, and anxiety (Koh et al., 2016).  
Consumption of pulses, as nutritionally balanced foods with moderate energy density, has 
been recommended to reduce energy intake, increase satiety, and control obesity (Li et al., 2014; 




satiety via their favourable macronutrient profile. Pulses are low in fat, high in protein and fiber, 
contain a high level of complex carbohydrate that is slowly digested, amylase inhibitors and 
phytochemicals(McCrory et al., 2010). Aside from weight loss, coupling pulse consumption with 
energy restriction has been shown to lower BP and dyslipidemia and decrease inflammation 
(Hermsdorff et al., 2011).  
Gastrointestinal symptoms and poor dietary compliance have been reported with the diets 
comprised of high quantities of pulses. Upset stomach, flatulence, bloating, diarrhoea, and 
increased stool frequency are among the reported adverse effects. Of note, gas production is a 
normal physiological process that, to some extent, aids in digestion by softening and helping to 
move stool through the colon (Hellendoorn, 1979). There is evidence that compliance to dietary 
pulses may be improved with regular consumption of pulse foods (Fleming et al., 1985; 
O'Donnell & Fleming, 1984). Chronic consumption of dietary pulses can improve gut microflora 
composition, with mechanisms associated with the intestinal fermentation of dietary fiber in 
cecum and colon, which could, in turn, influence gastrointestinal symptoms and improve the 
overall tolerance to pulse consumption (Roberfroid & Slavin, 2000; Swennen et al., 2006). Also, 
there are practices to remove galacto-oligosaccharide sugars, the primary flatulence-producing 
compounds in legumes), including overnight soaking, followed by pressure cooking, discarding 
both soaking and cooking liquids, irradiation, germination, and enzyme treatments (Minorsky, 
2003). Paradoxically, pulse foods are consumed in many cultures without reports of adverse 
effects that would limit consumption (McCrory et al., 2010).  
Pulses contain nutritive and non-nutritive components and have potential anti-
carcinogenic effects (Mathers, 2002; Wiseman, 2008). The theories surrounding the mechanism 
for cancer protection from pulse-containing-diets are multi-dimensional (Aune et al., 2009; 
Mathers, 2002; Wiseman, 2008). Pulses contain a rich variety of components, which may help to 
reduce cancer risk if consumed in sufficient quantities (Mathers, 2002). Nutrients such as 
resistant starch, non-starch polysaccharides, oligosaccharides, folate, selenium, zinc and 
bioactive macroconstituents such as protease inhibitors, phytosterols, lectins, phytochemicals, 
saponins, tannins, and phytates are purported to have anti-carcinogenic effects. The anti-
carcinogenic effects of pulses have been attributed to mechanisms associated with digestion, 
fermentation by gut microbiota, repair of DNA damage, and apoptosis of damaged cells 




the case of deficiency. Therefore, a food-first approach is warranted (Duffield‐Lillico et al., 
2003; Wiseman, 2008). 
The Second World Cancer Research Fund/American Institute for Cancer Research Expert 
Report recommends the consumption of “relatively unprocessed cereals (grains) and/or pulses, 
and other foods that are natural sources of dietary fiber, to contribute to a population average 
daily consumption of 25 grams of non-starch polysaccharides”. The inclusion of mostly plant-
based foods in the diet is recommended. Red meat consumption is recommended to be limited to 
less than 11 ounces weekly with little, if any, meat processing. A study assessing cancer risk in 
Uruguay conducted a multi-site case-control on 3539 cancer cases and 2032 controls to explore 
the association between legume intake and cancer risk (Aune et al., 2009). Legume intake was 
tiered into low, medium and high for each test group. Higher intake of legumes was associated 
with a decreased risk of several cancers including those of the upper digestive tract (odds ratio 
[OR] = 0.50, 95% CI: 0.40–0.63), stomach (OR = 0.69, 95% CI: 0.49–0.97), colorectum (OR = 
0.43, 95% CI: 0.32–0.59), and kidney (OR = 0.41, 95% CI: 0.24–0.71; all P<0.05). Comparisons 
between low and high intakes of legumes indicated that higher bean consumption was associated 
with lower risk of oral cavity/pharynx (OR = 0.54, 95% CI: 0.37–0.79), oesophagal (OR = 0.59, 
95% CI: 0.40–0.86), larynx (OR = 0.50, 95% CI: 0.34–0.73), upper digestive (OR = 0.53, 95% 
CI: 0.41–0.68), stomach (OR = 0.54, 95% CI: 0.37–0.80), colorectum (OR = 0.44, 95% CI: 
0.31– 0.61), and bladder cancers (all P<0.006). Lentil intake had similar results. However, unlike 
bean intake, no significant associations were observed for bladder (OR = 1.06, 95% CI: 0.71–
1.57; P= 0.81) or stomach cancers (OR = 0.84, 95% CI: 0.57–1.23; P=0.33), but, a reduced odds 
ratio was reported for kidney cancer (OR = 0.46, 95% CI: 0.25– 0.82; P=0.01). No significant 
associations with cancers of the lung, breast or prostate were observed for any of the legume-
based diets. Hartman et al. detected an improvement in biomarkers of inflammation when 
comparing usual diets to both a high legume-containing diet and a healthy American diet. No 
difference was found between the legume-diet and the healthy American diet for inflammatory 
biomarkers; however, results were possibly confounded given the heterogeneity in the degree of 
weight maintenance among subjects (Hartman et al., 2010). 
Pulses in the diet can improve the overall diet quality and reduce the risk of several 
chronic diseases. Recent research supports the notion that pulses may have further positive 




the reproductive, metabolic, and psychological improvements in women with PCOS is unclear. 
No published research addresses the potential benefits of pulse consumption in the PCOS 
population. The optimal dietary composition needs to be further explored to evaluate the 
potential to enhance outcomes for women with PCOS. It has been proposed that a pulse-based 
diet can improve the metabolic and reproductive outcomes and the overall quality of life and 
lifestyle of women with PCOS. 
2.1.6.3. Physical Activity  
Physical exercise has been accepted as an integral component of lifestyle therapy in the 
management of PCOS. Physical activity can improve the clinical manifestations, metabolic 
profile, and quality of life of women with PCOS (Harrison et al., 2011). Regular physical activity 
has been shown to decrease the risk of chronic diseases including CVD and DM2, and the 
overall prognosis of PCOS (Brown et al., 2009; J. A. Hawley, 2004; Vigorito et al., 2007). 
Exercise positively affects mood, anxiety, body image, depression, and overall psychological 
well-being of women with PCOS (Liao et al., 2008; Ramos et al., 2016). Exercise is a significant 
predictor of successful and sustainable weight maintenance in women with PCOS (Harrison et 
al., 2011; J. A. Hawley, 2004; Vigorito et al., 2007).  
Currently, there is no specific guideline for the amount or type of exercise that is 
recommended for women with PCOS. Exercise recommendations for women with PCOS are 
generally based on the Canadian and American Physical Activity Guidelines (Tremblay et al., 
2011; "The Department of Health and Human Services guidelines for exercise ", 2008). These 
guidelines have been established for all North American adults, based on evidence regarding the 
minimum amount of aerobic activity that is necessary to produce substantial health benefits. The 
guidelines support the recommendation that physical activity should not be less than 150 minutes 
total per week of moderate-intensity exercise, or 75 minutes of vigorous-intensity activity per 
week, or an equivalent combination of moderate- and vigorous-intensity physical activity. 
Activities such as brisk walking, water aerobics, ballroom and line dancing, tennis (doubles), 
general gardening, or sports in which one catches and throws (e.g., volleyball, baseball, and 
softball) are all considered to reflect moderate-intensity physical activity. Vigorous intensity 
activities include racewalking, aerobic dance, biking faster than 10 miles per hour, hiking uphill, 
heavy gardening, jumping rope, martial arts (e.g., Karate), jogging and running, swimming fast 




basketball, field hockey, and soccer). Activities that increase muscle mass, improve balance and 
preserve bone, such as weight training using resistance bands, weight-bearing aerobics, and 
heavy gardening, are recommended to be included 2 or more days per week (Tremblay et al., 
2011; "The Department of Health and Human Services guidelines for exercise ", 2008).  
The benefits of exercise training and its recommendation as a cornerstone of PCOS 
management are well-documented. However, few well-controlled studies have evaluated the 
benefits of exercise training on PCOS (Bruner et al., 2006; Hoeger et al., 2004; Norman et al., 
2002). Vigorito et al. evaluated the effects of a three-month structured exercise training program 
on the cardiopulmonary functional capacity of young women with PCOS. Subjects were 
randomly assigned to either the trained group, who underwent a three-month structured aerobic 
exercise training program for 3 times per week, or the untrained group, who did not exercise. 
Exercise regimen comprised of a 5-minutes warm-up, followed by a 30-minutes biking with the 
target of 60–70% of the maximal oxygen consumption (VO2max), and a 5-min cool-down. After 3 
months, trained women showed significant improvement in peak oxygen consumption, maximal 
workload, insulin sensitivity, BP, CRP, and BMI levels compared with an untrained group 
(Vigorito et al., 2007). Structured exercise training for 6-months has been shown to be superior 
to CHC therapy, comprised of 3 mg drospirenone plus 30 μg ethinyl estradiol, in improving the 
CVD risk factors of endothelial dysfunction, including intima-media thickness and flow-
mediated dilation. The observation might be attributed to the positive effects of physical activity 
on cardiopulmonary health and function (Orio et al., 2016). Exercise has been shown to improve 
the lipid profile in women with PCOS. Results of a 8–12-week ramp-up followed by a 12-week 
moderate-intensity exercise program (16–24 weeks total, ~228 minutes per week at 40–60% of 
the VO2max) on sedentary women with PCOS demonstrated the exercise, without significant 
weight loss, improved HDL-C, VLDL-C/chylomicrons, and TG levels in women who exercised 
compared with non-exercisers (Brown et al., 2009). Results of a prospective cohort of obese 
women with PCOS and anovulatory infertility who underwent supervised treadmill sessions for 
24 weeks showed greater increase in insulin sensitivity compared with women in a hypocaloric 
high-protein diet group. Although diet induced greater weight loss, exercise resulted in greater 
improvement in insulin sensitivity (Palomba et al., 2008). Researchers concluded that exercise 




Exercise training can improve insulin sensitivity by two major mechanisms. First, 
exercise can improve insulin sensitivity by modulating visceral adipose tissue, which is a 
metabolically active endocrine organ with a well-established contribution to the development of 
IR (Després et al., 2001; Lord et al., 2006). Second, physical activity can improve insulin 
sensitivity by the enhancement of muscle metabolism at the cellular level. Skeletal muscle is the 
main site of glucose deposition implicated in IR. Physical exercise mediates the expression and 
the activity of proteins involved in insulin signal transduction in skeletal muscles (John A 
Hawley, 2004). Exercise may enhance insulin sensitivity by affecting the oxidative capacity of 
skeletal muscle (Kirk et al., 2003). A few other mechanisms have been proposed by which 
exercise may improve PCOS outcomes. Physical activity may modulate exaggerated sympathetic 
nerve activity in women with PCOS (Lindmark et al., 2003; Stener-Victorin et al., 2009). 
Physical exercise can mediate an improvement of the psychological well-being of women with 
PCOS by improving body image, self-esteem, depression, and anxiety (Brown et al., 2009; 
Hoeger, 2008; Thomson et al., 2009).  
Physical activity has been attributed to positive changes in the mental health of women 
with PCOS (Conte et al., 2015). However, there is little evidence to support the isolated effects 
of exercise on psychological well-being in PCOS. A small nonrandomized study of a 6-month 
self-directed brisk walking program for overweight and obese women with PCOS demonstrated 
decreased body image distress scores (Liao et al., 2008). Improved scores on quality of life and 
depression have been reported following a 20-week clinical trial of energy-restricted diet 
combined with exercise (i.e., aerobic only or combined aerobic-resistance) in overweight women 
with PCOS (Thomson et al., 2010). Most recently, results of a 16-week structured resistance 
exercise training program showed modest improvements in the functional capacity, vitality, 
social aspects, and mental health of women with PCOS (Ramos et al., 2016). Resistance training 
was reported to improve depression and anxiety, as well as to enhance the indices of female 
sexual function including sexual desire, sexual excitement, and lubrication in women with PCOS 
(Lara et al., 2015). Banting et al. showed that active women with PCOS had fewer depressive 
symptoms compared with inactive counterparts. However, active women with PCOS still 
reported more depressive symptoms than active women without PCOS (Banting et al., 2014). 
Further high-quality research is required to clarify the relationship between physical activity and 




Few studies have examined the isolated effects of exercise training on reproductive 
outcomes in PCOS. Results of a 14-week medically supervised fitness program showed a 46% 
increase in the conception rate of women with PCOS who desired pregnancy, independent of 
changes in body composition or eating behaviour before pregnancy occurrence (Aubuchon et al., 
2009). A 3-month aerobic training program was reported to restore regular menstrual cyclicity in 
60% of women with PCOS who were previously diagnosed with anovulatory infertility (Palomba 
et al., 2008; Vigorito et al., 2007). Similarly, a 24-week program of dieting or aerobic exercise 
improved menstrual cyclicity and ovulation in overweight women with PCOS, with no 
differences in the quantity or lengths of menstrual cycles between treatments. However, the 
frequency of menses and rates of ovulation were higher in the exercising group. The exercising 
group exhibited a trend toward higher pregnancy rates and greater improvements in hormonal 
profile compared with the dieting group (Palomba et al., 2008). Results of a small 
nonrandomized study of progressive resistance training program for 16 weeks showed 
improvements in total testosterone, SHBG, and menstrual cyclicity in women with PCOS 
(Kogure et al., 2016). 
Physical activity appears to improve cardiopulmonary function, body composition, IR, 
hyperandrogenism, menstrual cyclicity, ovulation, quality of life, and psychological well-being 
of women with PCOS. No guideline has been established for the amount and type of physical 
activity that can improve the outcomes of PCOS. Additional research is needed to determine the 
optimal dose, type, intensity, and frequency of exercise that would improve multiple PCOS 
outcomes.  
2.1.6.4. Combined Dietary and Exercise Lifestyle Interventions 
There are surprisingly limited and mixed results on the short- and long-term impacts of 
combined dietary, exercise, and behavioural interventions on PCOS outcomes. Moran et al. 
conducted a systematic review on 21 RCTs to examine the effect of lifestyle interventions 
comprising dietary, exercise, behavioural management (separately/or combination of all three) 
compared with minimal treatment for women with PCOS (Moran et al., 2011). The outcomes 
measures assessed were reproductive (i.e., pregnancy, menstrual cyclicity, ovulation, total 
testosterone levels, SHBG levels, and clinical hyperandrogenism), metabolic (i.e., OGTT, fasting 
glucose and insulin levels, and lipid profile), and anthropometric (i.e., BMI, WC, android body 




of a control group, not being an RCT or no access to a full-text article. Six studies were included 
in the review (Badawy & Elnashar, 2011; Guzick et al., 1994; Hoeger et al., 2008; Stener-
Victorin et al., 2009; Vigorito et al., 2007). The studies were relatively small, with samples sizes 
of 11-90 participants, and relatively high drop-out rates in relation to the intervention period: 0% 
drop out at 12 weeks (Hoeger et al., 2008; Vigorito et al., 2007), 18% at 24 weeks (Stener-
Victorin et al., 2009), 25% at 24 weeks, 35% at 48 weeks (Hoeger, 2008), and 43%-46% at 16 
weeks (Badawy & Elnashar, 2011; Guzick et al., 1994). Researchers concluded an overall 
positive effect of lifestyle intervention on anthropometric measurements, including a 7% weight 
loss, with no significant improvements on reproductive or metabolic measures in women with 
PCOS undergoing lifestyle interventions, compared with minimal treatment. However, it is likely 
that the comparisons between studies were confounded by several factors, including variable 
clinical phenotypes and life stages of subjects, high drop-out rates of participants, low 
compliance to intervention protocols, lack of statistical power to detect a true effect if it existed, 
and small sample size.  
Long-term adherence to lifestyle interventions is difficult. Results of a systematic review 
and meta-analysis of RCTs compared the effects of a combined diet and exercise intervention 
versus diet-only intervention on both long-term and short-term weight loss success in women 
with PCOS. The combination of diet and exercise showed greater weight loss −0.25 SMD (95% 
CI −0.36 to −0.14). However, in studies lasting 2 years or longer, both diet plus exercise and 
diet-only programs were associated with partial long-term weight regain (Wu et al., 2009). 
Carefully monitored long-term PCOS studies with control subjects and adequate power to 
observe an effect are recommended to discern the impacts of combined lifestyle intervention on 
PCOS outcomes in short- and long-term evaluations/observations. Future research should 
address the compliance, attrition rate, and barriers to lifestyle modifications in PCOS. Attempts 
should be made to develop effective strategies for more successful engagement of women with 
PCOS with lifestyle modification that is sustainable.  
2.2. Significance of the Review and Relevance of the Study Objectives  
The PCOS is a complex endocrine condition in women of reproductive age, associated 
with metabolic and reproductive compilations and compromised HRQoL. Lifestyle 




optimal diet composition that would uniformly be beneficial for women with PCOS is not 
known.  
None of the reviewed studies focused on the implications of a pulse-rich dietary intervention 
on PCOS health outcomes. Instead, lifestyle modifications focused on the effects that weight loss 
have through short-term calorie restricted dietary interventions in PCOS, with minimal emphasis 
on a PCOS-optimized dietary composition. It is proposed that a pulse-based diet (i.e. a low GI 
diet including dry peas, beans, lentils, and chickpeas) can positively affect the metabolic, 
reproductive, and HRQoL outcome associated with PCOS. Pulses have a favourable nutritional 
composition, are high in fiber, have a low GI, are low in fat, and contain high-quality protein. 
Chronic consumption of pulses in non-PCOS populations has been associated with positive 
metabolic effects, including reduced postprandial blood glucose and insulin concentrations, and a 
more favourable lipid profile. Therefore, the influence of a pulse-based diet needs to be studied 
on multiple physiologic, metabolic, reproductive, and HRQoL indices in women with PCOS. As 
complementary components of a comprehensive multidimensional lifestyle intervention 
program, the proposed intervention will profit from the additional benefits of exercise, education 
and healthcare counselling about PCOS and lifestyle modification. To isolate the effect of diet 
and healthcare counselling, exercise was prescribed as a portion of ethical Good Clinical Practice 
Guidelines. Extended follow-up times will be used, to better understand the long-term effects of 
the pulse-based diet and aerobic exercise intervention on PCOS outcomes. Prior to presenting the 
results of the proposed lifestyle change program, the prevalence rate and individual components 
of MetS, impaired glucose control, DM2, and risk factors for CVD were evaluated in women 
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In this chapter, the prevalence and characteristics of MetS, glucoregulation, DM2, and risk 
factors for CVD in Canadian women with PCOS is examined. 
 
Abstract 
Background and objectives: PCOS is associated with profound metabolic disruptions. 
Limited research has comprehensively examined the contribution of PCOS-related alterations to 
MetS using the latest recommendations to diagnose PCOS and polycystic ovaries. The objective 
of the present work was to examine the prevalence and characteristics of MetS, glucoregulation, 
DM2, and risk factors for CVD in Canadian women with PCOS. 
Methods: Data were pooled from 2 prospective and cross-sectional studies on 237 women 
with PCOS (AE-PCOS Society criteria) and 42 (non-PCOS) controls (18-36y). Clinical and 
biochemical measures of MetS (International Diabetes Federation consensus definition) and 
DM2 (Canadian Diabetic Association criteria), and CVD risk factors (AE-PCOS Society 
statement) were evaluated. 
Results: The prevalence of MetS was 29.5% in the PCOS group, approximately 6-fold 
higher than age-matched controls (P<0.001), with worse glucose control, acanthosis nigricans, 
BMI, systolic blood pressure (SBP), TG, HDL-C, LDL-C, TC/HDL-C, and hsCRP levels 




responses to an oral glucose tolerance test, TC, TC/HDL-C ratio, hirsutism, and acanthosis 
nigricans than BMI-matched counterparts without MetS (P≤0.05). 
Conclusion: Reproductive-age women with PCOS have a high prevalence of MetS and 
exhibit adverse cardiometabolic and DM2 risk profiles. MetS exacerbates hyperandrogenicity, 
dyslipidemia, and glucose control in PCOS, possibly by aggravating inherent IR, with 
concomitant obesity having synergistic effects. 
 
Keywords: Polycystic ovary syndrome, obesity, insulin, cardiovascular disease, glucose 
intolerance 
3.1. Introduction 
PCOS is the most common hyperandrogenic disorder and cause of anovulatory infertility 
among reproductive-age women worldwide, with a prevalence of up to 18% (Carmina & Lobo, 
1999; March et al., 2010). PCOS is primarily characterized by hyperandrogenism, ovulatory 
dysfunction, and polycystic appearing ovaries on ultrasonographic examination and associated 
clinical manifestations, including oligo-amenorrhea, hirsutism, and infertility (Azziz et al., 
2006). Aside from reproductive complications, PCOS is associated with profound metabolic 
disruptions which represent important contributors to increased rates of long-term morbidity and 
mortality (Carmina & Lobo, 1999; E Diamanti-Kandarakis & A Dunaif, 2012; Wild et al., 2010). 
Women with PCOS exhibit IR and compensatory hyperinsulinemia, with associated metabolic 
disruptions, including impaired glucose metabolism, dyslipidemia, hypertension, and abdominal 
obesity. These symptoms are key components of MetS, which is defined as a complex of five 
interrelated risk factors for CVD and DM2. The prevalence rate of MetS in women with PCOS is 
estimated at 8.2-43% and varies depending upon the chosen diagnostic criteria, as well as 
regional, lifestyle, and ethnic variations (Apridonidze et al., 2005; Carmina et al., 2006; Glueck 
et al., 2003). Previous research has used older criteria for diagnosing polycystic ovarian 
morphology (PCOM), using a threshold of ≥12 follicles per ovary measuring 2-9 mm in diameter 
which appear to be obsolete after the introduction of advanced imaging technology that affords 
maximal resolution of ovarian follicles. No study has previously evaluated the metabolic 
derangements of PCOS using the recently introduced thresholds (≥25 AFC)) for PCOM. Further, 
the extended variability in the prevalence rates of MetS may in the previous reports be due, in 




employed, and the fact that older or less accurate criteria were used to diagnose PCOS and MetS, 
and variations in ages at diagnosis. The adverse effects of obesity on MetS have been 
exhaustively documented (Alberti et al., 2009; Grundy, 2008; Kahn et al., 2006; Vendrell et al., 
2004). Over the past three decades the prevalence of obesity has increased steadily in Canada, 
and is predicted to continue to increase (Twells et al., 2014). To our knowledge, there has been 
no coordinated effort to address the contribution of MetS and obesity to PCOS in Canada. 
Therefore, in the present study, we used a rigorous and comprehensive approach to diagnose 
PCOS using multiple clinical, biochemical, and ultrasonographic tests. Further, a precise 
methodology was implemented to determine the presence of MetS in PCOS population. The 
severity of metabolic derangements was evaluated in the affected women using multiple outcome 
measures across age and BMI categories.   
With MetS the risk of CVD doubles (Grundy, 2008) and the risk of DM increases 5-fold 
(Alberti et al., 2006). A high prevalence of CVD and DM2 risk factors in PCOS is associated 
with an increased risk of early-onset CVD and DM2. Early recognition and prevention of PCOS-
related metabolic sequelae can be attained through screening, diagnosis, and interventions 
("American College of Obstetricians and Gynecologists. Polycystic ovary syndrome. ACOG 
Practice Bulletin no. 108," 2009; Legro et al., 2013). Identification of concomitant metabolic 
abnormalities may assist healthcare professionals and patients to adopt feasible therapeutic 
modalities for the management and prognosis of PCOS. In the present study, we re-assessed the 
prevalence of MetS and risk factors for DM2 and CVD in a relatively large group of women in 
reproductive ages, using a carefully-defined PCOS population, advanced ultrasound technology, 
and rigorous outcome measures. We hypothesized that in women with PCOS 1) the prevalence 
of MetS, which can contribute to increased risk of CVD and DM2, is high during their 
reproductive-years; and 2) that MetS would exacerbate clinical and biochemical outcomes 
associated with PCOS. Our primary objective was to examine the prevalence rate and individual 
components of MetS, impaired glucose control, DM2, and risk factors for CVD in young women 
with PCOS. Secondly, we investigated the relevance of MetS to various clinical and biochemical 
characteristics in women who were diagnosed with PCOS. 
 
3.2. Materials and Methods 




Data were pooled from two separate prospective and cross-sectional studies on 279 
participants. Women were recruited by local newspaper advertisements, online bulletin posts, 
flyers available in physician offices, and placement of posters at the University of Saskatchewan 
and Royal University Hospital in Saskatoon, Canada between 2006 and 2016 for studies 
designed to evaluate ovarian morphology and the effects of lifestyle interventions in women with 
PCOS. The present study evaluated the baseline characteristics of women recruited for the 
purposed of the two abovementioned studies. Women aged 18-36 years that had any or a 
combination of irregular periods, unwanted facial and body hair growth, and/or a family history 
of DM2 were included and assessed to confirm the diagnosis of PCOS. Women with the 
following conditions were excluded: used hormonal and/or fertility medications within the last 3 
months of recruitment; women who took anti-seizure or anti-psychotic medications which are 
known to induce IR and PCO; women diagnosed with untreated hyperprolactinemia or thyroid 
disease; or, excessive adrenal androgen production confirmed by a diagnosis of congenital 
adrenal hyperplasia, Cushing’s syndrome, or an adrenal tumor. Age-matched healthy women 
were recruited for the control group and were assessed to confirm the absence of PCOS. A subset 
of participants evaluated in the present study was used to explore the prevalence of PCOS using 
updated sonographic thresholds for polycystic ovaries (Clark et al., 2014). PCOS was diagnosed 
according to the AE-PCOS Society criteria (Azziz et al., 2006), which also complied with the 
newest AE-PCOS Society recommendations for polycystic ovarian morphology as described 
elsewhere (Dewailly et al., 2014). The 2005 International Diabetes Federation consensus 
statement in collaboration with American Heart Association/National Heart, Lung, and Blood 
Institute was applied for the diagnosis of MetS. The presence of at least three of the following 
five metabolic risk factors constituted a diagnosis of MetS: FPG levels ≥5.6 mmol/L; TG levels 
≥1.7 mmol/L; HDL-C levels ≤1.3 mmol/L; elevated BP ≥130/85 mmHg; and, abdominal obesity 
(using ethno-specific cut-points) (Alberti et al., 2009). Study protocols were approved by the 
University of Saskatchewan Biomedical Research Ethics Board. Participants provided informed 
written consent to be enrolled in the studies. All procedures were conducted in compliance with 
the Declaration of Helsinki principles and the Guidelines for Good Clinical Practice in research.  
3.2.2. Study Procedures 
A standardized medical and physical examination was performed to obtain demographic, 




menstruation patterns as described previously (Clark et al., 2014; McBreairty et al., 2017). The 
presence and degree of acne vulgaris were recorded. Acanthosis nigricans was observed as 
velvety, dark-pigmented, hyperkeratotic areas affecting areas of flexural skin, including neck, 
axillae, under the breast, abdomen, and groin. Ovarian ultrasound scans were performed as 
described previously (Clark et al., 2014; McBreairty et al., 2017).  
Women were screened for glucose intolerance and IR using a standard 75-g OGTT, as 
described elsewhere (Goldenberg & Punthakee, 2013; McBreairty et al., 2017). Fasting blood 
samples were collected between 8:00 and 9:00 am, following a 10-12 hour overnight fast.    
3.2.3. Hormonal and Biochemical Analyses 
Hormonal and biochemical metabolites evaluated were testosterone, FSH, LH, SHBG, 
total cholesterol, LDL-C, HDL-C, TC/HDL-C ratio, TG, hsCRP, and HbA1c. Estradiol, 
progesterone, prolactin, 17-hydroxyprogesterone, dehydroepiandrosterone sulfate, and thyroid 
hormones were evaluated to exclude the endocrinopathies that mimicked the clinical symptoms 
and signs of PCOS. Fasting blood samples were taken when dominant follicles and corpora lutea 
were sonographically absent on days 1-5 of regular, predictable cycle lengths, or on random days 
for women with irregular/absent periods. All samples were analyzed immediately, or during the 
first week of the collection after freezing at -80 °C. 
Concentrations of plasma insulin concentrations and serum total testosterone (by solid-
phase, enzyme-labeled, competitive chemiluminescent immunoassay) were measured on 
Immulite 2000 Systems Analyzers (Tarrytown, USA) with Roche kits (Basel, Switzerland). The 
remaining metabolites were analyzed using Roche Cobas Modular Analyzers and Roche kits, 
with HbA1c analyzed using the turbidimetric inhibition immunoassay, plasma glucose using the 
hexokinase method, serum SHBG using the solid-phase, enzyme-labeled competitive 
chemiluminescent immunoassay, hsCRP using a particle-enhanced immunoturbidimetric assay, 
serum TG and cholesterol using the colorimetric assay, and serum FSH, and LH using the 
electrochemiluminescence immunoassay. Inulin resistance was estimated by the homeostasis 
model assessment of IR (HOMA-IR) method using the formula fasting plasma insulin (µIU/mL) 
× fasting plasma glucose (mg/dL)/405. The intra- and inter-assay coefficients of variation were 
<6.8% consistent with good assay performance in both PCOS and control populations. 




Statistical analyses were performed using the SPSS version 22.0 (Chicago, USA). 
Continuous and categorical variables were presented as mean±SD and percentages, respectively. 
For between-group comparisons, Student's t-tests were used for continuous variables, with chi-
squared analyses with the Pearson and Fisher’s Exact tests for categorical variables. Analysis of 
covariance was used to adjust for body mass index (BMI) differences between groups (control vs 
PCOS and PCOS with MetS [PCOS-MetS] versus PCOS without MetS [PCOS-noMetS]) for 
continuous variables, with logistic regression, when comparing the categorical outcome 
measures. Results were considered significant at P≤0.05. 
 
3.3. Results 
3.3.1. Demographic, Anthropometric, and Clinical Characteristics 
Of the 279 women examined, two-hundred and thirty-seven women were diagnosed with 
PCOS and 42 were designated as controls. Women with PCOS were subcategorized according to 
the presence or absence of MetS: PCOS-MetS (n=70) or PCOS-noMetS (n=167). Participant 
characteristics are presented in Table 5. Age and ethnicity were not different between groups. 
BMI was higher in the PCOS group versus controls (P<0.001) and in the PCOS-MetS group 
versus the PCOS-noMetS group (P<0.001).  
Women with PCOS had a higher maximum duration between bleeding intervals 
(P=0.005) and a tendency (P=0.06) for shortest intervals between bleedings to be increased 
compared to controls. The PCOS-MetS group had earlier menarche than the PCOS-noMetS 
group (P=0.03), with differences remaining significant after adjustment for BMI (P=0.02, Table 
5).  
Women with PCOS had a higher prevalence of hirsutism and acanthosis nigricans than 
controls (P<0.001). Hirsutism and acanthosis nigricans were more frequent in PCOS-MetS group 
than in the PCOS-noMetS group (P<0.001). The observed hirsutism (P=0.04) and acanthosis 
nigricans (P <0.001) trends remained significant after adjustment for BMI (i.e., PCOS versus 
controls and PCOS-MetS versus PCOS-noMetS groups). The PCOS-MetS group had increased 
severity of acne vulgaris than the PCOS-noMetS group (P=0.05). Groups did not differ in the 
prevalence of DM2, CVD and hypertension, among first- and second-degree relatives (Table 5). 





The overall prevalence of MetS was 29.5% (70/237) in the PCOS group versus 4.8% 
(2/42) in controls. FPG, systolic BP, WC, and TG levels were higher, and HDL-C lower in the 
PCOS group than in controls (P≤0.05, Table 5). The most prevalent components of the MetS in 
women with PCOS were increased WC (73.8% [175/237]) and reduced HDL-C levels (53.2% 
[126/237]), followed by hypertriglyceridemia (21.1% [50/237]) and hypertension (19.0% 
[45/237]). Elevated FPG (8.4% [20/237]) was the least common component of MetS. The PCOS-
MetS group had higher levels of all MetS components when compared with PCOS-noMetS 
group; trends remained significant after BMI adjustments (P≤0.001). The prevalence of MetS 
across BMI and age groups among women with PCOS is shown (Figure 2). The prevalence of 
MetS increased with BMI and age in women with PCOS (P<0.001). We observed no differences 
in the overall prevalence rate and the prevalence of individual components of MetS by ethnic 
background among groups. 
Women with PCOS had increased levels of WC, LDL-C, TC/HDL-C ratio, and hsCRP 
(P≤0.03) compared with controls. The PCOS-MetS group exhibited higher TC, LDL-C, 
TC/HDL-C ratio, and hsCRP (P≤0.006) levels than the PCOS-noMetS group. The TC (P=0.01) 
and TC/HDL-C (P<0.001) levels remained higher in PCOS-MetS group compared with the 
PCOS-noMetS group after adjustment for BMI. 
3.3.3. Prevalence and Characteristics of Glucose Intolerance 
Of the 279 participants, 237 completed the GTT. Twenty-one percent (50/237) of women 
with PCOS had impaired fasting glucose (IFG), IGT, or DM2 compared with 4.8% (2/42) of 
controls. In the PCOS group, less than half (47.1% [33/70]) of women with MetS were 
normoglycemic as opposed to 92.2% (154/167) without MetS (Table 5). After BMI-adjustment 
there were higher rates of IFG, IGT, and DM2 in the PCOS group than controls (P=0.03) and in 
PCOS-MetS (P=0.001) than PCOS-noMetS. Similarly, the PCOS and the PCOS-MetS groups 
exhibited higher levels of fasting insulin, 2-hour insulin, 2-hour glucose, and HOMA-IR than 
controls and women with PCOS-noMetS, respectively (P<0.001). Following the OGTT, 2-hour 
insulin (P=0.01) and glucose (P=0.001) concentration remained significantly higher in the 
PCOS-MetS group compared with the PCOS-noMetS group after BMI adjustment.  
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Table 5. Demographic, anthropometric, clinical, and laboratory characteristics of women with PCOS and controls without PCOS at 
the time of PCOS diagnosis (n=279) 









Age (year) 27.7±4.6 26.5±4.1 0.11 28.8±4.3 27.3±4.6 0.02
































Menarche (age in year) 12.6±2.3 12.6±1.3 0.88 12.1±0.3 12.8±1.6 0.02a
Shortest interval between 
bleeding (d) 
43.82±67.7 23.8±5.5 0.06 49.8±73.0 37.5±58.5 0.16 
Longest interval between 
bleeding (d) 
180.2±300.1 46.8±33.2 0.005 169.2±200.9 156.0±303.4 0.74 
Clinical measures 
Presence of hirsutism (n [%]) 164 [69.2] 0 <0.001
a 54 [77.1] 110 [65.9] <0.001a 























Presence of acanthosis 
nigricans (n [%]) 
123 [51.9] 3 [7.1] <0.001a 49 [70.0] 74 [44.3] <0.001a 
Family history of DM2 (n [%]) 164 [69.2] 27 [64.3] 0.16 48 [68.6] 116 [69.5] 0.64
Family history of CVD and/or 
hypertension (n [%]) 
166 [70.0] 30 [71.4] 0.38 52 [74.3] 114 [68.3] 0.26 
Anthropometric measures 
     Weight (kg) 87.1±24.4 65.0±12.3 <0.001 105.6±21.8 79.1±21.0 <0.001




BMI (kg/m2) 32.2±8.6 23.6±3.9 <0.001 38.9±6.9 29.2±7.6 <0.001
MetS prevalence (n [%]) 70 [29.5] 2 [4.8] <0.001a – – –
MetS components 
FPG (mmol/L) 5.0±0.6 4.8±0.3 0.05 5.4±0.9 4.8±0.3 <0.001a
WC (cm) 103.1±20.1 84.7±11.8 <0.001 118.7±15.9 96.3±18.0 <0.001
Systolic BP (mmHg) 116.8±10.0 111.3±8.2 0.002 122.0±11.1 114.7±8.8 <0.001a
Diastolic BP (mmHg) 76.4±11.8 74.8±18.6 0.49 81.9±16.5 74.2±8.3 <0.001a
TG (mmol/L) 1.3±0.8 0.8±0.4 0.001 2.0±0.9 1.0±0.73 <0.001a
HDL-C (mmol/L) 1.3±0.3 1.6±0.4 <0.001 1.0±0.2 1.4±0.3 <0.001a
Other lipid profile measures 
TC (mmol/L) 4.6±0.9 4.4±0.7 0.20 4.9±0.9 4.5±0.9 0.001a
LDL-C (mmol/L) 2.9±0.8 2.5±0.6 0.03 3.0±0.7 2.7±0.8 0.006
TC/HDL-C 3.8±1.2 2.9±0.8 <0.001a 4.9±1.0 3.3±1.0 <0.001a
Glycemic control measures 
      Normoglycemic (n [%])  
      IFG and/or IGT† (n [%])  

















      Fasting insulin (µIU/mL) 14.3±13.7 5.0±2.7 <0.001 19.2±11.3 10.7±13.0 <0.001
2-hour OGTT† insulin 
(µIU/mL) 
79.6±64.8 35.8±19.7 <0.001 114.6±71.5 54.1±48.4 <0.001a 
2-hour OGTT† glucose 
(mmol/L) 
6.2±2.0 4.8±1.1 <0.001      7.5±2.0 5.6±1.4 <0.001a 
HOMA-IR  2.4±2.4 0.8±0.4 <0.001 3.4±2.2 1.9±2.4 <0.001
HbA1c (%) 5.1±1.0 5.0±0.3 0.29 5.4±0.7 4.0±1.0 0.001
hsCRP (mg/L)  4.1±4.5 0.8±1.0 0.003 6.8±6.1 3.5±7.8 0.003
Endocrine parameters 
LH/FSH ratio 2.2±1.6 1.2±0.8 <0.001a 2.0±0.1 2.2±1.8 0.23
Total testosterone (nmol/L) 2.0±1.2 1.6±1.7 0.04 2.1±1.3 2.0±1.2 0.35
     SHBG (nmol/L) 38.7±25.4 61.3±26.9 <0.001a 26.5±12.5 43.6±27.5 <0.001a
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PCOS, polycystic ovary syndrome; MetS, metabolic syndrome; DM2, type 2 diabetes; CVD, cardiovascular disease; BMI, body mass 
index; FPG, fasting plasma glucose; WC, waist circumference; BP, blood pressure; TG, triglyceride; HDL-C, high–density lipoprotein 
cholesterol; TC, total cholesterol LDL-C, low-density lipoprotein cholesterol; IFG, Impaired fasting glucose; IGT, impaired glucose 
tolerance; OGTT, oral glucose tolerance test; HOMA-IR, homeostatic model assessment of insulin; HbA1c, glycated hemoglobin; 
hsCRP, highly sensitive C–reactive protein; LH, luteinizing hormone; FSH, follicle stimulating hormone; SHBG; sex–hormone 
binding globulin.  
Values are mean±SD except indicated otherwise. *Student t-test and chi-squared test were used for comparisons of means and 
proportions between the two groups of women with PCOS and controls without PCOS, and among women with PCOS between the 
two groups with and without MetS. †n=225. 
aP value≤0.05 when adjusted for BMI between the two groups using analysis of covariance for continuous variables and logistic 
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The prevalence of MetS was different across the three BMI and age categories (P<0.001). Unlike non-obese BMI classes, differences 
in the prevalence rate of MetS between age categories remained significant (P<0.01) in obese women with PCOS (BMI≥30 kg/m2). 
White bars, women with 18–24 years of age; grey bars, women with 25–30 years of age; Black bars, women with 30–36 years of age. 
Abbreviations: MetS: metabolic syndrome; BMI, body mass index; PCOS, polycystic ovary syndrome. 
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Our study is unique in characterizing the metabolic profile of women diagnosed with 
PCOS who demonstrate a higher diagnostic threshold for the polycystic ovary (PCO). The 
diagnosis of PCOS utilized the 2006 diagnostic criteria and also complied with the 2013 
recommendation for the PCO. In 2013 the AE-PCOS Task Force increased PCO threshold from 
>12 to >25 follicles 2-9 mm diameter (Dewailly et al., 2014). Many women without PCOS had 
polycystic ovaries according to the 2006 criterion. Our study also evaluated a subset of women 
diagnosed with PCOS who expressed menstrual cyclicity. Many researchers and clinicians have 
expressed concern that women with menstrual cyclicity did not have PCOS. However, a higher 
threshold for the PCO and hyperandrogenicity may increase confidence in the diagnosis of 
PCOS when the higher PCO threshold and hyperandrogenicity coexist. We prospectively 
recruited women with PCOS and healthy aged-matched controls in Saskatchewan, Canada. 
Recruits from 2 studies were pooled to increase our ability to identify their characteristics of 
PCOS.  
We adopted ethno-specific adjustments to determine abdominal obesity and hirsutism. 
The prevalence rate of MetS was 29.5% in women with PCOS, nearly 6-fold higher than the age-
matched control group without PCOS. Our findings align with previous evidence about the high 
prevalence rates of MetS in western populations with PCOS (Apridonidze et al., 2005; Ehrmann 
et al., 2006).  
Glucose homeostasis abnormalities including acanthosis nigricans, insulin resistance, 
estimated by HOMA-IR and exaggerated insulin and glucose responses to OGTT were common 
in women with PCOS compared with age-matched controls. Traditional CVD risk factors were 
seen in the PCOS group including higher levels of BMI, SBP, hsCRP, abdominal obesity, and 
worse dyslipidemia with lower HDL-C, and higher TG, LDL-C, and TC/HDL-C compared with 
controls.  
The features of MetS were noted in many women with PCOS. Insulin and glucose 
responses to OGTT were more abnormal compared with the MetS-free women; TC and 
TC/HDL-C ratio were higher in women with both PCOS and MetS compared with MetS-free 
women with PCOS, even after matching for BMI. Hyperinsulinemia secondary to IR stimulate 
ovarian theca compartment dysregulation and dysfunction of endothelial cells, leading to 




including androgen-dependent hirsutism and acne vulgaris, through pre-established mechanisms 
(E Diamanti-Kandarakis & A Dunaif, 2012). The severity of hirsutism and severity of acne 
vulgaris in women with PCOS were more pronounced in women with MetS. Hirsutism and acne 
can be exacerbated by higher levels of IR and BMI. Acanthosis nigricans was present in more 
than half of women with PCOS and in 70% of women who had both PCOS and MetS conditions. 
Decreased SHBG and increased total testosterone concentrations consistent with the endocrine 
profile of PCOS. After BMI adjustment, lower levels of SHBG were observed in the PCOS-
MetS group when compared with the PCOS MetS-free group. Our observations may be due to 
the complex interplay among deteriorated insulin sensitivity, deregulation of hypothalamic-
pituitary-adrenal and ovarian axes, chronically stimulated LH secretion, and ovarian and adrenal 
androgen hyper-responsiveness (Indran et al., 2016). 
Most (70.9%) women with PCOS were obese or overweight, consistent with the findings 
of previous studies (Barber et al., 2006; Norman et al., 2002). A unique aspect of the present 
study was the assessment of the influence of age and BMI categories on MetS in women with PCOS. 
We observed a progressive increase in the prevalence rate of MetS with age and BMI in the 
PCOS population, but not in controls. Unlike non-obese BMI classes, we observed an interaction 
between age and obesity (BMI≥30 kg/m2) in women with PCOS in the prevalence rate of MetS, 
indicating adverse effects of aging on the risk of MetS in obese women with PCOS. 
Age and BMI have been recognized as independent risk factors for MetS (Barber et al., 
2006). Interestingly, after adjustment for BMI, women with PCOS had higher prevalence rates of 
MetS, glucose metabolism alterations (IFG/IGT/DM2) and levels of TC/HDL-C compared with 
age-matched controls. The observed metabolic perturbations in the PCOS group may be due to 
peripheral IR and hypersecretion of insulin as common driving forces for the overlapping 
metabolic abnormalities of PCOS with MetS (E Diamanti-Kandarakis & A Dunaif, 2012).  
Women with PCOS exhibited worsened individual components of MetS compared with 
controls, most prominently increased WC and decreased HDL-C levels and corresponds to 
previous studies (Apridonidze et al., 2005; Soares et al., 2008). In addition to low HDL-C levels, 
women with PCOS exhibited elevated LDL-C, TG, and TC/HDL-C, hsCRP and SBP levels 
compared with controls. The high prevalence rate of MetS, IR, impaired glucose tolerance, 
central adiposity, and dyslipidemia have been recognized as detrimental cardiovascular risk and 




women with PCOS displayed non-traditional surrogate cardiometabolic risk markers including 
hyperandrogenism and chronic inflammation (Chiu et al., 2017). Hyperandrogenism can increase 
the risk of premature atherosclerosis in women with PCOS by inducing oxidative stress, 
exacerbating chronic inflammation, promoting endothelial dysfunction, stimulating the activity 
of the intrarenal renin-angiotensin system, deregulating appetite, and increasing carotid intima-
media thickness (Chen et al., 1992; Chiu et al., 2017; Diamanti‐Kandarakis et al., 2006; Fenkci 
et al., 2003; Kravariti et al., 2005; Luque-Ramírez et al., 2007). Elevated CRP level, an indicator 
for low-grade chronic inflammation, is a reliable and independent predictor of CVD and DM2 
(Duleba & Dokras, 2012). Inflammatory markers, such as hsCRP, can directly induce excess 
ovarian hyperandrogenism and promote atherosclerotic processes and endothelial cell 
inflammation independent of the cascade of molecular events that characterize metabolic 
aberration in PCOS (González et al., 2006; Ortega et al., 2014; Piotrowski et al., 2005). In the 
present study, 73.8% of women with PCOS had abdominal obesity, indicated by increased WC, 
similar to previous reports (Norman et al., 2002). Obesity is a chronic proinflammatory and 
prooxidant state that induces molecular alterations involved in the mechanisms of anovulation, 
hyperandrogenism, and metabolic disruptions in PCOS (Abdelhadi et al., 2013; González, 2015; 
González et al., 2013; González et al., 2012; Vendrell et al., 2004; Vincent & Taylor, 2005). 
Accumulation of visceral fat leads to excessive production of proinflammatory cytokines (mainly 
tumor necrosis factor-α and interleukin-6), non-esterified fatty acids, glycerol, and retinol-
binding protein; increases the secretion of leptin, resistin, and visfatin; and decreases the 
production of adiponectin, which can lead to the development of IR (Kahn et al., 2006; Vendrell 
et al., 2004).  
Our findings support the notion that reproductive-age women with PCOS have a 
substantial prevalence rate of MetS and exhibit adverse cardiometabolic and DM2 risk profiles. 
It is imperative to screen for metabolic abnormalities, including IGT, DM2, and dyslipidemia, 
for all women with PCOS, especially in women with increased BMI and age, at the time of 
diagnosis and regular follow up visits. The American College of Obstetricians and Gynecologists 
and the Endocrine Society recommended screening for IGT and DM2, using a standard 2-hour 
OGTT, and for dyslipidemia with a lipid profile for all women with PCOS ("American College 




108," 2009; Legro et al., 2013). However, screening for metabolic abnormalities is underutilized 
by clinicians and is not a standard practice.  
Study limitations included the potential for recall bias regarding obtaining the medical 
history related to menstruation patterns and the familial history of disease; and our inability to 
match the PCOS and control groups for BMI and sample size. Our PCOS group had higher BMI 
and WC than controls consistent with the anthropometric characteristic of women with PCOS. 
Thus, our results may have relevant implications for clinical practice. 
Given the paucity of evidence, future studies are warranted to determine the magnitude of 
metabolic abnormalities associated with PCOS. Disclosure of a pattern of impaired glucose 
metabolism and early metabolic aberrations may motivate and encourage the affected women to 
adopt healthy lifestyle behaviours, such as diet, physical activity, and use of appropriate medical 
therapies to improve their condition. Early recognition of metabolic abnormalities can provide 
clinicians with preventive and management options, including lifestyle modifications and 
pharmaceutical modalities, such as insulin-sensitizing agents, to control the signs and symptoms 
of PCOS and to prevent or delay the long-term comorbidities associated with PCOS, including 
CVD and DM2.  
As Objective і of the thesis, the contribution of the clinical and biochemical aberrations 
associated with PCOS to CVD and DM2 cardiometabolic risk profiles were evaluated. The 
results of the present study are important to convey the risk factors for women with PCOS. 
Controversy surrounds the optimal diet composition to mediate PCOS-associated reproductive 
disruptions. Chapter 4 of this thesis represents the first component of the thesis Objective іі – to 
compare the influence of a pulse-based diet with the standard TLC diet on reproductive health 
outcome measures in women with PCOS who also participated in an aerobic exercise program 







EFFECTS OF THE LIFESTYLE INTERVENTION ON REPRODUCTIVE HEALTH 
OUTCOMES IN WOMEN WITH PCOS 
Kazemi M, Pierson RA, McBreairty LE, Chilibeck PD, Zello GA, Chizen DR.  
Insulin and ovarian morphology changes in polycystic ovary syndrome: a pulse-diet and 
exercise randomized controlled trial* 
*format and structure of the original manuscript have been revised to provide a better flow 
within the thesis and be consistent with the format of previous chapters. 
Abstract 
Background and objective: Controversy surrounds the optimal diet composition to 
mediate PCOS-associated reproductive disruptions. The purpose of current work was to compare 
the influence of a pulse-based diet (i.e. a low-glycemic index diet including lentils, beans, split 
peas, and chickpeas) with the standard TLC diet, on insulin response to the standard OGTT, 
ultrasonographic markers of ovarian and uterine morphology, hyperandrogenism, and menstrual 
regularity in PCOS.  
Methods: Participants and Intervention: Ninety-five women with PCOS (18-35y) enrolled 
in a 16-week lifestyle changes program; 30 assigned to receive the pulse-based diet and 31 in 
TLC diet group completed the study. All women participated in an aerobic exercise program and 
received education and counselling about PCOS and lifestyle modification. 
Results: Women in the pulse-based diet group had a greater reduction in total area under 
the curve (AUC) for insulin response to OGTT (mean change±SD: -121.0±229.9 vs -27.4±110.2 
µIU/mL/min; P=0.05) than the TLC diet group. AFC and ovarian volume in the right 
(P<0.00001; P<0.001) and left ovaries (P<0.001;  P<0.0001), testosterone levels (P=0.05), 
average (P<0.01) and longest (P<0.001) intervals between menses decreased in both groups. 
Endometrial thickness (P=0.02) and pattern (P<0.001) increased in both groups. Sex-hormone 
binding globulin levels increased (P=0.0001) in both groups with a tendency for a group-by-time 




Conclusions: Both ad libitum lifestyle interventions improved ultrasonographic markers 
of ovarian and uterine morphology, hyperandrogenism, and menstrual bleeding intervals. The 
pulse-based diet was more effective for decreasing total insulin AUC in women with PCOS.  
 




PCOS is a heterogenous endocrinopathy and the worldwide leading cause of 
anovulatory infertility among reproductive-age women with a prevalence of up to 18% 
(Carmina & Lobo, 1999; March et al., 2010). Most women with PCOS present with 
hyperinsulinemia, IR, hyperandrogenism, oligo-amenorrhea, enlarged, and PCO. 
Ultrasonographic examination of the PCO reveals an “increased number of pre-antral and 
antral follicles” distributed peripherally around or scattered through a bright echodense 
stroma due to disruptions at multiple stages of folliculogenesis (Azziz et al., 2006; 
Stephen Franks et al., 2008; Jonard & Dewailly, 2004).  
Lifestyle modifications, comprised of dietary, exercise, and cognitive behavioural 
therapies, are recommended as the first-line strategy to mediate reproductive health 
outcomes in PCOS ("Practice Committee of American Society for Reproductive 
Medicine, Society for Reproductive Endocrinology and Infertility. Optimizing natural 
fertility: a committee opinion," 2013). However, a dietary composition optimized to 
ameliorate the reproductive sequelae of PCOS is less clear. A pulse-based diet has the 
potential to improve the metabolic changes associated with PCOS that culminate in 
reproductive problems. Pulses, that is, split-peas, beans, lentils, and chickpeas, are high in 
fiber, contain complex carbohydrates with a low GI are low in fat, contain high-quality 
protein, have low sodium content, and are a significant source of vitamins and minerals, 
such as iron, zinc, folate, calcium, magnesium, and potassium (Mudryj et al., 2014). 
Chronic consumption of pulses in other populations has been associated with decreased 
postprandial blood glucose and insulin concentrations, decreased lipids, and reduced 
obesity (Ha et al., 2014; McCrory et al., 2010; Sievenpiper et al., 2009). Insulin 




exacerbate PCOS reproductive sequelae (E Diamanti-Kandarakis & A Dunaif, 2012). 
The TLC diet, endorsed by the NCEP ATP III, is nutritionally balanced, with high fiber 
levels, reduced saturated fat and cholesterol, and options to include LDL-C lowering 
dietary components such as viscous fiber and plant stanol/sterol esters ("The NCEP ATP 
III final report," 2002). The TLC diet was considered, for our study, as a healthy control 
diet with the potential to improve PCOS reproductive abnormalities. We were unable to 
find a study involving women with PCOS where either a pulse-based or TLC diet were 
evaluated and where calorie restriction was not an integral component of the dietary 
alteration. We hypothesized that using diets with no energy restriction and where all 
participants were encouraged to exercise regularly, reproductive health outcome 
measures would improve when women with PCOS consumed a low-GI, pulse-based diet 
when compared to a standard TLC diet. Further, we hypothesized the pulse-based diet is 
more effective compared to the TLC diet after 6 and 12 months post-intervention to 
maintain improvements in reproductive outcome measures. 
 
4.2. Materials and Methods 
4.2.1. Study Design and Protocol 
A multi-disciplinary, single-blind, metformin-stratified, parallel group randomized 
controlled trial design was conducted between April 2011 and June 2016 with women diagnosed 
with PCOS, in Saskatoon, SK, Canada at an academic research center. The primary objective of 
the trial was the assessment of reproductive outcomes, and the secondary outcome was an 
evaluation of MetS risk. Women were randomly allocated to receive either a pulse-based diet or 
the TLC diet after exclusion criteria were applied (McBreairty et al., 2017). As a standard of 
care, all women were enrolled in an aerobic training program and received education and 
counselling about PCOS and the value of lifestyle modifications in the management of the 
syndrome.  
Participants were randomly allocated into one of the two diet groups after following the 
TLC diet for two weeks. Randomization was done with a computer-generated allocation 
schedule performed by an investigator who was not involved in obtaining, entering, or analyzing 
participant data. Randomization was stratified based on the current use of metformin, using a 




generator. Participants were notified of diet allocation via email (and were not blinded). 
Although the participants were not blinded to the diet assignment, they were blinded to the 
hypothesis that the low-GI pulse-based diet would be more effective than the TLC diet to 
improve the risk of MetS. The allocation sequence was concealed from the dietitian who 
educated women about the TLC diet at baseline, as well as from individuals performing exercise 
training and data entry. The participants and group allocations were coded, and the investigators 
collecting and analyzing data were blinded to group assignment. 
The pulse-based diet included soups, salads, and main course meals prepared with yellow 
split peas, green lentils, red split lentils, chickpeas, pinto, black, and kidney beans. Two meals 
(i.e., lunch and dinner) were supplied daily for participants in the pulse-based diet group. Each 
meal contained approximately 90 g of split peas or 225 g of chickpeas or beans or 150 g of 
lentils (cooked weight). The amount of dietary pulses in each meal was based on the amounts 
that have been beneficial for reducing blood glucose and lipid concentrations in prior 
investigations (Abeysekara et al., 2012; Schäfer et al., 2003; Shutler et al., 1989).  
Each participant received a 1.5-hour, individualized dietary consultation session by a 
registered dietitian who was blinded to the intervention assignment. During the session, all 
women received a guide booklet outlining TLC diet guidelines. The guidelines were developed 
by the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol 
in Adults ("The NCEP ATP III final report," 2002). A second dietitian who was not blinded to 
the randomization provided dietary consultation sessions after all women followed the TLC diet 
for two weeks. Women who were randomized to the pulse-based diet group were counselled to 
follow the TLC diet recommendations for breakfast and snacks. Women who were randomized 
to the TLC diet were instructed to consume minimal intake of dietary pulses, and consume low-
fat cuts of meat and poultry and low fat or skim dairy as the main sources of protein, according 
to the TLC diet guidelines ("The NCEP ATP III final report," 2002). Caloric restriction was not 
part of the protocol design. Dietary intake was assessed using 24-hour dietary recall. Dietary 
intake data were analysed using the ESHA Food Processor SQL Software (version 7.02, ESHA 
Research, Salem, OR).  
Each participant received standardized aerobic exercise training and was counselled to 
exercise for a minimum of 5 d/wk for 45 min/d of low-impact aerobic activity at an intensity 




elliptical, cycling, and rowing machines, or stationary bike jogging, or any other aerobic exercise 
depending on the participants’ preferences. Leisure time physical activity (i.e., physical activity 
outside the intervention) was evaluated using the Godin Leisure-Time Exercise Questionnaire 
(Godin & Shephard, 1985).  
As a standard of care, before randomization to the diet groups each participant received 
two sessions of education and counselling for approximately four hours by a gynaecologist, MSc 
and PhD researchers who were knowledgeable about reproductive endocrinology and clinical 
nutrition. Topics included the human menstrual cycle, ovarian morphology in normal ovulating 
women, polycystic ovarian morphology, criteria used to diagnose PCOS and pathophysiology of 
PCOS. Other issues included determinants of health risk, complications and associated 
comorbidities of PCOS, medical, and diet and exercise lifestyle options to manage PCOS.  
The trial protocol was approved by the Biomedical Research Ethics Board at the 
University of Saskatchewan. Before participants were enrolled in the study, consent was 
obtained in writing. All procedures were conducted in compliance with the World Medical 
Association Declaration of Helsinki, the Guidelines of the International Conference on 
Harmonization on Good Clinical Practice, and the Tri-Council Policy Statement on the Ethical 
Conduct for Research Involving Humans. We adhered to the CONSORT guidelines for reporting 
on randomized clinical trials (Schulz et al., 2010). The trial was registered at ClinicalTrials.gov 
(https://clinicaltrials.gov/, NCT01288638. Lifestyle Intervention for Polycystic Ovary Syndrome: 
Pulse-Based Diet and Exercise). 
4.2.2. Participants  
Recruitment was carried out by local newspaper advertisements, online bulletin posts, 
flyers available in physician offices, and placement of posters at the University of Saskatchewan 
and Royal University Hospital in Saskatoon, Canada. Three hundred twenty-four women 
responded to the recruitment advertisement. Ninety-five women, 18 to 35 years of age, who met 
the diagnostic criteria for PCOs were eligible for inclusion and were enrolled in the study.  
After informed consents were obtained, women were enrolled if they met the following 
inclusion criteria: were between 18 to 35 years of age, had irregular periods, unwanted facial 
and/or body hair growth, and infertility. Women with the following conditions were excluded: 
used hormonal and/or fertility medications within the last 3 months of recruitment; took anti-




untreated hyperprolactinemia or thyroid disease; or, exhibited excessive adrenal androgen 
production confirmed by a diagnosis of congenital adrenal hyperplasia, Cushing’s syndrome, or 
an adrenal tumor. Further, women with medical or dietary conditions that were limited in 
exercising or consumption of a pulse-based diet (allergies or intolerances) were excluded.  
The diagnosis of PCOS was made according to the 2006 AE-PCOS Society criteria 
(Azziz et al., 2006) and complied with the 2014 AE-PCOS Society guidelines for polycystic 
ovarian morphology (a threshold of ≥25 antral follicle counts) (Dewailly et al., 2014). The 
diagnosis of MetS was made according to the 2005 International Diabetes Federation in 
collaboration with the American Heart Association/National Heart, Lung, and Blood Institute 
criteria (Alberti et al., 2009). Barrier contraceptive methods and a negative pregnancy test were 
required.  
Women were screened for glucose intolerance and IR before and after the lifestyle 
intervention using a standard 2-hour 75-g OGTT. Blood samples were taken before, and 
following oral ingestion of a standard drink containing 75 g of glucose (Trutol 75; Thermo 
Scientific Inc., East Providence, RI, USA), every 30 minutes for 2 hours, using an intravenous 
catheter placed in the distal arm as previously described (McBreairty et al., 2017). Initial blood 
samples were collected between 8:00 and 9:00 am, after fasting overnight for 10 to 12 hours. 
Blood was collected in 6 mL EDTA and 10 mL empty collection tubes at baseline and at 30, 60, 
90, and 120 mins following the consumption of the glucose drink. Plasma and serum samples 
were obtained by hospital staff by aliquoting samples into cryogenic vials which were frozen at -
80 °C for future analysis of biochemical markers including glucose, lipid, and endocrine 
parameters as described in the biochemical analysis section below.  
4.2.3. Ultrasonography Procedures and Measurements 
Two experienced ultrasonographers performed transvaginal ultrasound scans using a 
standardized protocol for collecting ultrasonographic images and cine loops of the ovaries. 
Ovaries were scanned from inner to outer margins in the longitudinal and transverse planes using 
a Voluson E8 Expert (GE Medical Systems, Zipaf, Austria) and a three-dimensional 6-12-MHz 
transvaginal transducer. Scans were obtained during days 1-5 of women’s menstrual bleeding 
cycles, with the first day of bleeding defined as day 1, or randomly if there was an absence of a 
dominant follicle (≥10 mm) or corpus luteum in women reporting irregular or absent cycles. 




cross-sectional view of each ovary (JPEG file format) were recorded for off-line analysis. 
Ovaries were examined in transverse and sagittal planes, and images were captured as real-time 
cine-loop recordings and 3-dimensional images. A single observer analyzed the stored ultrasound 
scans using Santesoft DICOM Editor software (Emmanouil Kanellopoulus, Athens, Greece) for 
the OV and AFC. Reliable follicle counts were achieved for each ovary by imposing a grid 
system onto the viewing window as previously described (Lujan et al., 2010; Lujan et al., 2013). 
The corresponding level of intra-observer agreement for AFC was 0.95, based on an interclass 
correlation coefficient analysis of follicle counts on 35 case files. OV was estimated using the 
equation for a prolate spheroid: ð/6 (transverse diameter) × (anteroposterior diameter) × 
(longitudinal diameter), when no follicles ≥10 mm in diameter were present.  
4.2.4. Menstrual Bleeding Intervals 
Intervals between menstrual bleeding (days) were recorded for the six months before the 
intervention and were tracked during the intervention via a self-report recall format. A menstrual 
bleeding interval was defined as the first day of bleeding to the start of a subsequent first day of 
bleeding. The shortest and the longest periods of time between bleeding intervals were recorded 
at baseline. Participants maintained a menstrual diary through the study and informed the 
researchers about the date on which menstrual bleeding began. The average length and the 
longest length between bleeding intervals were calculated. 
4.2.5. Biochemical Analyses 
Hormones and biochemicals evaluated included TT, estradiol, progesterone, FSH, LH, 
SHBG, and HbA1c; dehydroepiandrosterone sulfate, cortisol, prolactin, 17-hydroxyprogesterone, 
and thyroid hormones were measured to exclude endocrinopathies that mimicked the profile of 
PCOS. Plasma insulin and serum SHBG (Alpco Diagnostics, Salem, USA) were measured using 
high-sensitivity enzyme-linked immunosorbent assay, and plasma glucose (BioAssay Systems, 
Hayward, USA) by conventional colourimetric technique, using commercial kits. Serum TT by 
solid-phase, enzyme-labeled, chemiluminescent immunoassay was measured on Immulite 2000 
Systems Analyzers (Siemens Healthcare Diagnostics Inc., Tarrytown, USA) with Roche kits 
(Roche Diagnostics Ltd., Basel, Switzerland). The remaining metabolites were analyzed using 
Roche Cobas Modular Analyzers and Roche kits, with HbA1c analyzed using the turbidimetric 
inhibition immunoassay, and serum FSH and LH using the electrochemiluminescence 




al., 1975) were calculated as previously described. Fasting blood samples were taken when 
follicles ≥10 mm and corpora lutea were absent at ultrasonography done on days 1-5 of regular 
and predictable menstrual cycle lengths, or on random days for women with irregular/absent 
periods. Serial blood samples were taken pre-intervention, mid-intervention (9-weeks), and post-
intervention (16-weeks), as well as at 6- and 12-months post-intervention. All samples were 
analyzed by the Saskatoon Health Region Laboratories immediately or during the first week of 
the collection after freezing at -80 °C. The intra- and inter-assay coefficients of variation were 
<6.8% consistent with good assay performance in both groups.  
4.2.6. Statistical Analysis  
Statistical analyses were carried out according to intention-to-treat principles with 
analyses carried out on all participants. Analyses were performed using SPSS for Windows 
(version 22.0; SPSS Inc., Chicago, IL, USA). Categorical variables were presented as numbers 
and percentages and continuous variables as mean±SD, except in figures, where mean±SEM was 
used for clarity. For between-group comparisons at baseline, Student's t-tests were used for 
continuous variables with chi-squared analyses with the Pearson and Fisher’s Exact tests for 
categorical variables. To examine the differences in the outcome variables between women 
taking metformin compared with women not taking metformin, a three-factor ANOVA, with 
between-group factors (pulse-based vs TLC diet), and metformin (metformin users vs non-users) 
and a within-subjects factor of time (baseline and post-intervention) were used. If there were no 
metformin-group by time interactions, metformin groups were combined, and a two factor 
ANOVA was used to compare responses between groups (the pulse-based vs TLC diet groups) 
over all measurement time points (baseline, 16-week post-intervention, 6- and 12-month follow 
up) to increase the statistical power of the ANOVA. The area under the 2-hour response versus 
time curves (AUC) for insulin and glucose was determined using the trapezium rule (Tai, 1994). 
The incremental AUC, calculated as the increment in AUC over baseline concentrations, was 
used as summary measures of the postprandial insulin and glucose responses. The reliability 
analysis for the intra-observer agreement on ultrasound scan data was determined by Cohen's 
kappa statistic. Missing observations were assumed to be missing completely at random. Fasting 
blood samples and ultrasound scan data were collected nine weeks following the intervention 
(mid-intervention); mid-intervention data were carried forward for three women in the pulse-




missing data at the post-intervention time-point. To verify that mid-intervention data were an 
appropriate substitute for post-intervention, all analyses were also run using only participants 
who completed all testing time points (i.e., women who dropped out after mid-intervention were 
excluded from the secondary analysis). Long-term follow-up results of the study obtained at 6- 
or 12-months post-intervention were analysed in comparison to pre- and post-intervention data 
using repeated measure ANOVA as described above. For each ANOVA result that was 
significantly different 6- and 12-months post-intervention, pairwise comparisons were performed 
using a post hoc Bonferroni analysis to identify where the differences occurred. Changes in the 
mean fasting glucose from our previous pilot study (unpublished) on 28 women with PCOS were 
used to determine the required sample size for recruitment into the study. Changes in glucose 
levels were -0.18 and 0.14 mmol/L for the pulse-diet group and TLC group, respectively, with a 
population standard deviation of 0.46 and an effect size of -0.70. A sample size of 34 per group 
was determined to detect a significant difference in fasting glucose concentrations between 
groups at α=0.05 with 80% power, assuming an anticipated dropout rate of 32%. Mean estimates 
with corresponding 95% confidence intervals were calculated for each time-point. Results were 
considered significant at P<0.05. 
 
4.3. Results 
The participant flow through the phases of the clinical trial, along with losses and 
exclusions, is displayed in Figure 3. A total of 324 women responded to the recruitment 
advertisement; 95 were confirmed eligible and were enrolled in the study. Baseline 
characteristics of women enrolled in the study, including the use of metformin (1000-1500 
mg/day) were comparable in both groups (Table 6). Baseline characteristics of women 
randomized to receive the intervention who did not complete the intervention were not different 
when compared with women who completed the intervention. Thirty women in the pulse-based 
diet group and 31 in the TLC diet group completed the 16-week intervention. The loss to follow 
up was similar between intervention groups (P=0.94). Two women refused to complete the 
OGTT following the intervention due to lack of time. The final analysis included 64 women 
(n=33 in the pulse-based and n=31 in the TLC diet groups). Final numbers analyzed for each 
outcome measure are presented in the outcome tables and figures. The level of compliance with 




groups, respectively (P=0.09). A mean diet adherence of 5.5±0.4 and 5.3±0.3 d/wk was reported 
in the pulse-based and TLC diet groups, respectively (P=0.12). 
4.3.1. Metformin-Dietary Intervention Interactions  
Eighteen women (38.3%) in the pulse-based and 20 [41.7%] in the TLC diet groups used 
metformin (Table 6). There were no group by time by metformin interactions for any of the 
evaluated outcome measures (data not shown) (P>0.05). 
4.3.2. Anthropometric Measures  
Following the intervention, both pulse-based diet and TLC diet groups exhibited lower 
BMI (P=0.01) and WC (P=0.02) over time; no group by time interaction was observed. 
4.3.3. Endocrine Measures 
Following the intervention, FPG (P<0.01), fasting plasma insulin (P<0.01), and HOMA-
IR (P<0.001) decreased over time. There was a group by time interaction (P=0.05) for total 
insulin AUC with a greater decrease in the pulse-based diet group compared with the TLC diet 
group. Incremental insulin AUC (P=0.03), total (P<0.0001), and incremental (P<0.01) glucose 
AUC decreased over time without a group by time interaction. The LH/FSH ratio (P=0.03), TT 
(P=0.05), and SHBG (P<0.001) concentrations decreased over time in both groups, with a 
tendency for a group-by-time interaction for SHBG (P=0.07; Table 7).  
4.3.4. Ultrasonographic Markers of Ovarian and Uterine Morphology 
AFC in the left (P<0.001) and right ovaries (P<0.001), as well as OV in the left 
(P<0.0001) and right (P<0.00001) ovaries decreased over time without a group by time 
interaction (Table 7).  
4.3.5. Menstrual Cyclicity 
The average (P<0.01) and longest (P<0.001) period of time between spontaneous 
menstrual bleeds decreased over time in both groups without differences between groups (Table 
7).  
4.3.6. Endocrine measures following 6 and 12 months post-intervention  
Thirty-two women completed the endocrine measures 6 months post-intervention 
including n=16 in the pulse-based diet group and n=16 in the TLC diet group. There were no 
group by time interactions for FPG (P=0.86) and fasting insulin (P=0.83) levels 6-months post-
intervention. Results of pairwise post hoc analysis showed fasting insulin levels increased in both 




post-intervention timepoint (P=0.01); however, changes were not significant for FPG levels 
(P=0.08).  
Twenty-five women completed the endocrine measures 12 months post-intervention 
including n=12 in the pulse-based diet group and n=13 in the TLC diet group. Both groups 
showed increased levels of FPG (P=0.04) and fasting insulin (P=0.02) over time, expressed as 
changes from baseline (Table 15). Results of the post hoc analyses showed there were no 
changes in the levels of FPG 12-months after the completion of the intervention (P=0.20) when 
compared to the 16-week post-intervention; however, the levels of insulin increased (P=0.05) in 
both groups 12 months following the completion of the intervention. Further details about 
changes in insulin and FPG levels over time have been presented in Chapter 5, Tables 11 and 12. 
The levels of LH/FSH ratio and TT did not change significantly 6 and 12 months post-
intervention when compared to 16-weeks post-intervention (P>0.05). Further details about the 
level of adherence to the adopted healthy lifestyle practices in long-term have been presented in 
























Table 6. Baseline characteristics of women with PCOS (n=95) 
Measure Pulse-based diet 
group 
TLC diet group P value* 
Age (year) 27.0±4.6 26.9±4.4 0.91 
Metformin therapy (n [%]) 18 [38.3] 20 [41.7] 0.45 
Anthropometric and physiologic measures    
Weight (kg) 87.36±23.9 92.24±24.5 0.33 
Body mass index (kg/m2) 32.52±8.4 33.35±9.0 0.65 
Waist circumference (cm) 102.4±19.8 103.5±20.6 0.78 
Menstruation     
    Shortest interval between bleeding (d) 43.8±40.3 45.4±46.7 0.87 
    Longest interval between bleeding (d) 96.7±63.8 112.1±61.6 0.29 
Total energy intake (kcal/d) 2165.1±774.3 2128.1±720.3 0.82 
Leisure physical activity score (arbitrary units) 28.2±24.9 20.4±19.0 0.08 
Insulin sensitivity measures    
Fasting plasma glucose (mmol/L) 5.2±1.4 5.3±1.3 0.68 
Fasting insulin (µIU/mL) 13.0±10.0 15.6±12.2 0.25 
HbA1c (%) 5.2±0.4 5.3±0.5 0.27 
HOMA-IR index 3.0±2.3 4.0±4.0 0.16 
Clinical presentations    
Presence of hirsutism† (n [%]) 32 [68.1] 35 [72.9] 0.39 
Presence of acanthosis nigricans (n [%]) 23 [48.9] 18 [37.5] 0.18 
Endocrine parameters    
LH/FSH ratio 2.2±1.1 2.6±1.7 0.32 
Total testosterone (nmol/L) 1.5±0.5 1.7±1.1 0.41 
    Sex–hormone binding globulin (nmoL/L) 32.0±18.7 36.5±25.8 0.60 
    Free androgen index 5.8±3.7 7.6±7.6 0.17 
Ultrasonographic markers    
Left ovary antral follicle counts 39.4±15.9 44.0±17.3 0.19 
Right ovary antral follicle counts 43.8±21.0 45.6±18.0 0.67 
Left ovary volume (cm3) 10.2±6.1 10.0±4.6 0.81 





Notes: Data are expressed as mean±SD except indicated otherwise. Numbers in each group for 
baseline characteristics were as follows: Pulse-based diet group=47; TLC diet group=48.  
 
Abbreviations: PCOS, polycystic ovary syndrome; HbA1c, glycated hemoglobin; HOMA-IR, 
homeostatic model assessment of insulin; LH/FSH, the ratio of luteinizing hormone to follicle 
stimulating hormone. 
 
 *Student t-test and chi-squared test were used for comparisons of means and proportions 






Table 7. Endocrine, ultrasonographic, and menstrual bleeding characteristics of women with PCOS pre- and post-intervention 
 Pulse-based diet group TLC diet group P value 
 






        
Weight (kg) 89.9±27.0 84.4±26.8 -5.5±4.5 93.3±25.4 88.4±23.0 -4.9±15.8 <0.01 0.62
BMI (kg/m2) 33.3±9.0 32.0±9.0 -1.3±1.4 34.0±9.8 32.2±8.6 -1.8±6.1 0 01 0.62
WC (cm) 103.9±19.8 99.5±18.0 -4.4±11.2 103.5±20.2 101.8±19.3 -1.7±7.6 0.02 0.30








HOMA-IR index 3.1±2.5 2.1±1.9 -1.0±2.1 4.2±4.4 2.9±3.6 -1.3±2.1 <0.001 0.66
Fasting insulin/glucose 
ratio 
0.2±0.1 0.1±01 -0.0±0.1 0.2±0.1 0.1±0.1 -0.1±0.1 0.21 0.17 
Total insulin AUC 
(µIU/mL/min) 
326.9±266.5 205.9±106.7 -121.0±229.9 307.2±181.7 279.8±176.7 -27.4±110.2 <0.01 0.05 
Incremental insulin 
AUC (µIU/mL/min) 
49.8±45.7 32.5±22.4 -17.3±47.2 45.6±26.1 41.1±29.3 -4.5±22.1 0.03 0.19 
LH/FSH ratio  2.6±1.1 1.8±1.2 -0.8±1.7 2.5±2.0 1.9±0.9 -0.6±2.2 0.03 0.69
Total testosterone 
(nmol/L) 
1.7±0.6 1.5±0.5 -0.2±0.6 1.8±0.9 1.6±0.8 -0.2±0.6 0.05 0.98 
Sex–hormone binding 
globulin (nmol/L) 
24.0±11.6 40.0±23.1 16.0±20.5 27.6±19.6 36.5±22.5 8.9±12.4 0.0001 0.07 
Ultrasonographic markers  
Left ovary antral 
follicle counts 






Notes: Data are expressed as mean±SD. Numbers in each group for endocrine measures were as follows: Pulse-based diet group=20; 
TLC diet and group=22; Total testosterone: Pulse-based diet group=30; TLC diet group=29; SHBG: Pulse-based diet group=30; TLC 
diet group=29; Numbers in each group for sonographic measures were as follows: Pulse-based group=31; TLC diet group=31. 
Numbers in each group for menstruation measures were as follows: Pulse-based group=33; TLC diet group=31. 
 
Abbreviations: PCOS, polycystic ovary syndrome; BMI, body mass index; WC, waist circumference; HOMA-IR, homeostatic model 
assessment of insulin; AUC, the area under the curve; LH/FSH ratio, the ratio of luteinizing hormone to follicle stimulating hormone. 
 
Right ovary antral 
follicle counts 
44.4±20.4 33.4±15.1 -11.0±11.5 48.3±16.4 36.9±14.4 -11.4 ±19.4 <0.001 0.91 
Left ovary volume 
(cm3) 
9.5±5.7 7.7±3.8 -1.8±4.5 11.7±4.7 8.5±3.8 -3.2±3.9 <0.0001 0.21 
Right ovary volume 
(cm3) 
11.8±4.8 8.9±4.0 -2.9±3.5 12.9±6.4 10.7±4.8 -2.2±4.5 <0.00001 0.49 
Menstruation   
Mean length between 
bleeding intervals (d) 









In the light of a state-of-art high-resolution ultrasound technology, reliable, 
innovative, and non-invasive examination of ultrasonographic features, and a well-
defined PCOS population, the present study showed both pulse-based and TLC diets, 
when both groups exercised and received healthcare counselling, yielded substantial 
changes in ultrasonographic measures of ovarian reserve - including a reduction in AFC 
and OV; decreased TT; and reduced menstrual bleeding intervals. The severity of 
reproductive disruption and/or the likelihood of response to treatment in PCOS   may be 
reflected by the changes in ovarian size, follicle number and the interval between 
menstrual bleeding (Jarrett & Lujan, 2017; Lujan et al., 2013). The pulse-based diet was 
more effective than the TLC diet to increase insulin sensitivity post-intervention, 
reflected by a reduction in total insulin AUC and a tendency toward a lower SHBG. 
Our study evaluated the effects of two ad libitum diets with physical activity and 
lifestyle change counselling on ovarian morphology in PCOS. Prior studies have 
evaluated the effects of short-term physical activity, caloric restriction and low GI diets 
on overweight women. The loss of 5-10% weight had positive effects including a 
decrease of hyperandrogenism, IR, and fertility.(M. M. Huber-Buchholz et al., 1999; 
Marsh et al., 2010; Palomba et al., 2008; Thomson et al., 2008).  Several mechanisms 
have been proposed for the positive effects of lifestyle interventions. .iThe regulation of 
gonadotropin  secretion, neuroendocrine signalling,  a decline in ovarian androgen 
secretion, increased insulin sensitivity and function, redistribution of body fat, especially 
central fat, recovery of spontaneous ovulation, and increased frequency of menstrual 
bleeding across age, BMI, and race/ethnicity categories  appear following the lifestyle 
interventions(Bützow et al., 2000; Moran et al., 2011; Moran et al., 2007; Moran et al., 
2009; Palomba et al., 2008). An increase in insulin sensitivity and decrease in insulin 
concentration are hypothesized to be the central physiological mechanism for changing 
ovarian morphology and function, and hyperandrogenism in both groups in our study, (E 
Diamanti-Kandarakis & A Dunaif, 2012). Although the pulse-based diet group 
experienced a greater decrease in total insulin AUC than the TLC diet group, a decline in 
the ultrasonographical features of ovarian morphology, hyperandrogenism, and menstrual 




groups may be due to an insufficient reduction in total insulin AUC in the pulse-based 
diet group versus the TLC diet group.  
Apart from inducing satiety and weight loss, several factors can explain the 
beneficial effects of a pulse-based diet on improving insulin response to OGTT and 
ovarian androgen biosynthesis, including high fiber content, low-GI, significant anti-
oxidant content, and favourable micro- and macro-nutrient composition (McCrory et al., 
2010; Mudryj et al., 2014; Sievenpiper et al., 2009). While our study goals were not 
focused on weight loss, our subjects achieved a 5% weight loss. We attributed the 
voluntary decrease in energy intake following education about lifestyle modification and 
increased physical activity, important ingredients to improve health, as explanations for 
the weight loss. Of note, because weight loss was not a stated goal or compensatory 
component of the present study, we believe that the study has not been biased by weight 
loss motivation as in most research. Also, our findings have broader generalizability 
across BMI categories.  
Identification of abnormal morphological features in women with PCOS is 
required to guide innovative approaches, evaluate prognosis and derive tailored 
recommendations for the successful management of life-long reproductive and metabolic 
sequelae associated with the condition (Azziz et al., 2006; Homburg, 2006). 
Ultrasonographic features of ovarian morphology – specifically AFC, and to a lesser 
degree OV – have the diagnostic potential to reliably predict and detect the severity of 
reproductive, clinical, and metabolic abnormalities associated with PCOS (Jarrett & 
Lujan, 2017; Lujan et al., 2013). Enlarged ovaries and an excess of small antral follicles 
have been associated with follicle arrest and anovulation in PCOS (Adams et al., 1985; 
Stephen Franks et al., 2008) reflecting increased activation from the primordial pool 
(Webber et al., 2003), slower maturation (Maciel et al., 2004), or decreased atresia 
(Webber et al., 2007). The paucity of follicles >10 mm in diameter has been interpreted 
as a failure of selection, dominance, and ovulation (Franks et al., 1998). Aberrations in 
gonadotropin secretion (Franks et al., 1998) and impaired granulosa and theca cell 
function (Erickson et al., 1992; Gilling-Smith et al., 1994) likely inhibit the terminal 
follicular development and result in anovulation (Stephen Franks et al., 2008; Jonard & 




intervention. Importantly, in the present study, we used the latest criteria to diagnose  the 
morphology of the PCO (Dewailly et al., 2014), which has been shown to yield a 
stringent cutoff to inform the severity of endocrine disturbances in women with PCOS 
(Clark et al., 2014). Decreased AFC is correlated with a modulated local ovarian 
hyperinsulinemia and androgen production, an increased sensitivity of granulosa cells  to 
FSH, a systemic reduction in insulin levels and decreased IR, and weight loss , all 
features that could synergistically lead to increased menstrual cyclicity (Ding et al., 2006; 
Dunn et al., 1981). In our study, both intervention groups reported decreased intervals 
between spontaneous menstrual bleedings or improvements from irregular cycles to the 
shorter duration between bleeding that were not classified as regular menstrual cycles but 
did have a cyclic pattern (33 to 50 days). It is difficult to fully appreciate differences 
between the present study and previous investigations as previous reports were less clear 
regarding the ultrasonographic measures of the PCO. Our observations are in agreement 
with previous studies indicating increased menstrual regularity following lifestyle 
modification in PCOS populations (M. M. Huber-Buchholz et al., 1999; Marsh et al., 
2010; Thomson et al., 2008). A decreased interval between menstrual bleeds may 
translate into the resumption of menstrual cyclicity in most women. The decreased 
interval between menstrual bleeding can be mapped by ultrasonography to reveal 
spontaneous ovulation with longer than normal follicular phase lengths, normal luteal 
phase dynamics and therefore less inherent risk for unopposed endometrial exposure to 
estrogen and long-term risk of uterine cancer. Our study is limited regarding reporting the 
resumption of spontaneous ovulation rates by the use of insufficient markers to confirm 
ovulation (Jarrett & Lujan, 2017).  However, women with shorter intervals between 
menstrual bleeding did report fewer features of abnormal bleeding, with short limited 
flow seen after ovulation.  
Contrary to our hypothesis, women in both intervention groups tended to revert to 
baseline levels for fasting insulin levels in long-term; however, women maintained their 
improvements in the levels of TT and LH/FSH ratio after the completion of the 
intervention. In the present study, we used supervised diet exercise programs combined 
with regular healthcare counselling, which were not continued after the trial period. Our 




follow up phases reflected by lower frequency of pulse consumption, less favourable diet 
quality, and decreased physical activity as described in Chapters 5 and 7. Successful and 
sustainable adherence to healthy lifestyle change programs has been challenging with less 
favourable and mixed results in the context of PCOS (Domecq et al., 2013). Our 
observations reinforce the importance of healthy eating practices, increased physical 
activity, and reduce sedentary behaviour with continual monitoring, frequent assessment, 
and feedback from a multidisciplinary healthcare team to transfer the benefits of healthy 
lifestyle behaviours to usual daily activities after initial interventions in women with 
PCOS.     
Limitations of the study included the potential for recall and self-reporting bias in 
reporting menstrual bleeding patterns; a high attrition rate; which is expected when  
voluntary participation  is requested over prolonged time intervals, and when participants 
are asked to make marked lifestyle changes such as diet and exercise; technical and 
financial barriers to the biochemical assessment of TT by liquid or gas chromatography-
tandem mass spectrometry  and financial limitations to evaluate other markers such as 
inflammation, dyslipidemia and metabolism (Rosner et al., 2007).  
In a diet intervention without energy restriction where aerobic exercise was 
recommended, and healthcare counselling was provided, both pulse-based and TLC diets 
showed similar favourable changes of ultrasonographic markers of ovarian morphology, 
hyperandrogenism, and menstrual regularity. The pulse-based diet was more effective for 
decreasing total insulin AUC in women with PCOS and had a tendency toward a greater 
increase in SHBG levels. Our results support the position that multi-dimensional lifestyle 
modifications are crucial in the management of PCOS and corroborate the potential of an 
ad libitum low-GI pulse-rich diet to improve reproductive features in young women with 
PCOS.  
The second component of my thesis Objective іі was to compare the effect of a 
pulse-based diet to the TLC diet on cardio-metabolic outcome measures in women with 
PCOS. Next chapter (Chapter 5) represents changes in the risk factors of cardiometabolic 







EFFECTS OF THE LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK IN 
WOMEN WITH PCOS 
Kazemi M, McBreairty LE, Chizen DR, Pierson RA, Chilibeck PD, Zello GA.  
Cardio-metabolic disease risk in women with polycystic ovary syndrome after an ad libitum 
pulse-based diet in a multidisciplinary randomized controlled trial* 
*format and structure of the original manuscript have been revised to provide a better flow 
within the thesis and be consistent with the format of previous chapters. 
Abstract 
Background and objective: Lifestyle modifications are recommended as the first-line 
approach in the management of PCOS. However, the optimal diet composition to mediate 
advantageous cardio-metabolic outcomes for women with PCOS remains unclear. The study 
objective was to compare the effect of a low-glycemic index pulse-based diet, containing lentils, 
beans, split peas, and chickpeas, to the NCEP’s TLC diet, chosen because of LDL-C lowering 
effects, on cardio-metabolic risk measures in women with PCOS. 
Design: Ninety-five women with PCOS (18-35 y) were randomized to receive either the 
pulse-based diet or TLC diet, without inducing calorie restriction, for 16 weeks. All women 
participated in an aerobic exercise program and received education and counselling about PCOS 
and lifestyle modification. 
Results: Thirty women in the pulse-based diet and 31 in TLC diet group completed the 
study. The pulse-based diet group had a greater reduction in total AUC for insulin response to a 
standard oral glucose tolerance test (mean change ± SD: -121.0±229.9 vs -27.4±110.2 
µIU/mL/min; P=0.05) than the TLC diet group. The pulse group exhibited lower diastolic BP 
(DBP; -3.6±6.7 vs -0.2±6.7 mmHg, P=0.03), TG (-18.1±51.9 vs 7.1±42.3 mg/dL, P=0.04), LDL-
C (-10.7±17.0 vs -2.2±15.6 mg/dL, P=0.05), and TC/HDL-C ratio (TC/HDL-C; -0.4±0.4 vs 
0.1±0.4, P<0.001), as well as a greater increase in HDL-C (2.0±7.4 vs -2.8±6.2 mg/dL, P<0.01) 




(P<0.001), SBP (P<0.01), HOMA-IR (P<0.0001), incremental glucose (P<0.0001) and insulin 
(P=0.03) AUC, total glucose AUC (P<0.01), and TC (P<0.01) decreased in both groups. 
Conclusions: A pulse-based diet was more effective than the TLC diet at improving many 
key risk factors for cardio-metabolic disease in women with PCOS.  
 
Keywords: Exercise; insulin; lifestyle; lipid; metabolic syndrome; pulse foods; 
Therapeutic Lifestyle Changes diet 
 
5.1. Introduction 
 PCOS is the most common endocrinopathy and the leading cause of anovulatory 
infertility among reproductive-age women worldwide, with a prevalence of up to 18% (Carmina 
& Lobo, 1999; March et al., 2010). Women with PCOS exhibit many metabolic abnormalities 
including peripheral IR and compensatory hyperinsulinemia, impaired glucose metabolism, 
dyslipidemia, HTN, and abdominal adiposity. These features are components of metabolic 
syndrome (MetS), which is defined as a complex of five interrelated risk factors for CVD and 
DM2. Compared to other clinical presentations associated with PCOS, metabolic aberrations 
represent critical contributors to increased rates of long-term morbidity and mortality (Carmina 
& Lobo, 1999; E Diamanti-Kandarakis & A Dunaif, 2012; Wild et al., 2010). 
Lifestyle modifications comprised of dietary, exercise and behavioural therapies are 
recommended as first-line approaches in the management of PCOS. Optimizing body weight, 
engaging in regular physical activity, and learning cognitive behavioural skills are key strategies 
for PCOS. The most favourable dietary composition to facilitate metabolic changes in women 
with PCOS has been debated (Moran, Ko, et al., 2013). The positive effects of weight loss upon 
women with PCOS have been reported after short-term hypocaloric dietary interventions; 
however, a PCOS-optimized dietary composition has not been addressed. A pulse-based diet has 
the potential to improve the metabolic sequelae associated with PCOS. Pulses, that is, split-peas, 
beans, lentils, and chickpeas, are high in fiber, contain complex carbohydrates with a low GI, are 
low in fat, contain high-quality protein, have low sodium content, and are a significant source of 
vitamins and minerals, such as iron, zinc, folate, calcium, magnesium, and potassium (Mudryj et 
al., 2014). Chronic consumption of pulses in other populations has been associated with positive 




decreasing hypercholesterolemia, BP and obesity (Ha et al., 2014; McCrory et al., 2010; 
Sievenpiper et al., 2009). The TLC diet, endorsed by the NCEP Adult Treatment Panel III, is an 
integral component of a non-pharmacologic healthful lifestyle habits program designed to 
decrease LDL-C concentrations in individuals with hypercholesterolemia. The TLC diet, 
endorsed by the NCEP Adult Treatment Panel III, is an integral component of a non-
pharmacologic healthy lifestyle habits program designed to decrease LDL-C concentrations in 
individuals with hypercholesterolemia. The TLC diet is a nutritionally balanced diet, 
accomplished by increasing fiber consumption, decreasing saturated fat and cholesterol, and 
adding LDL-C lowering dietary options such as viscous fiber and plant stanol/sterol esters ("The 
NCEP ATP III final report," 2002). The TLC diet was considered, for our study, as a healthy 
control diet with the potential to improve PCOS metabolic abnormalities. We were unable to find 
a study involving women with PCOS where either a pulse-based or TLC diet were evaluated. We 
hypothesized that when there is no energy restriction, a low-GI, pulse-based diet is more 
effective than the standard TLC diet for improving multiple risk measures of cardiometabolic 
disease in women with PCOS. Further, we hypothesized the pulse-based diet is more effective 
compared to the TLC diet after 6 and 12 months post-intervention to maintain improvements in 
cardio-metabolic outcome measures. 
 
5.2. Materials and Methods 
5.2.1. Study Design and Protocol 
Details of the RCT design and protocol have been elaborated in Chapter 4, page 69. 
5.2.2. Participants 
Details of study subjects have been presented in Chapter 5, page 71.   
5.2.3. Study Procedures 
A standardized medical history and physical examination was performed to obtain a 
menstrual, medical and endocrine history, demographics, lifestyle factors, anthropometric, 
physiologic, and clinical measures as described previously (McBreairty et al., 2017). Weight was 
measured in light clothing using a mechanical weight scale (model 160KL; Health-O-Meter Inc., 
Bridgeview, IL, USA) to the nearest 0.1 kg. Height was measured without shoes using a portable 
stadiometer (Seca 208; Vogel and Halke, Hamburg, Germany) to the nearest millimeter. BMI 




(WC) was measured following the World Health Organization Waist Circumference Expert 
Consultation on Waist Circumference protocol, with a measurement taken to the nearest 
millimeter (World Health Organization. Waist circumference and waist-hip ratio: report of a 
WHO Expert Consultation, Geneva, 8–11 December 2008). Body composition was evaluated 
from whole-body scans measured by dual-energy X-ray absorptiometry (QDR Discovery Wi; 
Hologic Inc., Bedford, MD, USA) using QDR software for Windows XP (QDR Discovery, 
Hologic Inc.). The coefficients of variation for total body fat mass, lean tissue, and trunk fat mass 
were 3.0%, and 0.5%, 5.0% respectively. BP was measured after a 10-minute rest period, in the 
supine position in the right arm using a standard manual mercury sphygmomanometer and a 
stethoscope (Littmann Master Classic, 3M Health Care, St. Paul, MN, USA), with both feet on 
the floor and the arm supported at heart level. BP was recorded to the nearest two mmHg. 
Transvaginal ultrasound examinations were performed using a Voluson E8 Expert (GE Medical 
Systems, Zipaf, Austria) and a three-dimensional 6-12-MHz transvaginal transducer, during days 
1-5 of women’s bleeding cycle, with the first day of bleeding defined as day 1, or at a time when 
no dominant follicle or ovulation gland was detected in women reporting irregular or absent 
cycles.  
Hormones and biochemicals evaluated included total testosterone, estradiol, 
progesterone, FSH, LH, SHBG, TC, LDL-C, HDL-C, TC/HDL-C ratio, TG, hsCRP, and HbA1c; 
dehydroepiandrosterone sulfate, cortisol, prolactin, 17-hydroxyprogesterone, and thyroid 
hormones were measured to exclude endocrinopathies that mimicked the profile of PCOS. 
Fasting blood samples were taken when follicles ≥10 mm and corpora lutea were absent at 
ultrasonography done on days 1-5 of regular and predictable menstrual cycle lengths, or on 
random days for women with irregular/absent periods. Serial blood samples were taken pre-
intervention, mid-intervention (9-weeks), and post-intervention (16-weeks), as well as at 6- and 
12-months post-intervention. All samples were analyzed by the Saskatoon Health Region 
Laboratories immediately or during the first week of the collection after freezing at -80 °C. 
5.2.4. Hormonal and Biochemical Analyses 
Plasma insulin (Alpco Diagnostics, Salem, NH, USA) and serum SHBG (Alpco 
Diagnostics, Salem, NH, USA) were measured using high-sensitivity enzyme-linked 
immunosorbent assay (ELISA), and plasma glucose (QuantiChrom, DIGL-100, BioAssay 




total testosterone (by solid-phase, enzyme-labeled, competitive chemiluminescent immunoassay) 
was measured on Immulite 2000 Systems Analyzers (Siemens Healthcare Diagnostics Inc., 
Tarrytown, NY, USA) with Roche kits (Roche Diagnostics Ltd., Basel, Switzerland). The 
remaining compounds were analyzed using Roche Cobas Modular Analyzers and Roche kits, 
with HbA1c analyzed using the turbidimetric inhibition immunoassay, serum SHBG using the 
solid-phase, enzyme-labeled competitive chemiluminescent immunoassay, hsCRP using a 
particle-enhanced immunoturbidimetric assay, serum TG and cholesterol using the colourimetric 
assay, and serum FSH and LH using the electrochemiluminescence immunoassay. Insulin 
resistance was estimated by the HOMA-IR method using the formula fasting plasma insulin 
(µIU/mL) × fasting plasma glucose (mg/dL)/405. FAI was calculated as total testosterone 
(nmol/L) / SHBG (nmol/L) × 100. The intra- and inter-assay coefficients of variation were 5.1% 
to 10.3% and 6.7% to 16.6% for insulin respectively, <3% for glucose, 1.2 and 1.2% for HbA1c, 
2.1 and 3% for cholesterol, 3.3 and 3.0% for HDL-C, 2.1 and 3.0% for LDL-C, 2.1 and 2.5% for 
TG, 1.1 and 3.6% for hsCRP, 3.9 and 1.9% for FSH, 3.5 and 0.8% for LH, 4.2 and 1.3% for 
SHBG, and 6.8 and 5.4% for testosterone, consistent with good assay performance in both 
intervention groups.  
5.2.5. Statistical Analysis  
Details of the statistical analysis have been elaborated in Chapter 4, page 74 and 75. 
5.3. Results 
The flow-diagram of participants' progress through the phases of the clinical trial 
according to the CONSORT statement, along with losses and exclusions, is displayed in Figure 
4. A total of 324 women responded to the recruitment advertisement; 95 were confirmed eligible 
and were enrolled in the study. Baseline data are presented in Table 8. Baseline characteristics, 
including the use of metformin (1000-1500 mg/g/d) were comparable in both groups (Table 8). 
The average age of women was 27.0±4.5 years, and average BMI was 32.9±8.7 kg/m2. Most 
participants (74.7%; 71/95) were Caucasian. At baseline, the pulse-based and TLC diet groups 
did not differ regarding age, ethnicity, anthropometric and body composition measures, family 
history of DM2/CVD and/or HTN, insulin sensitivity measures, lipid profile, clinical and 
endocrine features of PCOS. There were no differences between groups at baseline for total 
energy intake and leisure time physical activity (Table 8). Baseline characteristics of women 




when compared with women who completed the intervention. Thirty women in the pulse-based 
diet group and 31 in the TLC diet group completed the intervention. There were no differences 
between baseline characteristics of women who completed the study (Table 9). Baseline 
characteristics of women who did not complete the 16-week intervention were not different from 
those who completed the intervention (P>0.05; data not shown). The final analysis included 
61/95 women. The percentages of women who did not complete the study intervention were 
similar between groups (P=0.94). Two women who completed the diet refused to complete the 
post-intervention OGTT due to lack of personal time. Incomplete questionnaire data (24-hour 
dietary recall, n=16 and physical activity record n=4) were due to errors in collection, lack of 
time, or refusal by participants. Final numbers analyzed for each outcome measure are presented 
in the outcome tables and figures. The level of compliance with exercise and dietary 
interventions have been presented in Chapter 4, pages 75 and 76. 
5.3.1. Metformin-Dietary Intervention Interactions 
There were no group by time by metformin interactions for any of the evaluated outcome 
measures (data not shown). No differences were observed between metformin users and 
nonusers in the pulse-based and TLC diet groups regarding baseline and changes in 
anthropometric and body composition measures, physiologic measures, insulin sensitivity, and 
serum plasma lipid concentrations. 
5.3.2. Anthropometric, Body Composition and Blood Pressure Measures  
Following the intervention, both pulse-based diet and TLC diet groups exhibited lower 
BMI (P=0.01) and WC (P=0.02), and trunk fat mass (P<0.001) over time; no group by time 
interaction was observed. Similarly, there was a time main effect for total body mass (P<0.01) 
and total %body fat (P<0.01) with both decreasing across groups, without a group by time 
interaction (Table 9). SBP decreased following the intervention across groups (time main effect; 
P<0.01). There was no difference between groups concerning a change in SBP post-intervention. 
There was a group by time interaction for DBP (P=0.05) with a greater decrease in the pulse-
based diet compared to the TLC diet group (Table 9). 
5.3.3. Insulin and Glucose Responses to OGTT 
Details of the glucose and insulin responses of participants to intervention have been described in 




are shown in Figure 5, A. Glucose response to the OGTT and the ratio of plasma insulin to 
plasma glucose concentrations are shown in Figures 5, B and C, respectively.  
5.3.4. Lipid Profile 
There was a group by time interaction for TG (P=0.04), HDL-C (P<0.01), LDL-C 
(P=0.05), and TC/HDL-C ratio (P<0.001). The pulse-based diet group exhibited greater 
reductions in TG, LDL-C, TC/HDL-C ratio, and a greater increase in HDL-C concentrations 
when compared with the TLC diet group (Table 9). There was a time main effect (decrease) for 
TC (P<0.01). Further, to verify that mid-intervention data were an appropriate substitute for post-
intervention, women who dropped out after mid-intervention were excluded from the analysis. 
Analyses of results using data only from participants who completed all testing time points 
showed a similar group by time interaction for TG (P<0.01), HDL-C (P<0.01), LDL-C (P=0.05), 
and TC/HDL-C ratio (P<0.0001). The pulse-based diet group showed greater reductions in TG, 
LDL-C, TC/HDL-C ratio, and a greater increase in HDL-C concentrations when compared with 
the TLC diet group (data not shown). Similarly, there was a time main effect (decrease) for TC 
(P<0.01) for women who completed all testing time points.  
The prevalence rate of MetS decreased from baseline in the pulse-based (from 36.7%; 
11/30 to 30.0%; 9/30) and TLC diet (37.9%; 11/29 to 34.5%; 10/29) groups. When compared to 
pre-intervention, changes in the prevalence rate of MetS were no differences between groups in 
the post-intervention (P=0.78). 
5.3.5. Physical Activity and Dietary Intake  
During the intervention women in the pulse-based diet and TLC diet groups voluntarily 
reduced their average daily energy intake from baseline (-565.2±667.0 vs -556.4±696.3 kcal/g/d, 
respectively; time main effect; P<0.0001). There were no differences for changes in the energy 
intake from baseline between the pulse-based and TLC diet groups (P=0.97). Total carbohydrate, 
total fat, dietary cholesterol, saturated fat, trans fat, monounsaturated fat, polyunsaturated fat, and 
total protein intakes decreased from baseline during the intervention (time main effect, P≤0.05, 
Table 13). The pulse-based diet group exhibited a greater decrease in dietary cholesterol intake 
during intervention when compared to the TLC diet group (P<0.001). The pulse-based diet group 
had a tendency toward a greater decrease in trans-fat intake during intervention from baseline 
than the TLC diet group (P=0.06). The pulse-based diet group consumed a higher amount of 




group had a greater consumption of low-GI foods compared with the TLC diet group during the 
intervention (P<0.01).  
Results of pairwise post hoc analysis of dietary intake of women who completed the 
long-term follow up phases of the study showed both the pulse-based and TLC diet groups 
maintained the reductions in total energy intake achieved during the intervention period 6 (mean 
energy intake: 1762±288 vs 1687±386 kcal/d; P=0.34) and 12 months (mean energy intake: 
1735±358 vs 1749±324 kcal/d; P=0.20) after the completion of the intervention. Both groups 
maintained their levels of dietary cholesterol, saturated fat, trans fat, monounsaturated fat, 
polyunsaturated fat, and total protein intakes between 6 and 12 months follow up timepoints and 
during the intervention (P>0.05). When compared to the intervention period, the pulse-based diet 
group exhibited a tendency toward decreased dietary fiber intake versus the TLC diet group 6 
months after the completion of the intervention (-18.2 vs 4.5 g/d; P=0.07). Both the pulse-based 
(-10.1 g/d) and TLC diet (-5.0 g/d) groups consumed a lower amount of dietary fiber 12 months 
after the completion of the intervention when compared to the intervention period (P=0.02). 
Unlike the 12-month follow-up timepoint (P=1.00), both the pulse-based and TLC diet groups 
had a tendency toward decreased intakes of soluble fiber (-0.2 vs -0.7 g/d P=0.06) between the 
intervention period and 6 months post-intervention. Further, the consumption of low-GI foods 
decreased in both groups 6 (P<0.01) and 12 months (P<0.01) after the completion of the 
intervention.  
Leisure time physical activity score increased in both groups during intervention from 
baseline in both of the pulse based (31.6±25.5 to 37.7±28.6 arbitrary units) and TLC (24.0±20.2 
to 33.6±23.8 arbitrary units) (P<0.01); no differences were observed between groups (P=0.53). 
Results of the post hoc analysis on women who completed the long-term follow-up phases of the 
study showed decreased scores of leisure time physical activity in both the pulse-based and TLC 
diet groups 6 months after the completion of the intervention when compared to the intervention 
period (-16.6±22.7 vs -7.3±20.8 units; P=0.008). Both the pulse-based and TLC diet groups 
showed a trend toward decreased scores of leisure-time physical activity 12 months after the 
completion of the intervention when compared to the intervention period (-16.1±25.4 vs -
12.4±18.5 units; P=0.08). 




Three volunteers reported four side effects in the pulse-based diet group during the 
intervention. The side effects were upset stomach (n=2), flatulence (n=1) and bloating (n=1). 
One participant reported a combination of upset stomach and bloating, one participant 
experienced only upset stomach, and one participant reported flatulence. The side effects were 
rated as mild-moderate in severity, were classified as “possibly” related to the intervention and 
led to withdrawal of participants from the study.  
5.3.7. Clinical and biochemical measures following 6 and 12 months post-intervention  
Thirty-two women completed the endocrine measures 6 months post-intervention 
including n=16 in the pulse-based diet group and n=16 in the TLC diet group. Results of the post 
hoc analyses showed an increase in body weight (P<0.0001) and BMI (P=0.006), expressed as 
changes from 16-week post-intervention, 6 months following the completion of the intervention. 
However, WC levels (P=1.00), total body fat mass (P=0.17), and total body fat% (P=0.90) 
remained unchanged between the two time points. There were no group by time interactions for 
FPG (P=0.86) and fasting insulin (P=0.83) levels 6-months post-intervention. Results of the post 
hoc analyses showed fasting insulin levels increased in both groups over time after 6 months of 
completing the intervention when compared to 16-week post-intervention timepoint (P=0.01). 
Both groups had an increased level of TC 6 months following the intervention expressed as 
changes from 16-week post-intervention (time main effect; P=0.03). There were no differences 
in the changes of HDL-C levels 6-month following the intervention when compared to 16-week 
post-intervention (P=1.00). Both groups had a tendency toward increased levels of LDL-C 6 
months post-intervention (P=0.07). The reduction in the levels of TC/HDL-C that was observed 
following the intervention, maintained 6 months post-intervention (P=0.34; Table 10).  
Twenty-five women completed the clinical and biochemical measures 12 months post-
intervention including n=12 in the pulse-based diet group and n=13 in the TLC diet group. 
Results of the pairwise post hoc analyses showed no changes between the 16-week post-
intervention and the long-term follow up time point at 12 month following the completion of the 
intervention in body weight (P=0.17), BMI (P=0.37), total body fat mass (P=1.00), total body 
fat% (P=1.00), and SBP (P=0.07). Both groups showed increased levels of FPG (P=0.04) and 
fasting insulin (P=0.02) over time (Table 11). There were no changes in the levels of FPG 12-
months after the completion of the intervention when compared to post-intervention (P=0.20); 




completion of the intervention, expressed as changes from the 16-week post-intervention. 
Similarly, 12 months after the completion of the intervention the levels of TC increased when 
compared to the post-intervention levels (P=0.005); however levels of HDL-C (P=0.30), LDL-C 
(P=0.70), and TC/HDL-C (P=0.09) remained unchanged between the 16-week post-intervention 
and 12-month follow up timepoints for both groups. Further details have been presented in 




























In the “follow-up” section – “completed the intervention represented” –  women who completed 
the 16-week lifestyle intervention; – “discontinued the intervention” – represented women who 
dropped out of the study before completing the 16-week lifestyle intervention. In the analysis 
section, the number of subjects that were analyzed in the pulse-based and TLC diet groups 
included women who completed the 16-week lifestyle intervention and women who dropped out 
of the study before completing the 16-week intervention period, but their last observation data 
which were collected at 9-weeks post-intervention were carried forward to 16-week time point 
according to the intention-to-treat principle.  




Table 8. Baseline characteristics of women with PCOS by intervention group (n=95) 






Age (year) 27.0±4.6 26.9±4.4 0.91 



















Metformin Tx (n [%]) 18 [38.3] 20 [41.7] 0.45
Anthropometrics and body composition 
measures 
   
Weight (kg) 87.36±23.9 92.24±24.5 0.33 
BMI (kg/m2) 32.52±8.4 33.35±9.0 0.65 
WC (cm) 102.4±19.8 103.5±20.6 0.78 
Total body fat mass (kg) 36.1±13.0 39.6±16.7 0.26 
Total body fat (%) 41.3±7.2  42.3±8.5 0.54 
Total body lean mass (kg) 46.4±7.3 48.8±9.5 0.18 
Physiologic measures    
SBP (mmHg) 115.3±8.2 117.3±10.6 0.33 
DBP (mmHg) 76.4±7.5 76.8±9.2 0.81 
Pulse rate (beats/min) 73.7±14.0 74.4±14.2 0.82 
Total energy intake (kcal/g/d)  2165.1±774.3 2128.1±720.3 0.82 




Family history of DM2 (n [%]) 34 [77.3] 32 [76.2] 0.55 
Family history of CVD and/or HTN (n [%]) 32 [72.7] 34 [81.0] 0.26 
Insulin sensitivity measures    
Fasting plasma glucose (mmol/L) 5.2±1.4 5.3±1.3 0.68 
Fasting insulin (µIU/mL) 13.0±10.0 15.6±12.2 0.25 
HbA1c (%) 5.2±0.4 5.3±0.5 0.27 
HOMA-IR index 3.0±2.3 4.0±4.0 0.16 
Fasting insulin/glucose ratio 0.2±0.1 0.2±0.1 0.55 
Lipid profile    
TC (mmol/L) 4.7±1.0 4.5±0.7 0.38 
TG (mmol/L) 1.4±0.8 1.3±0.7 0.81 
HDL-C (mmol/L) 1.3±0.3 1.3±0.4 0.80 
LDL-C (mmol/L) 2.8±0.9 2.6±0.7 0.31 
TC/HDL-C ratio 3.8±1.2 3.7±1.3 0.84 
Prevalence of MetS‡ (n [%]) 18 [38.3] 16 [33.3] 0.67 
Presence of hirsutism⸹ (n [%]) 32 [68.1] 35 [72.9] 0.39 
Endocrine parameters    





Data are expressed as mean±SD except indicated otherwise. Numbers in each group for baseline 
characterises of all women who were enrolled in the study were as follows: pulse-based diet and 
aerobic exercise group=47; TLC diet and aerobic exercise group=48. 
 
Abbreviations: PCOS, polycystic ovary syndrome; TLC, Therapeutic Lifestyle Changes; Tx, 
therapy; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; DM2, type 2 diabetes; CVD, cardiovascular disease; HTN, 
hypertension; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HOMA-IR, 
homeostatic model assessment of insulin resistance; TC, total cholesterol; TG, triglyceride; 
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; 
TC/HDL-C, ratio of total cholesterol/high-density lipoprotein cholesterol; LH/FSH, ratio of 
luteinizing hormone to follicle stimulating hormone; SHBG, sex–hormone binding globulin; 
hsCRP, highly sensitive C–reactive protein. 
 
*Student t-test and chi-squared test were used for comparisons of means and proportions between 
groups. †Determined using the Godin Leisure-Time Exercise Questionnaire (Godin & Shephard, 
1985). ‡Determined according to the 2005 International Diabetes Federation in collaboration 
with the American Heart Association/National Heart, Lung, and Blood Institute criteria (Alberti 
et al., 2009). ⸹Determined using the Ferriman–Gallwey Index, adjusted for ethnicity (Yildiz et al., 
2010)
Total testosterone (nmol/L) 1.5±0.5 1.7±1.1 0.41 
    Sex–hormone binding globulin (nmoL/L) 32.0±18.7 36.5±25.8 0.60 
    Free androgen index 5.8±3.7 7.6±7.6 0.17 





Table 9. Anthropometric, body composition, physiologic, insulin sensitivity, and lipid outcomes at baseline and after intervention 
 Pulse-based diet group  TLC diet group  P value 
 Baseline 16-weeks Change Baseline 16-weeks Change Time 
Group 
x Time
Anthropometric and body 
composition measures 
        
Weight (kg) 89.9±27.0 84.4±26.8 -5.5±4.5 93.3±25.4 88.4±23.0 -4.9±15.8  <0.01 0.62 
BMI (kg/m2) 33.3±9.0 32.0±9.0 -1.3±1.4 34.0±9.8 32.2±8.6 -1.8±6.1 0 01 0.62 
WC (cm) 103.9±19.8 99.5±18.0 -4.4±11.2 103.5±20.2 101.8±19.3 -1.7±7.6 0.02 0.30 
Total body fat mass (kg) 36.3±13.5 34.6±13.8 -1.7±2.4 40.5±15.0 37.5±15.3 -3.0±7.5 <0.01 0.41 
Trunk fat mass (kg) 16.0±13.8 14.9±13.3 -1.1±2.0 19.3±14.0 17.3±13.5 -2±3.9 <0.0001 0.25 
Total body fat (%) 41.1±7.2 40.1±7.8 -1.0±2.0  41.4±8.7 40.4±8.5 -1.0±2.4 <0.01 0.96 
Total body lean mass (kg) 47.5±8.1 46.8±8.1 -0.7±2.2 49.5±9.1 49.7±9.3 0.2±14.1 0.22 0.09 
Physiologic measures         
SBP (mmHg) 116.0±7.3 112.6±10.3 -3.4±8.3 117.9±10.5 112.8±9.9 -5.1±8.1 <0.001 0.45 
DBP (mmHg) 77.2±7.4 73.6±8.0 -3.6±6.7 77.1±9.4 76.9±9.8 -0.2±6.7 0.03 0.05 
Pulse rate (beats/min) 73.6±14.4 74.0±14.3 0.4±10.0 73.0±12.5 73.0±14.1 0.0±11.8 0.89 0.89 
Insulin sensitivity 
measures 
        
FPG (mmol/L) 5.0±1.5 4.6±1.3  -0.4±1.7 5.6±1.4 4.8±1.6 -0.8±1.5 <0.01 0.38 
Fasting insulin (µIU/mL) 14.0±11.4 10.0±7.7  -4.0±9.7 15.7±12.4 12.7±10.3 -3.0±6.8 <0.01 0.60 
HbA1c (%) 5.3±0.4 5.2±0.4 -0.1±0.3 5.3±0.5 5.3±0.4 0.0±0.3 0.18 0.71 
HOMA-IR index 3.1±2.5 2.1±1.9 -1.0±2.1 4.2±4.4 2.9±3.6 -1.3±2.1 <0.001 0.66 
Fasting insulin/glucose 
ratio 0.2±0.1 0.1±0.1 -0.0±0.1 0.2±0.1 0.1±0.1 -0.1±0.1 0.21 0.17 
Total insulin AUC 
(µIU/mL/min) 






Data are expressed as mean±SD. Numbers in each group were as follows: pulse-based diet group=31 (30 for insulin sensitivity data); 
TLC diet group=30 (29 for insulin sensitivity data).  
 
Abbreviations: TLC, Therapeutic Lifestyle Changes; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment 
of insulin resistance; AUC, Area under the curve; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; 




Incremental insulin AUC 
(µIU/mL/min) 
49.8±45.7 32.5±22.4 -17.3±47.2 45.6±26.1 41.1±29.3 -4.5±22.1 0.03 0.19 
Total glucose AUC 
(mmol/L/min) 
32.3±9.6 26.8±5.3 5.5±10.4 33.7±5.8 29.7±7.1 -4.0±6.3 <0.01 0.77 
Incremental glucose 
AUC (mmol/L/min) 
6.7±1.9 6.2±1.4 -0.5±2.3 7.2±1.5 6.4±1.5 -0.8±1.5 <0.0001 0.51 
Lipid profile          
TC (mmol/L) 5.0±1.0 4.6±0.8 -0.4±0.5 4.4±0.8 4.3±0.8 -0.1±0.5 <0.01 0.12 
TG (mmol/L) 1.5±0.8 1.3±0.7 -0.2±0.6 1.3±0.7 1.3±0.8 0±0.5 0.36 0.04 
HDL-C (mmol/L) 1.3±0.3 1.4±0.3 0.1±0.2 1.3±0.4 1.2±0.3 -0.1±0.2 0.64 <0.01 
LDL-C (mmol/L) 2.9±0.4 2.7±0.8 -0.2±0.4 2.6±0.7 2.5±0.6 -0.1±0.4 <0.01 0.05 
TC/HDL-C 4.0±1.2 3.6±1.1 -0.4±0.4 3.7±1.3 3.8±1.3 0.1±0.4 0.01 <0.001






Solid dark lines represent women in the pulse-diet group at baseline (n=30). Solid light lines represent women in the TLC diet group 
at baseline (n=29). Dotted dark lines represent women in the pulse-diet group after intervention (n=30). Dotted light lines represent 
women in the TLC diet group after intervention (n=29). Insulin time course in response to OGTT (A); glucose time course in response 
to OGTT (B); ratio of plasma insulin to glucose time course in response to OGTT (C). Groups were comparable at baseline. Data are 
expressed as mean±SEM. Abbreviations: OGTT, oral glucose tolerance test; PCOS, polycystic ovary syndrome; TLC, Therapeutic 
Lifestyle Changes. 
      
Figure 5. Plasma insulin and glucose response to a standard 75-g OGTT before and after 16-week of intervention combined with 






Table 10. Clinical and biochemical characteristics of participants who completed the 6-months follow up phase of the study at baseline, 16- 
weeks, and 6 months post-intervention 
 Pulse-based diet group  TLC diet  P value 





        
Weight (kg) 81.6±13.5 78.0±12.6 79.6±13.4 95.8±21.1 92.0±20.5 94.8±18.1 <0.00001 0.43 
BMI (kg/m2) 30.4±6.2 29.0±5.6 31.2±7.2 35.1±9.1 33.9±8.9 34.7±8.8 <0.0001 0.30 
WC (cm) 98.0±13.7 94.6±13.6 94.9±14.2 108.2±20.6 105.5±17.7 105.5±17.1 <0.005 0.95 
Total body fat mass (kg) 32.3±10.7 29.8±10.1 30.3±9.9 42.7±14.3 40.3±14.3 41.5±14.9 <0.001 0.67 
Total body fat (%) 38.9±7.8 37.3±8.1 37.4±7.6 43.8±8.2 42.3±8.0 43.0±8.1 0.001 0.52 
Total body lean mass 
(kg) 
46.5±4.4 45.7±4.7 46.7±4.9 51.0±8.4 51.1±8.5 51.4±8.6 0.18 0.42 
Physiologic measures         
SBP (mmHg) 115.1±8.2 112.0±10.7 111.7±8.8 120.9±10.5 114.9±9.4 117.8±10.8 0.01 0.49 
DBP (mmHg) 75.4±7.4 71.3±7.1 73.6±7.8 80.8±6.9 80.6±5.0 76.7±8.2 0.11 0.01 
Pulse rate (beats/min) 73.1±13.7 70.1±13.9 69.5±15.3 72.8±15.8 73.6±13.2 76.8±9.6 0.78 0.27 
Insulin sensitivity 
measures
        
FPG (mmol/L) 5.3±1.7 4.6±1.6 4.9±0.2 5.5±1.5 4.6±1.8 5.3±0.9 0.08 0.86 
Fasting insulin (µIU/mL) 13.5±12.8 9.8±8.7 13.3±11.2 14.6.1±3.6 10.4±11.9 16.7±9.1 0.002 0.83 
Lipid profile         





TG (mmol/L) 1.4±0.9 1.3±0.8 1.3±0.7 1.2±0.6 1.2±0.6 1.3±0.6 0.68 0.86 
HDL-C (mmol/L) 1.2±0.3 1.3±0.4 1.3±0.4 1.3±0.4 1.2±0.3 1.2±0.2 0.98 0.02 
LDL-C (mmol/L) 2.8±1.0 2.4±0.8 2.6±0.8 2.5±0.7 2.4±0.6 2.6±0.5 0.008 0.35 
TC/HDL-C 4.0±1.5 3.6±1.4 3.6±1.2 3.5±0.8 3.5±1.0 3.6±0.8 0.005 0.02 
hsCRP (mg/L) 3.2±3.4 2.4±2.8 2.9±4.1 5.2±7.3 6.3±10.8 5.6±7.4 0.99 0.22 
PCOS, polycystic ovary syndrome; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-C, high–density lipoprotein cholesterol; 
LDL-C, low-density lipoprotein cholesterol; hsCRP, highly sensitive C–reactive protein. 
Data are expressed as mean±SD. Numbers in each group for anthropometric, body composition, and physiologic measures were as follows: 
Pulse-based diet group=20; TLC diet group=19. Numbers in each group for insulin sensitivity measures, lipid profile, and hsCRP were as 





Table 11. Clinical and biochemical characteristics of participants who completed the 12-months follow up phase of the study at baseline, 16- 
weeks, and 12 months post-intervention 
 Pulse-based diet group  TLC diet group  P value 





        
Weight (kg) 84.0±14.6 78.9±11.7 80.4±14.0 96.1±24.6 92.8±24.9 95.9±27.4 0.01 0.53 
BMI (kg/m2) 31.6±6.0 30.0±5.5 30.7±6.8 35.5±10.9 34.5±10.6 35.3±11.2 0.02 0.74 
WC (cm) 98.7±11.6 94.4±9.3 93.6±11.4 107.6±24.6 104.3±20.9 105.5±21.7 0.13 0.66 
Total body fat mass (kg) 32.2±11.1 29.4±9.2 29.8±9.9 42.1±16.2 40.9±16.5 41.3±16.9 0.003 0.34 
Total body fat (%) 39.4±8.0 37.7±7.2 38.2±7.6 44.6±8.4 43.9±8.0 43.6±7.9 0.01 0.45 
Total body lean mass (kg) 45.6±3.5 45.4±3.9 45.2±4.3 48.7±10.2 48.4±1.0 49.4±1.0 0.49 0.50 
Physiologic measures         
SBP (mmHg) 112.4±8.1 109.1±10.9 113.8±8.3 120.9±10.9 112.1±9.4 116.7±10.8 0.02 0.17 
DBP (mmHg) 76.4±6.4 73.2±7.5 76.0±7.6 79.5 ± 7.8 77.7±6.1 77.7±6.3 0.12 0.64 
Pulse rate (beats/min) 75.8±16.2 71.5±12.7 70.2±10.2 72.9±17.4 73.6±14.5 76.6±18.0 0.85 0.50 
Insulin sensitivity measures         
FPG (mmol/L) 5.2±1.1 4.3±0.8 4.9±0.6 5.5±1.4 4.7±1.9 5.3±0.5 0.04 0.98 
Fasting insulin (µIU/mL) 16.3±15.3 11.4±11.2 14.1±9.6 18.0±17.3 11.9±12.6 16.5±10.0 0.02 0.90 
Lipid profile         
TC (mmol/L) 4.8±1.1 4.5±0.9 5.0±1.1 4.8±0.5 4.5±0.5 4.7±0.7 0.001 0.43 
TG (mmol/L) 1.5±0.8 1.2±0.5 1.4±0.6 1.2±0.6 1.2±0.5 1.4±0.6 0.41 0.38 
HDL-C (mmol/L) 1.1±0.2 1.3±0.4 1.3±0.3 1.4±0.4 1.3±0.2 1.4±0.4 0.22 0.02 





TC/HDL-C 4.4±1.3 3.8±1.2 3.7±0.9 3.6±0.8 3.5±0.7 3.6±0.8 0.003 0.005 
hsCRP (mg/L) 4.5±4.0 5.0±7.6 5.8±4.4 5.9±7.7 7.1±11.4 8.0±14.4 0.48 0.95 
PCOS, polycystic ovary syndrome; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-C, high–
density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; hsCRP, highly sensitive C–reactive protein. 
 
Data are expressed as mean±SD. Numbers in each group for anthropometric, body composition, and physiologic measures 
were as follows: Pulse-based diet group=19; TLC diet group=17. Numbers in each group for insulin sensitivity measures, 















The most significant finding from our PCOS study was that without inducing energy 
restriction, a low-GI pulse-based diet was more effective at decreasing total insulin AUC, 
concentrations of LDL-C, TG, TC/HDL-C ratio, DBP, and increasing concentration of HDL-C 
than the TLC diet. Improved lipid profiles were noteworthy as the control TLC diet is 
recommended to elicit LDL-C lowering effects in subjects at risk for CVD and DM2 ("The 
NCEP ATP III final report," 2002); the pulse-based diet was even more effective in the lowering 
effect on LDL-C. We showed greater favourable effects with the pulse-based diet than the heart-
healthy TLC diet. Similar improvements in both dietary groups were seen with glucoregulation, 
BMI, WC, %body fat, SBP, and TC in women with PCOS. The current study was a unique 
multi-dimensional lifestyle changes program designed to evaluate the potential of a low-GI 
pulse-rich diet, without energy restriction, to improve the cardio-metabolic and DM2 risk 
profiles in young women with PCOS.  
Our observations are in agreement with previous studies regarding the positive effects of 
dietary pulses upon risk indicators of MetS, CVD, and DM2 (Abeysekara et al., 2012; Anderson 
& Major, 2002; Ha et al., 2014; Jayalath et al., 2014; Sievenpiper et al., 2009). There was a 
greater reduction from baseline of TC by 4%, LDL-C by 8.2%, and TC/HDL-C ratio by 12.7% in 
the pulse diet group compared with the TLC diet group; by extrapolation, an estimated risk 
reduction of 8-12% in future major cardiovascular events may be realized (Cholesterol 
Treatment Trialists' (CTT) Collaborators et al., 2012; Manson  et al., 1992). Results of two meta-
analyses of 26 RCTs (n=1037) (Ha et al., 2014) and 10 RCTs (n=268) (Bazzano et al., 2011) 
established evidence for a modest reduction in LDL-C (-0.17 to -0.21 mmol/L) and TC (-0.31 
mmol/L), following the consumption of pulses over 3-16 weeks across age, BMI classes, and 
metabolic phenotypes. Hypocholesterolemic effects of pulses appear to be multifactorial and can 
be attributed to their fiber content and antioxidant capacity. In our study, the pulse-based diet 
group had higher dietary fiber intake than the TLC diet group during the intervention (i.e. an 
increase in fiber intake of ~10 versus 1 g/d, respectively). Approximately 60% of the fiber in 
pulses is insoluble, and 31% is soluble. Both types of fiber in pulses modulate blood cholesterol 
by binding to bile acids in the intestine and preventing the reabsorption of bile acids and 
cholesterol (Brown et al., 1999; Galisteo et al., 2008; Kishimoto et al., 1995). Gut microbiota in 




energy and signalling molecules with prebiotic effects involved in the retention of beneficial 
bacterial flora, regulation of hepatic gluconeogenesis, lipogenesis, and lipid storage (Kishimoto 
et al., 1995; Koh et al., 2016; van Bennekum et al., 2005). Tannins, flavonoids, polyphenols, 
phytates, and saponins found in pulses have antioxidant effects (Mudryj et al., 2014). The 
inhibition of oxidation of LDL-C and modulation of TC concentrations are attributed to dietary 
pulses (Mudryj et al., 2014).  
Following the intervention, the pulse-based diet group had a greater decrease in total 
insulin AUC during an OGTT when compared to the TLC diet group. An increase in insulin 
sensitivity in response to a pulse-based diet may be due to relatively slow digestibility and thus 
low GI of pulses. Low GI of the pulse-rich foods has been attributed to complex carbohydrate 
profile, protein composition, protein-starch matrix, and anti-nutrient factors of pulses including 
phytates, saponins, lectins, and tannins (McCrory et al., 2010; Mudryj et al., 2014; Sievenpiper et 
al., 2009; Thorne et al., 1983). The direct effect of pulses on glucoregulation, recommended 
dosage of pulses, and optimal duration of pulse consumption needed to prevent insulin 
resistance, impaired glucose tolerance and DM2 is less clear (Jacobs et al., 1998; Jang et al., 
2001; Swennen et al., 2006).  
In addition to improving lipid and insulin profiles, the pulse-based diet group exhibited a 
4.4% greater reduction in DBP when compared to the TLC diet group. A reduction of this 
change of DBP is estimated to reduce the risk of myocardial infarction by 9-13% (Manson  et al., 
1992). Jayalath et al. performed a meta-analysis on eight isocaloric trials (n=554 participants) 
and showed pulse consumption (~162 g/d) over ten weeks reduced mean arterial BP by -0.75 
mmHg in middle-aged subjects (Jayalath et al., 2014). A diet rich in pulses shares many 
nutritional characteristics with the Dietary Approaches to Stop Hypertension eating plan (Sacks 
et al., 2001b) and the Mediterranean diet (Willett et al., 1995) that are endorsed for the 
prevention and treatment of HTN. Pulses can confer BP-lowering effects by increasing dietary 
intakes of low-GI foods, dietary fiber, plant protein, potassium, and magnesium, as well as by 
decreasing sodium intake through pre-established mechanisms (Aburto et al., 2013; Altorf–van 
der Kuil et al., 2010; Jee et al., 2002; Mudryj et al., 2014; Tielemans et al., 2013).  
Lifestyle management research in PCOS has been focused primarily upon short-term 
calorie restriction designed to achieve weight loss. In overweight and obese women with PCOS, 




& Brand-Miller, 2005). However, weight loss through calorie restriction often has not been 
attainable or sustainable (Legro, 2017). Innovative PCOS-specific diets have been largely 
overlooked as a means to achieve persistent, long-term lifestyle change. The optimal dietary 
recommendations for obese and non-obese women with PCOS has been debated. Our results 
align with the findings of Marsh et al. (Marsh et al., 2010) who found positive effects on insulin 
sensitivity with an ad libitum low-GI diet when compared with a macronutrient- and fiber-
matched healthy diet. Increased insulin sensitivity was attributed to the consumption of low-GI 
foods and a modest weight loss (4-5% of baseline body weight). It should be noted that the low-
GI diet of the Marsh et al. study had very few pulse-based foods, and in contrast to our study, no 
improvement in lipid profiles was observed. While our study goals were not focused on weight 
loss, our subjects achieved a 5% weight loss across both diet groups. The observed weight loss 
can be attributed to a voluntary decrease in energy intake following education about lifestyle 
modification and increase in physical activity. A 5-10% weight loss is considered clinically 
significant and has been associated with a substantial improvement in the metabolic profile and 
risk factors for CVD and DM2 (Knowler et al., 2002; Orchard et al., 2005).  
The participation attrition rate was high (33.7%) in both groups in the current study. A 
high attrition rate (27-49%) in other RCTs focused on lifestyle changes in women with PCOS 
reported a progressive increase in dropouts corresponding with the duration of intervention 
(Crystal C. Douglas et al., 2006; Hoeger et al., 2004; Marsh et al., 2010; Turner-McGrievy et al., 
2014b). Difficulties in sustaining a new lifestyle program, the time-consuming nature of the 
intervention, and competing family, work, and school obligations were among the reasons that 
contributed to attrition rate of our participants. During the study, we found regular 
communication for assessments, provision of education, encouragement, and feedback by a 
multidisciplinary healthcare team improved our participants’ adherence to new lifestyle 
strategies specific to women with PCOS and likely decreased the rate of attrition; we postulate 
that more frequent, regular communication with participants as a deliberate study design feature 
may have increased long-term adherence and maintained long-term improvements over the 6 and 
12 month follow-up intervals.  We also postulate that providing pulse-based foods to participants 
may have left participants ill-equipped to prepare and include pulses in their meals following the 
16-week intervention. In the long-term women in the pulse-based diet group maintained some of 




levels. However, both groups tended to regain weight and exhibited signs of deteriorated cardio-
metabolic profile, reflected by increased fasting insulin and TC levels in long-term after the 
completion of the intervention. As elaborated in Chapters 4 and 7, these observations can be 
contributed to a sub-optimal adherence to healthy lifestyle practices including lower frequency of 
pulse consumption, less favourable diet quality, and decreased physical activity. The duration of 
our intervention might not have been adequate to sustain and maintain the newly adopted healthy 
lifestyle practices in our participants in long-term. Our observations reinforce the importance of 
long-term treatment and continual monitoring of patients by their healthcare providers.  
Strengths of the study included diverse ethnicity sample with ~25% of subjects being 
non-Caucasian; a well-defined PCOS population; and use of ethno-specific adjustments when 
determining hirsutism to diagnose PCOS and abdominal obesity to identify MetS. Limitations 
included a high attrition rate, economic limitations against recruiting more subjects, overlooking 
an invitation to indigenous populations by advertising in the urban areas where they live, 
spending more time with follow-up communication to ensure long-term dietary and exercise 
adherence and potential for recall and self-reporting bias for physical activity and dietary intake. 
Although a 24-hour recall was the most accurate/least biased method for self-reporting dietary 
intake, our participants’ dietary recall may have had a tendency toward underreporting and 
reactivity (Thompson et al., 2015). Our study was underpowered to detect FPG differences 
between groups post-intervention. Our results may be interpreted with caution in terms of 
generalization to all PCOS populations. 
In conclusion, in a diet intervention without energy restriction where aerobic exercise 
was recommended as a part of a healthy lifestyle and healthcare counselling was provided, the 
pulse-based diet was more effective than the TLC diet for improving insulin response to OGTT, 
concentrations of TG, LDL-C, HDL-C, TC/HDL-C ratio, and DBP in women with PCOS. Our 
results support the position that lifestyle modifications are crucial in the management of PCOS 
and add another dimension to the existing evidence concerning the positive effects of pulse 
consumption on cardio-metabolic and DM2 risk profiles in women with PCOS.  
In Chapters 4 and 5 the reproductive health and cardiometabolic risk outcome 
components of research Objective іі were addressed. We demonstrated the positive impacts of 
our multidimensional lifestyle change program comprised of dietary, exercise, education, and 




following a 16-week intervention. In the next Chapter, Chapter 6, the third component of 



























 EFFECTS OF THE LIFESTYLE INTERVENTION ON QUALITY OF LIFE IN WOMEN 
WITH PCOS 
Kazemi M, McBreairty LE, Pierson RA, Chilibeck PD, Gordon JJ, Serrao SB, Zello GA, Chizen 
DR.  
Quality of life in a polycystic ovary syndrome randomized controlled pulse-diet trial, with 
exercise* 
*format and structure of the original manuscript have been revised to provide a better flow 
within the thesis and be consistent with the format of previous chapters 
Abstract 
Background and objective: PCOS is the most common endocrinopathy and cause of 
anovulatory infertility among reproductive-age women. Aside from metabolic and reproductive 
complications, PCOS is associated with compromised HRQoL which is often neglected. The 
objective of the present study was to compare PCOS-specific HRQoL indices among women 
with PCOS before and after receiving a pulse-based diet, a low glycemic index diet including 
split peas, lentils, beans, and chickpeas, or the TLC diet, alongside exercise, education and 
counselling.  
Methods: Ninety-five women with PCOS (18-35 years) enrolled in a 16-week lifestyle 
changes trial were randomized to Pulse or TLC diets, without calorie restriction. All participants 
completed aerobic exercise and received education and counselling about PCOS and lifestyle 
modification. The HRQoL survey was administered before and after the education, counselling 
and diet intervention. The recruitment sample size was calculated with a study drop-out rate of 
32% to achieve n=34 per diet group. The primary study outcome was to observe changes in 
HRQoL domains over time for each diet group. 
Results: Of 95 enrolled women, 30 assigned to receive the pulse-based diet and 31 in 
TLC diet group completed the diet intervention. Ninety percent (55/61) of women completed the 
HRQoL survey pre- and post-intervention. Despite no caloric restriction, both lifestyle 




for all outcomes. The HRQoL scores of both groups increased in the domains of knowledge 
(P<0.0001), concerns about PCOS (P<0.05), healthcare satisfaction (P<0.001), and lifestyle 
practices comprised of physical activity (P<.0001) and healthy diets (P<0.001). Women had 
greater positive feelings and experiences about participating in the intervention (P<0.01). The 
greatest positive changes occurred in the healthy eating domain (effect size=0.68). Healthy 
lifestyle changes were regarded by participants as the most helpful and least anticipated 
management strategies for PCOS.  
Conclusion: Both dietary interventions, without calorie restriction, in combination with 
aerobic exercise and healthcare counselling, yielded substantial improvements in all evaluated 
domains of HRQoL in women with PCOS.  
 
Keywords: Aerobic exercise; Diet; Health-related quality of life, Lifestyle, Pulse-foods 
 
6.1 Introduction 
The PCOS is a common endocrinopathy among reproductive-age women with a 
prevalence of up to 18% (Carmina & Lobo, 1999; Knochenhauer, 1998; March et al., 2010). 
Most women with PCOS present with excess weight and metabolic complications, including 
insulin resistance, glucose intolerance, dyslipidemia, and predisposition to develop DM2 and 
CVD (Carmina & Lobo, 1999; Teede et al., 2006). Women with PCOS are affected by several 
psychological issues: altered self-perception, altered feminine identity, eating disorders, anxiety, 
depression, social phobia, and suicidal attempts (Deeks et al., 2010b; Elsenbruch et al., 2003). 
Mental-health and health-related quality of life (HRQoL) are adversely affected in many women 
with PCOS (Deeks et al., 2010a; Rasgon et al., 2003). HRQoL is defined as the “physical, 
psychological, and social domains of health”, described as “distinct areas influenced by a 
person’s experiences, beliefs, expectations, and perceptions” (Testa & Simonson, 1996). 
Healthcare providers can assess HRQoL, design individually-tailored therapies to control PCOS 
symptoms, and evaluate the effectiveness of treatment, that are relevant from patients’ 
perspectives (Crosby et al., 2003; Wilson & Cleary, 1995).  
There is limited evidence to demonstrate positive effects of lifestyle modification on 




lentils, and chickpeas) has a favourable nutritional composition. Chronic pulse consumption has 
been shown to modify postprandial glucose and insulin levels, and potentially reduce the risk of 
DM2 and CVD (Ha et al., 2014; Sievenpiper et al., 2009). The TLC diet has been considered a 
standard healthy diet with the capacity to improve lipid profiles. Increased insulin sensitivity 
alleviated metabolic disruptions, and weight management, can exert psychological benefits and 
positively impact HRQoL of women with PCOS (Harris-Glocker et al., 2010; McCook et al., 
2005; Thomson et al., 2010). We hypothesized that independent of calorie restriction, a pulse-
based diet would be more effective than the TLC diet in improving HRQoL in women with 
PCOS who had participated in an exercise program and received healthcare counselling. 
6.2. Materials and Methods 
6.2.1. Study Design and Protocol 
Details of the study design, randomization, dietary and exercise interventions, and ethics 
have been presented in Chapter 4, page 69. A brief description about the education and 
healthcare counselling provided to the study subjects follows.  
Before randomization to the diet groups, each participant received two four-hour sessions 
of counselling as a standard of care. Counselling topics included the human menstrual cycle, 
ovarian morphology in normal ovulating women, polycystic ovarian morphology, criteria used to 
diagnose PCOS and pathophysiology of PCOS. Other topics included risk determinants, 
complications, and associated comorbidities of PCOS, as well as medical and lifestyle (i.e., diet 
and exercise) options to manage PCOS. The counselling was delivered by a gynaecologist, an 
MSc and a PhD researcher. All personnel had specialization in reproductive endocrinology and 
clinical nutrition. Before randomization, and after the initial HRQoL survey, each participant 
received an individualized dietary consultation session by a registered dietitian for approximately 
1.5 hours. During the dietary consultation session, all women received a guide booklet outlining 
TLC diet guidelines.  
The HRQoL survey was given to the participants after the diagnosis of PCOS, but before 
the start of the counselling and intervention, and was repeated at the end of the intervention. 
Compliance with diet and exercise regimens was monitored by self-administered food and 
exercise daily logs completed by participants throughout the intervention. 
6.2.2. Participants  




6.2.3. HRQoL Survey 
Participants’ HRQoL was assessed using a researcher-devised and validated PCOS-
specific survey described elsewhere (Colwell et al., 2010). The survey was administered at 
baseline and after the completion of the 16-week intervention. The survey was revised to be 
compatible with the administration at baseline and after the completion of the intervention. The 
survey was used to evaluate quantitative changes in HRQoL scores after participating in the 
study in the domains of knowledge, concerns, and understanding about PCOS, documentation 
and tabulation of participants’ lifestyle behaviours, and evaluation of participants’ satisfaction 
with prior healthcare services. Also, the survey was used qualitatively as a means to gauge the 
participants’ feelings and experiences about their PCOS diagnosis, and their attitude and comfort 
level toward participation in the study.  
The HRQoL survey of 82 items was devised to gather quantitative and qualitative 
information. Quantitative information was obtained using 7 domains: health concerns (12 items), 
healthcare satisfaction (5 items), knowledge about PCOS (23 items), healthy lifestyle behaviours 
(6 items about active living, and 8 items about eating a healthy diet), feelings and experiences 
about PCOS diagnosis (7 items), and feelings and experiences about participating in the lifestyle 
intervention (13 items). Raw data were compiled and reviewed for accuracy. A 5- or 6-point 
Likert scale was used to measure the extent to which each participant agreed with a suggested 
statement and the level of active engagement in certain lifestyle behaviours, respectively. The 
highest scores represented the optimal function or highest level of agreement and the lowest 
reflected maximum level of impairment or lowest level of agreement. The mean score of all 
items within a domain provided a domain score; lower scores indicated a greater negative 
impact. Qualitative information was obtained using eight open-ended questions. Participants 
were asked to share their feelings, experiences, emotions, comprehension, and comments about 
their condition and participation in the trial. Following the trial intervention, participants were 
asked to disclose the most surprising and most helpful issues perceived as a result of study 
participation. The HRQoL survey was completed primarily by a self-administered online survey. 
When participants did not have internet access, the survey was completed on paper. A summary 
of the HRQoL survey and the mean scores of groups for each survey item is presented in 
Appendix A. 




Statistical analyses were performed using SPSS version 22.0 (SPSS Inc., Chicago, 
Illinois, USA). Continuous variables were presented as mean ± SD and categorical variables as 
numbers and percentages. Baseline differences between continuous variables were determined 
by t-tests and categorical variables by chi-squared tests. An ANOVA test was used to assess 
baseline differences in the pulse-based diet, TLC diet, and the group who were randomized but 
failed to complete the HRQoL survey following the intervention. A mixed model ANOVA was 
used to compare changes in the scores of HRQoL domains over time (time effect) between 
groups (the pulse-based and TLC diets), and to examine differences in the scores of HRQoL 
domains over time (group by time interaction). An average effect size was calculated to estimate 
the magnitude of improvement in each domain over time following the intervention. Effect sizes 
of 0.10, 0.30 and 0.50 were deemed small, medium and large effect sizes, respectively (Aron et 
al., 2006). Results were considered significant at P<0.05. 
 
6.3. Results 
6.3.1. Demographic, Anthropometric, and Clinical Characteristics 
The flow-diagram of subjects' progress through the phases of the clinical trial according 
to the Consolidated Standards of Reporting Trials statement is shown in Figure 6. Of 95 enrolled 
participants, 30 women in the pulse-based diet group and 31 women in the TLC diet group 
completed the intervention trial. Fifty-five (n=55; 90%) of the 61 women who completed the 
intervention trial also completed both initial and post-intervention HRQoL surveys: 28 in the 
pulse-based diet group and 27 in the TLC diet group.  
 Sociodemographic, anthropometric, and clinical characteristics of the women included in 
the analysis are shown (Table 12). The average age of women was 26.4±4.9 years, and average 
BMI was 33.3±8.9 kg/m2. Participants were Caucasian (67.3%, 37/55), worked full-time (50.9%, 
28/55), had a university degree (49.1%, 27/55), and were single (36.4%, 20/55). At baseline, 
pulse-based and TLC diet groups did not differ regarding age, ethnicity, weight, BMI, WC, 
sexual orientation, menarche, menstruation patterns, clinical features of PCOS, and number of 
pregnancies and children. Baseline characteristics of women randomized to receive the 
intervention who did not complete the HRQoL survey post-intervention (n=40) were not 
different when compared with women who completed the intervention. The level of compliance 




Following the intervention, both groups exhibited a reduction in body weight (pulse-based diet 
group –3.8±1.3 kg, TLC diet group –5.9±2.7 kg; time main effect P=0.005): no differences were 
observed between groups regarding weight loss (P=0.53).  
6.3.2. HRQoL Survey 
Results of the comparisons of HRQoL domains are presented in Figure 7. At baseline, 
pulse-based diet and TLC diet groups were comparable in the domains of health concerns and 
knowledge about PCOS, healthcare satisfaction, active living, eating a healthy diet, and feelings 
and experiences toward participation in a lifestyle intervention study. Scores for all domains 
increased over time with no group by time interaction (Figure 7). The largest mean increases in 
time-effects occurred in the domains of healthy eating (P=0.0001, effect size=0.68), knowledge 
about PCOS (P<0.0001, effect size=0.48), physical activity (P<0.0001, effect size=0.37), 
healthcare satisfaction (P=.0001, effect size=0.35), feelings and experiences about participating 
in the lifestyle intervention (P=0.004, effect size=0.14), and health concerns (P=0.02, effect 
size=0.11). Of note, there were no differences in the evaluated domains at baseline among 
women who did not complete the HRQoL survey post-intervention and women who completed 
the intervention.  
Analysis of results from women who completed the survey (n=55) showed most of our 
participants (58.2% [32/55]) were first diagnosed with PCOS as a result of participation in the 
study, and 49.1% (27/55) had been unaware of having male-pattern excess hair growth until 
being examined and informed during the pre-study diagnosis. Eighty percent (44/55) of 
participants were overweight or obese (BMI≥25 kg/m2), and 70.9% (39/55) stated excess weight 
to be frequent among their first-degree relatives. At baseline, 76.4% (42/55) of our participants 
felt a need to lose weight for health reasons. However, inquiry about feelings and experiences 
about weight loss revealed that only 22.9% (8/35) were motivated to lose weight, and 77.1% 
(27/35) reported feelings of “frustration”, “anger”, “pressure”, “stigma”, “embarrassment”, 
“intimidation”, “desperation”, “depression”, and “sadness”, mainly due to multiple failed 
attempts at weight loss in the past.  
Over one-third (34.3% [12/35]) of responders reported to have suffered from being “just 
told by doctors to lose weight”, had “lack of knowledge” and had no “tools” to lose weight. A 
majority of the responders (85.7% [30/35]) complained about the lack of “guidance” and 




and sustainable weight-control strategy for PCOS. One participant stated, “if it was easy, I 
[would have] had done it already”. One participant stated weight loss to be “unhealthy”, “risky”, 
and “inadequate”. When asked the same questions after the intervention, 32.5% (13/40) of 
responders reported feelings of “frustration”, “hopelessness”, and “stress” about weight loss, 
while 67.5% (27/40) reported to feel “motivated” and “good” to “lose more weight”. Overall, the 
motivated women reported to be more “confident” and “determined” to follow the newly 
adopted lifestyle strategies, had “the solution in their “hands”, and were “…coached on proper 
eating and exercise” during the study, while admitting weight management to be “important” and 
a “lifelong challenge”. When inquired about the implemented medical procedures during the 
intervention, 91.1% (41/45) of responders described the transvaginal ultrasound examination as a 
“positive” and “interesting” experience, and expressed their gratitude for having informative 
conversations about polycystic appearing ovaries on the ultrasound machine screen with the 
study gynecologist performing ultrasound examinations, despite feeling mild levels of pressure 
(37.8% [17/45]) and pain (4.4% [2/45]) by some of the responders during the procedure. 
Likewise, 97.4% (37/38) of responders reported the physical examination to be a “respectful”, 
“comfortable”, and “informative” experience. One participant reported feeling “embarrassment” 
when her body hair was examined. Women expressed their gratitude for being listened to, 
respected, engaged, and informed about PCOS during the PCOS diagnosis and healthcare 
counselling sessions. The responders felt that being informed about development and progress 
toward treatment goals during the study’s medical procedures promoted their levels of 
engagement and motivation during the intervention.  
Figure 8 illustrates the information received from the lifestyle intervention study that 
women found most helpful (A) and most surprising (B). The most helpful information obtained 
(50.9% [28/55]) was related to management of PCOS symptoms with dietary and exercise 
modification and to physiological mechanisms through which PCOS can increase the risk of 
DM2, CVD, and endometrial cancer (12.7% [7/55]). Participants were most surprised to learn 
the importance of dietary and exercise modification on PCOS management (38.2% [21/55]), and 
secondly, to receive a positive diagnosis of PCOS and comprehend that their symptoms have 
been related to PCOS (12/55 [21.8%]). There were no statistical differences between the 
intervention groups for all the information obtained in the domain of feelings and experiences 












Table 12. Baseline sociodemographic, anthropometric, and clinical characteristics of women 
with PCOS (n=55) 





Age (years) 26.2±4.8 26.7±5.2 0.76 















































Shortest interval between 
bleeding (days) 


















Hirsutism† (n [%]) 
Acne vulgaris (n [%]) 













































Highest level of education 



























Abbreviations: PCOS, polycystic ovary syndrome; TLC, Therapeutic Lifestyle Changes; BMI, 
body mass index. 
 
Notes: Values are mean±SD except indicated otherwise. *Student t-test and chi-squared test were 
used for comparisons of means and proportions between the groups. †Hirsutism was defined 
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Dark bars represent all women in the pulse-
diet group (n=28); light bars represent all 
women in the TLC diet group (n=27); white 
bars represent women who failed to 
complete the HRQoL survey following the 
intervention (n=40). HRQoL domains of 
women who did not complete the 
intervention were compared with women in 
the pulse and TLC diet groups to determine 
whether women who dropped out of the 
study had lower scores in any of the 
domains of the quality of life. Groups were comparable at baseline. Improvements over time were significant (P<0.05) in all domains as 
determined by repeated measure ANOVA, with no group by time interaction. Scores are mean±SD. A 5-point Likert scale was used to 
measure the extent to which the participant agreed with a suggested statement, and a 6-point scale measured how frequently the participant 
engaged in certain lifestyle behaviours. A higher change reflects a greater improvement in each domain. HRQoL, health-related quality of life; 
PCOS, polycystic ovary syndrome; TLC, Therapeutic Lifestyle Changes.  
Figure 7. Mean scores of the five domains of the HRQoL survey at baseline and after the 16-week of intervention. 
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PCOS, polycystic ovary syndrome; CVD, cardiovascular disease; DM2, diabetes type 2; MetS, metabolic syndrome; TLC, Therapeutic 










Figure 8. Information received about PCOS following the intervention that participants found most helpful (A) and most surprising (B, next 
page; n=55). 
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All evaluated domains of HRQoL: knowledge and concerns about PCOS; healthcare 
satisfaction; and lifestyle behaviours (i.e., physical activity and healthy eating) improved after 
women with PCOS engaged in the pulse-based and TLC diet interventions. Before the 
intervention, women were highly troubled by lack of information about effective, sustainable 
weight-control strategies for PCOS. It was very helpful to receive detailed, patient-centered 
lifestyle counselling sessions and education about the mechanisms and methods through which 
healthy eating behaviours and physical activity could improve insulin sensitivity and diminish 
PCOS associated health complications. Women identified dietary and physical activity 
recommendations as the least anticipated and most helpful information to effectively manage 
PCOS. The clinical implication of our study is that HRQoL improved after a multidisciplinary 
healthcare team delivered medical, dietary, and exercise counselling after diagnosis and study 
visits. Women felt empowered to manage their condition after understanding reasons for PCOS 
symptoms and how many acts of daily living influence improvement or deterioration of health. 
Compromised HRQoL and high psychological morbidity in women with PCOS has been 
well documented (Elsenbruch et al., 2003; Hahn et al., 2005; McCook et al., 2005). Obesity is an 
important concern to women with PCOS that negatively impacts HRQoL (Susanne Hahn et al., 
2006; Hahn et al., 2005; McCook et al., 2005). At baseline, over 75% of our participants had 
feelings of exasperation, guilt, sadness, stigma, shame, and anger about excess weight and 
ongoing difficulties with weight loss. Women reported a negative body image, lowered 
confidence and reduced quality of life following multiple unsuccessful attempts at weight loss. 
Persistent feelings of futility, in turn, may lower motivation to adopt healthy lifestyle changes 
and adhere to medical treatments. Following the intervention, our participants exhibited the 
greatest positive changes in the domains of healthy eating, knowledge about PCOS, and physical 
activity participation. The second highest positive changes were observed regarding healthcare 
satisfaction, feelings and experiences about participating in a research study, and health concerns 
about PCOS. Our observations align with the findings of Thomson et al., where women showed 
improvements in HRQoL and less depression after participation in a lifestyle intervention 
involving an energy-restricted high protein diet alone or in combination with aerobic exercise 




the development and management of PCOS, as well the promotion of physical activity and 
healthy eating practices without calorie restriction. Our pulse-based diet was a low fat, high fiber 
diet with a low glycemic index. The TLC diet was nutritionally balanced with increased fiber, 
decreased saturated fatty acids and cholesterol, and contained low-density lipoprotein cholesterol 
lowering dietary options: viscous fiber and plant stanol/sterol esters ("The NCEP ATP III final 
report," 2002). While study goals were not focused on calorie restriction or weight loss, both 
intervention groups lost weight post-intervention, improved motivation to make positive changes 
in their lifestyle habits and gained the confidence to continue to lose weight by implementing the 
learned healthy lifestyle patterns. Our findings revealed that education is integral when 
promoting the consumption of healthy food items, improving dietary composition, and sustaining 
long-term healthy eating behaviours and did not require focusing on short-term energy restriction 
for weight loss.  
Strengths of our study methods included identifying a well-defined PCOS population; 
educating women about the pathophysiology and diagnosis of PCOS; enabling women to 
understand why recommended management strategies help; using a comprehensive PCOS-
specific HRQoL survey; BMI- and age-matched treatment groups: RCT design. Because 
improvements in health for women with PCOS have been demonstrated when both exercise and 
dietary changes are achieved, we sought to include exercise for all participants with the 
allocation to a dietary intervention. We were therefore able to encourage two modalities of 
lifestyle change that would potentially improve quality of life during the study. We were limited 
however in ability to differentiate whether the combination of exercise and diet or either 
modality alone or whether the counselling sessions were integral and responsible for 
improvements in quantitative QOL indices. Limitations included potential recall and self-
reporting bias and high participant drop-out rate. We were ethically unable to ask if “dropouts” 
were poorly motivated to complete the intervention. Although some results may need to be 
interpreted with caution, an improvement in HRQol was realized overall for both dietary groups 
as a result of participating in the diet and exercise interventions. 
The present study supports the importance of lifestyle interventions and education to 
improve HRQoL in women with PCOS. The positive HRQoL outcomes in the present study may 
be attributed to educating women about improving a range of healthy eating practices, the 




encouraging aerobic exercise via healthcare counselling. Our findings reinforce the urgency to 
educate women using a multidisciplinary approach, through regular, detailed, individualized 
counselling, to provide knowledge about PCOS and motivate healthy lifestyle practices. 
Empowering women with feasible and sustainable lifestyle and medical therapies to improve 
health will help women to adopt effective strategies to cope with PCOS. By identifying and 
minimizing barriers to long-term lifestyle modification, women’s relationship with 
multidisciplinary healthcare providers will also improve (Brady et al., 2009; Y. Li et al., 2011). 
Our study results reinforce the need for physicians and allied health professionals to 
acknowledge the importance of providing education and counselling to improve healthy lifestyle 
behaviours of women with PCOS and focus not only the physical symptoms but also on ways to 





EFFECTS OF THE LIFESTYLE INTERVENTION ON DIETARY INTAKE AND PULSE 
CONSUMPTION IN WOMEN WITH PCOS 
Kazemi M, McBreairty LE, Chizen DR, Pierson RA, Chilibeck PD, Zello GA.  
Participating in a pulse-based diet and exercise randomized clinical trial affects dietary 
intake and pulse consumption behaviours in women with polycystic ovary syndrome* 
*format and structure of the original manuscript have been revised to provide a better flow 
within the thesis and be consistent with the format of previous chapters 
Abstract 
Background and Objectives: Controversy surrounds the optimal diet composition to 
mediate favourable health-related outcomes for women with PCOS. In Canada, pulse 
consumption is low despite its health benefits. We hypothesized that a nutritionally balanced, 
low-glycemic index, pulse-based diet containing lentils, beans, split peas, and chickpeas would 
increase insulin sensitivity and function; thereby, improving metabolic and reproductive sequelae 
associated with PCOS. In a secondary outcome analysis of a randomized controlled trial, we 1) 
compared the effects of a pulse-based diet with the National Cholesterol Education Program 
TLC diet on dietary patterns in women with PCOS; and 2) evaluated the effects of participating 
in a pulse-based versus standard TLC dietary intervention study on knowledge, attitude, and 
consumption of pulses in women with PCOS using a self-administered Pulse Consumption 
Survey. 
Methods: Dietary intake were assessed in women randomly assigned to 1 of 2 diets 
without energy restriction in a controlled, prospective clinical intervention using serial 24-hour 
dietary recalls. Ninety-five women with PCOS (18-35y) enrolled in a 16-week lifestyle changes 
program; 30 women assigned to the pulse-based diet group and 31 women in the TLC diet group 
completed the study. All women participated in an aerobic exercise program and received 




Results: Both the pulse-based (2273 vs 1707 kcal) and TLC diet (2211 vs 1654 kcal) 
groups voluntarily reduced their average daily energy intake from baseline (P<0.001). Dietary 
cholesterol intake decreased, expressed as change from baseline, in the pulse-based diet group 
compared to the TLC diet group (-228.8 vs 3.2 mg/d, respectively; P<0.001). Dietary intakes, 
expressed as change from baseline, increased for fiber (10.5 vs 0.0 g/d), folate (259.5 vs -48.9 
µg/d), magnesium (73.1 vs -8.0 mg/d), and iron (1.9 vs -8.6 mg/d) in the pulse-based diet group 
compared to the TLC diet group (all P<0.05). The pulse-based diet group tended toward a greater 
decrease in the change of trans-fat intake from baseline than the TLC diet group (-0.9 vs -0.1 g/d; 
P=0.06). Following the intervention, women in the pulse-based diet group exhibited higher 
scores in the domain of knowledge about the nutritional composition of pulses, recommended 
servings of legumes based on Canada Food Guide, environmental, and economic benefits of 
pulse consumption when compared with the TLC diet group (P<0.05). Both groups exhibited 
increased scores in the domain of attitudes about the palatability, accessibility, preparation, and 
affordability of pulse foods over the 16 weeks (P<0.01). Changes in scores in the domain of 
attitude toward pulses were not different between groups over time (P=0.11). Following the 
intervention, women in the pulse-based diet group exhibited a greater frequency of pulse 
consumption compared with the TLC diet group (93% vs 68%; P<0.01). 
Conclusion: Participating in a pulse-based diet intervention resulted in more favourable 
diet quality and greater knowledge about the health benefits of pulses versus the TLC diet 
intervention. Increased knowledge about pulses and a higher frequency of pulse consumption in 
women who were randomized to the pulse-based diet group were attributed to a greater 
awareness of pulses through education and receiving pulses as meals over a 16-week 
intervention.  
 
Keywords: Polycystic ovary syndrome; lifestyle; Therapeutic Lifestyle Changes diet; 
pulse-foods; glucose; Dietary Reference Intake 
7.1. Introduction 
PCOS is a heterogenous endocrinopathy and the leading cause of anovulatory 
infertility among reproductive-age women worldwide with a prevalence of up to 18% 




adverse CVD and DM2 risk indicators including hyperinsulinemia, compensatory IR, 
excess weight, and hyperandrogenism (Azziz et al., 2009; E. Diamanti-Kandarakis & A. 
Dunaif, 2012).  
Lifestyle modifications, comprised of dietary, exercise, and cognitive behavioural 
therapies, are recommended as the first-line strategy to mediate health-related outcomes 
in PCOS ("Practice Committee of American Society for Reproductive Medicine, Society 
for Reproductive Endocrinology and Infertility. Optimizing natural fertility: a committee 
opinion," 2013). Low-GI calorie-restricted diets have been demonstrated to induce 
weight loss, ameliorate IR, and improve health-benefits in overweight and obese women 
with PCOS (Barr et al., 2013; Marsh et al., 2010; Turner-McGrievy et al., 2014a). 
However, calorie restricted dietary interventions are limited in terms of sustainability in 
the long-term and their applicability to women with normal weight. There is a paucity of 
evidence about a PCOS-optimized dietary composition to ameliorate PCOS health 
outcomes. As the underlying premise of the RCT in the present thesis, we hypothesized a 
nutritionally balanced pulse-based diet containing lentils, beans, split peas, and chickpeas 
would increase insulin sensitivity and function, thereby improving metabolic and 
reproductive sequelae associated with PCOS. Pulses are high in fiber, contain complex 
carbohydrates with a low GI, are low in fat, contain high-quality protein, have low 
sodium content, and are a significant source of vitamins and minerals, such as iron, zinc, 
folate, calcium, magnesium, and potassium (Mudryj et al., 2014). In Canada, pulse 
consumption is low despite its health benefits. Only 13% of Canadians consume pulses 
on any given day (Mudryj et al., 2014). Chronic consumption of pulses in other 
populations has been associated with decreased postprandial blood glucose and insulin 
concentrations, hypercholesterolemia, and obesity in non-PCOS populations (Ha et al., 
2014; McCrory et al., 2010; Sievenpiper et al., 2009). The TLC diet is a nutritionally 
balanced diet, accomplished by increasing fiber consumption, decreasing saturated fat 
and cholesterol, and adding LDL-C lowering dietary options such as viscous fiber and 
plant stanol/sterol esters ("The NCEP ATP III final report," 2002). The TLC diet was 
considered, for our study, as a healthy control diet with the potential to mediate health-




We were unable to find a study involving women with PCOS where either a 
pulse-based or TLC diet were evaluated. For the purposes of the present study, we 
hypothesized participation in a pulse-based diet would result in greater improvements in 
dietary intake and pulse consumption behaviours versus the TLC diet in women with 
PCOS. In a secondary outcome analysis of a randomized controlled trial, we evaluated 
the effects of participating in a pulse-based versus standard TLC dietary intervention 
study on changes in dietary intake (macronutrients, micronutrients, GI and GL), 
knowledge, attitude, and consumption of pulses in women with PCOS. This study also 
determined the barriers to pulse consumption in this population.  
 
7.2. Materials and Methods 
7.2.1 Study Design and Protocol 
Details of the RCT design and protocol have been elaborated in Chapter 4, page 69. 
7.2.2 Participants  
Details about the study participants have been presented in Chapter 4, page 71.   
7.2.3 Dietary Assessment 
Dietary intake was assessed using serial 24-hour dietary recalls through a self-
administered method. Dietary recalls were obtained at baseline and monthly during the 16-week 
intervention period. To standardize reporting portion sizes, we used a photo album that 
illustrated different portion sizes. All women were instructed about filling out the dietary recalls 
during dietary counselling sessions. Dietary intake data were analyzed using the ESHA Food 
Processor SQL Software (version 7.02, ESHA Research, Salem, OR). For mixed meals, nutrients 
were calculated by meal components. GI was calculated according to the UN Food and 
Agriculture Organization/WHO ("World Health Organization. Preventing and managing the 
global epidemic," 1998) as described elsewhere (Graff et al., 2013). The GI values were 
determined using the International Table of Glycemic Index Values and Glycemic Load 
(Atkinson et al., 2008) using white glucose as the standard reference. For various foods reported 
in the recalls, the best matched GI was assigned by manually reviewing the table as previously 
used in several publications (Beulens et al., 2007; Egan et al., 2011; Jenkins et al., 2002). The 
GL of a serving of each food was calculated as ([g of carbohydrate from food item × GI value of 




were presented in comparison with the National Institute of Health Dietary Reference Intakes 
("Nutrient Recommendations: Dietary Reference Intakes (DRI)," 2011) 
7.2.4. Pulse Consumption Survey 
The Pulse Consumption Survey (PCS) was completed by participants before healthcare 
counselling and randomization and after finishing the dietary interventions and exercise training 
as previously described  (McBreairty et al., 2017). As elaborated in Chapter 6, all women 
received education and counselling about PCOS and healthy lifestyle behaviours to manage their 
condition.  
The PCS has been developed by our research group. The survey was a modified version 
of the previously validated Diet Approaches to Increase Lentils in Youth (DAILY) questionnaire 
(Phillips et al., 2014). The PCS was designed to determine pulse consumption in the population 
as well as to assess knowledge, attitudes, and barriers related to dietary pulses and pulse foods 
consumption. The survey had 3 parts; part 1 included 21 questions to assess attitude about the 
palatability, accessibility, preparation, and affordability of pulse foods; part 2 included 2 
questions to determine the frequency and barriers of consumption; and part 3 included 10 
questions to assess the participants’ knowledge about the nutritional composition of pulses, 
recommended servings of legumes based on Canada’s Food Guide, environmental, and 
economic benefits of pulse consumption. The PCS is presented in Appendix B. 
7.2.5. Statistical Analysis  
Details of the statistical analysis have been elaborated in Chapter 4, page 74 and 75. An 
average effect size was calculated to estimate the magnitude of improvement in each part of the 
PC survey over time following the intervention. Effect sizes of 0.10, 0.30 and 0.50 were deemed 
small, medium and large effect sizes, respectively (Aron et al., 2006). Results were considered 
significant at P<0.05. 
 
7.3. Results 
The CONSORT flow diagram of the study has been presented in Figure 5, Chapter 5. Of 
a total of 324 women responded to the study recruitment advertisement, 95 were enrolled in the 
study. Thirty women in the pulse-based diet group and 31 in the TLC diet group completed the 
16-week intervention. There were no significant differences in the clinical or biochemical 




characteristics of participants have been presented in Table 13. Only 44 women responded to the 
serial 24-hour dietary recalls during the intervention: n=21 in the pulse-based diet group and 
n=23 in the TLC diet group. Final numbers analyzed for each outcome measure are presented in 
Table 13. The level of compliance with exercise and dietary interventions have been presented in 
Chapter 4, pages 75 and 76. 
7.3.1. Dietary Intake 
Both diet groups voluntarily reduced their average daily energy intake from baseline 
(P<0.001, Table 13). There were no differences for changes in the energy intake from baseline 
between the pulse-based and TLC diet groups (P=0.97). The percentage of energy intake from 
carbohydrates showed a greater increase in the pulse-based diet group (9.6% [47.6% to 57.2%]) 
than the TLC diet group (3.0% [50.2% to 53.2%]) expressed as changes from baseline (P=0.05); 
however, the pulse-based diet group (-16.7) exhibited a greater decrease in dietary GI levels from 
baseline when compared to the TLC diet group (-3.8; Table 13). The percentage of energy intake 
from dietary fats decreased from baseline in both pulse-based (-4.9 [34.2% to 29.3%]) and the 
TLC diet (-4.4% [34.5% to 30.1%]) groups over time (P<0.01) without a group by time 
interaction (P=0.88). Changes in the percentage of energy intake from dietary proteins in the 
pulse-based (0.3% [16.8% to 16.5%]) and the TLC diet (1.8% [16.2% to 18.0%]) groups were 
comparable (P=0.08), without a group by time interaction (P=0.07). Dietary cholesterol, 
saturated fat, trans fat, monounsaturated fat, and polyunsaturated fat intakes decreased from 
baseline during the intervention (time main effect, P≤0.05; Table 13). The pulse-based diet group 
exhibited a greater decrease in dietary cholesterol intake during the intervention when compared 
to the TLC diet group (P<0.001). The pulse-based diet group had a tendency toward a greater 
decrease in trans-fat intake during the intervention from baseline than the TLC diet group 
(P=0.06). The pulse-based diet group consumed higher amount of dietary fiber than the TLC diet 
group during the intervention (P<0.01), and there was a time main effect (increase) for soluble 
fiber intake (P=0.04). Vitamin B3 and B5 intakes decreased over time in both groups (P≤0.05). 
Dietary intakes, expressed as change from baseline, increased for folate, vitamin K, copper, 
magnesium, manganese, and iron in the pulse-based diet group compared to the TLC diet group 
(P<0.05, Table 13). The pulse-based diet had a greater decrease in dietary sodium intake when 
compared to the TLC diet group (P<0.05). The pulse-based diet exhibited a decrease in omega 3 




(P=0.03, Table 13). There were no changes in the dietary intake of other nutrients in response to 
intervention (data not shown). Results of the post hoc comparisons of macronutrients between 
the intervention period and long-term follow up phases of the study have been presented in 
Chapter 5. When compared to the intervention period, the pulse-based diet group exhibited a 
tendency toward decreased dietary magnesium intake versus the TLC diet group 6 months after 
the completion of the intervention (-99.3 vs 23.5 mg/d; P=0.06). There were no changes in 
magnesium intake between the intervention period and 12 months after the completion of the 
intervention (P=0.35). Dietary intake of manganese, expressed as change from the intervention 
period, decreased in both the pulse-based and the TLC diet groups 6 (-2.6 vs -0.2 mg/d; P=0.02) 
and 12 months after the completion of the intervention (-3.0 vs -1.2 mg/d; P<0.001). Unlike the 
12-month follow up timepoint (P=1.00), both the pulse-based (1400 mg/d) and the TLC diet (922 
mg/d) groups exhibited increased intakes of sodium intake 6 months after the completion of the 
intervention when compared to the intervention period (P=0.01). The potassium intake of groups 
did not change 6 months after the completion of the intervention (P=0.27); however, both the 
pulse-based (-1338 mg/d) and TLC diet (-737 mg/d) groups decreased their intakes of potassium 
12 months after the completion of the intervention from the intervention period (P=0.03). There 
were no changes in the dietary intake of other nutrients between intervention and long-term 
follow-up time points (data not shown). 
7.3.2.  PCS 
Analysis of the results from the PCS at baseline showed a low frequency of pulse 
consumption in women with PCOS. Forty-three percent [26/61] of responders consumed 1-3 
pulse meals per month and 27.9% [17/61] never or rarely ate pulse foods. The most frequent 
barriers associated with pulse consumption pertained to a lack of preparation knowledge (rank 1, 
47.5% [29/61] agreed), time constraints (rank 2, 21.3% [13/61]), and a belief that pulses do not 
taste good (rank 3, 13.1% [8/61]). Most participants believed pulses would be too expensive to 
add to meals (85.2% [52/61] agreed), were motivated to consume pulses (65.6% [40/61] agreed) 
and needed more information about preparing pulse foods (78.7% [48/61] agreed). There were 
no differences between groups for all the measured outcomes at baseline (P>0.05). 
Following the intervention, women in the pulse-based diet group exhibited higher scores 
in the part of knowledge about the nutritional composition of pulses, recommended servings of 




consumption when compared with the TLC diet group (P=0.04; effect size=0.53). Both groups 
exhibited increased scores in the part of attitudes about the palatability, accessibility, preparation, 
and affordability of pulse foods over the 16 weeks (P<0.01; effect size=0.76). Changes in scores 
in the section on attitude toward pulses were not different between groups over time (P=0.11).  
As expected, following the intervention, women in the pulse-based diet group exhibited a 
higher frequency of pulse consumption (defined as the consumption of ≥1 pulse meals per week) 
than the TLC diet group (93.3% [28/30] vs 67.7% [21/31]; P<0.01). However, results of the 
long-term follow phases of the study showed the frequency of pulse-food consumption decreased 
in both the pulse based and TLC diet groups when compared with the 16-week post-intervention 
timepoint (P<0.01); there were no differences in the frequency of pulse consumption between 
women who completed the 6- and 12-month follow up phases and were randomized to receive 
either the pulse-based and TLC diets 6 (43.7% [7/16] vs 37.5% [6/16]; P=0.45) and 12 (58.3% 





Table 13. Dietary intakes at baseline and during the intervention 
 Pulse-based diet group  TLC diet group  P value 
 Baseline 16-weeks Change Baseline 16-weeks Change Time Group 
x Time 
Diet  
Total energy intake 
(kcal/d) 
2273±724 1707±27 -566±667 2211 ±536 1654±406 -557±696  <0.0001 0.97 
Carbohydrate intake 
(g/d) 
272.3±100.4 243.5±64.1 -28.8±93.4 281.5±95.1 221.2±71.8 -60.3±106.8 <0.01 0.30 
Fat intake (g/d) 88.0±42.0 56.7±24.8 -31.3±43.6 84.6±27.5 55.3±19.8 29.3±37.0 <0.0001 0.87 
Protein intake (g/d) 92.0±29.3 69.1±15.7 -22.9±24.9 87.3±25.7 75.3±25.7 -12.0±34.6 <0.001 0.24 
Dietary fiber (g/d) 22.8±7.8 33.3±8.2 10.5±10.2 24.5±14.6 24.5±9.5 0.0±14.4 <0.01 <0.01 
Cholesterol intake 
(mg/d) 
357.0±184.9 128.2±114.0 -228.8±20.6.5 284.6±154.8 287.7±164.9 3.2±195.6 <0.01 <0.001 
Saturated fat (g/d) 27.9±12.2 14.0±5.4 -13.9±13.1 24.7±15.7 17.4±9.9 -7.3±18.8 <0.0001 0.18 
Trans fat (g/d) 1.3±1.9 0.4±0.5 -0.9±2.0 0.4±0.4 0.3±0.4 -0.1±0.5 0.04 0.06 
Monounsaturated fat 
(g/d) 
25.2±14.2 19.0±5.9 -6.2±13.5 22.1±12.5 16.9±8.4 -5.2±12.0 <0.01 0.78 
Polyunsaturated fat 
(g/d) 
13.4±12.0 9.9±3.3 -3.5±11.2 11.1±6.5 8.8±3.3 -2.3±7.0 0.05 0.68 
Glycemic index (GI) 55.5±7.3 38.8±6.7 -16.7±10.3 54.3±7.7 50.5±8 -3.8±8.0 <0.0001 <0.01 
Glycemic load (g) 142.1±59.8 96.3±25.3 45.8±56.7 162.7±58.1 101.3±26.2 61.3±49.3 <0.0001 0.43 
Vitamin B3 (mg/d) 29.3±23.7 20.7±18.1 -8.6±17.4 26.3±23.4 20.7±9.9 -5.6±25.5 0.04 0.64 
Vitamin B5 (mg/d) 9.1±13.6 7.7±8.7 -1.4±7.0 8.4±11.7 5.3±5.5 -3.1±7.6 0.05 0.47 
Folate (µg/d) 380.0±205.1 639.5 ±266.0 259.5±286.6 344.0±260.0 295.1±159.5 -48.9±271.4 0.02 0.001 
Vitamin K (µg/d) 76.4±41.1 146.9±83.2 70.5±84.7 91.1±121.7 102.0±107.4 10.9±80.3 <0.01 0.02 
Copper (µg/d) 1542.2±1126.7 2068.3±918.2 526.1±960.5 1412.4±1169.4 1060.0±438.7 -352.4±1193.4 0.60 0.01 
Manganese (mg/d) 2.9±1.4 5.0±1.8 2.1±2.0 3.5±2.6 3.0±1.1 -0.5±2.8 0.03 0.001 






Data are expressed as mean±SD. Numbers for dietary intake in each group were as follows: pulse-based diet group=23; TLC diet group=21. 
Numbers for leisure physical activity score in each group were as follows: pulse-based diet group=27; TLC diet group=30.
Iron (mg/d) 17.1±8.2 19.0±5.4 1.9±6.7 21.8±20.8 13.2±4.0 -8.6±21.8 0.16 0.03 










The purpose of current study was to determine changes in dietary intake, knowledge, 
attitude, and frequency of pulse consumption after participating in an ad libitum pulse-based 
versus standard TLC dietary intervention in women with PCOS who exercised and received 
education and counselling about PCOS and healthy lifestyle behaviours. The most significant 
finding of the study was participating in a pulse-based diet intervention resulted in more 
favourable diet quality and greater knowledge about the health benefits of pulses versus the TLC 
diet intervention. To our knowledge, the present study is the first multi-dimensional lifestyle 
changes program to demonstrate the positive impacts of a pulse-based dietary intervention on 
dietary intakes and pulse consumption behaviours in women with PCOS. 
The percentages of energy intake from macronutrients were within the acceptable 
macronutrient distribution range (AMDR) in our participants both at baseline and after the 16-
week intervention. Our observations are consistent with previous reports on the proportion of 
energy intake from macronutrients in women with PCOS (Altieri et al., 2013; Crystal C Douglas 
et al., 2006; Shishehgar et al., 2016a; Toscani et al., 2011). Previous studies have shown worse 
dietary intakes in women with PCOS compared to healthy controls, characterized by increased 
consumption of high-GI foods, saturated fats, and a low intake of dietary fiber, despite 
similarities in the overall energy and nutrient intakes (Crystal C Douglas et al., 2006; Shishehgar 
et al., 2016a). By contrast, the mean dietary GI of our subjects (56.6) was interpreted as moderate 
at baseline (Frost & Dornhorst, 2012). Our participants had a marginally low (23.6 g/d) intake of 
dietary fiber at baseline when compared to the adequate intake (AI) of 28g/d ("Nutrient 
Recommendations: Dietary Reference Intakes (DRI)," 2011). Instead, our observations align 
with those of Barr et al. and Moran et al. on similarities between dietary GI and fiber intakes of 
women with PCOS and non-PCOS healthy controls (S. Barr et al., 2011; Moran, Ranasinha, et 
al., 2013). 
Unlike the TLC diet group, women who were randomized to the pulse-based diet group 
achieved a low GI  (≤45) during the intervention. A low GI diet has been recommended to 
reduce the risk of CVD and DM2 in long-term (Barclay et al., 2008). The pulse-based diet group 
also showed a greater increase in the proportion of energy intake from dietary carbohydrates and 
a low GL, expressed as changes from baseline, which indicate an improvement in the type of 





intake per se may not be optimal or a practical strategy for all women with PCOS, including 
those with normal BMI, certain non-insulin resistant phenotypes, and women with obesity in 
long-term. Further, women in the pulse-based diet group exhibited a higher improvement in the 
type of dietary fat intake, reflected by a greater decrease in dietary cholesterol and a tendency 
toward a greater decrease in trans-fat intakes during intervention when compared to the TLC diet 
group. Dietary consumption of trans fats and excessive cholesterol intake have been shown to 
aggravate IR, dyslipidemia, hyperandrogenism, and proinflammatory state (Lefevre et al., 2005; 
Mozaffarian et al., 2004). Previous studies have shown the positive effects of PUFA intake on 
the metabolic health outcomes of PCOS including IR, abdominal adiposity, chronic-low 
inflammation, and dyslipidemia (Bahcecı et al., 2007; Diamanti‐Kandarakis et al., 2006; Kasim-
Karakas et al., 2004; Kirchengast & Huber, 2001; Velazquez et al., 2000). However, in our 
study, both groups showed decreased levels of PUFA intake during the intervention.  
In the present study, decreased insulin levels and increased insulin sensitivity were 
hypothesized to be the key pathophysiological factors for improving health-outcomes associated 
with PCOS, even if a voluntary weight loss occurred (E. Diamanti-Kandarakis & A. Dunaif, 
2012). Our study goals did not focus on calorie restriction; however, both intervention groups 
achieved a 5% weight loss post-intervention, attributed to a decrease in total energy intake, 
increased intake of low-GI foods, and increased physical activity, as described in Chapter 5. 
While both intervention groups exhibited decreased glucose and insulin responses to OGTT, the 
pulse-based diet group showed a greater decrease in total insulin AUC. Our results are similar to 
those of Marsh et al. (Marsh et al., 2010) on increased insulin sensitivity following an ad libitum 
low-GI diet versus a macronutrient-matched healthy diet. Apart from inducing satiety and weight 
loss, several factors can explain the beneficial effects of a pulse-based diet on improving 
glycemic response to OGTT including a high fiber content, low-GI, significant anti-oxidant 
content, and a favourable micronutrient and macronutrient composition (McCrory et al., 2010; 
Mudryj et al., 2014; Sievenpiper et al., 2009).  
During the course of the intervention, we observed changes in the micronutrient intakes 
of groups, including achieving the recommended intakes of folate, magnesium, and iron in the 
pulse-based diet group and decreased iron intake in the TLC diet group in relation to the 
recommended RDA. However, it is difficult to derive a conclusion about the positive impact of 





significant potential to overestimate the dietary requirement of women who do not meet the 
recommended RDA cut-offs because the values have been defined to meet the recommendations 
of 97.5% of the North American population (Dietary reference intakes: the essential guide to 
nutrient requirements, 2006; "Nutrient Recommendations: Dietary Reference Intakes (DRI)," 
2011). The sodium intake of our participants exceeded the American Heart Association 
recommendations (≤2400 mg/d) at baseline, consistent with the sodium intake of American 
women with PCOS (Crystal C Douglas et al., 2006). The mean sodium intake of the pulse-based 
diet group was still higher than the adequate intake (AI; 1500 mg/d) during the intervention; 
however, the pulse-based diet group experienced a greater decrease in dietary sodium intake 
during the intervention when compared to the TLC diet group. High sodium intake has been 
associated with increased glucocorticoid synthesis, IR, hyperglyceridemia, and lower adiponectin 
levels (Baudrand et al., 2014; Vedovato et al., 2004). 
Compliance with healthy dieting habits has been challenging and poor in the context of 
PCOS especially in long-term studies (S. Barr et al., 2011; Marsh & Brand-Miller, 2005; Turner-
McGrievy et al., 2015). In the present study, the compliance to the dietary interventions was 
increased by education about healthy eating behaviours and dietary counselling. Consumption of 
pulses among our participants was low at baseline. Our observation was similar that of Mudryi et 
al. reporting low intake of pulses in Canadian diet (Mudryj et al., 2014). Low consumption of 
pulse foods has been attributed to a lack of knowledge about the health benefits of pulses, 
negative feelings and experiences pertaining to pulse foods, including poor texture, flavour, 
gastrointestinal intolerance, and social norms of eating in Canada (Mudryj et al., 2012). 
Following the intervention, we observed increased knowledge about pulses and a higher 
frequency of pulse consumption in women who were randomized to the pulse-based diet group. 
These observations can be attributed to a greater awareness of pulses through education and 
consumption of pulse foods over the intervention period. Our observations reinforce the 
importance of patient-centred dietary interventions on improving the compliance to healthy 
lifestyle behaviours in women with PCOS, beyond the consumption of pulse foods. 
Limitations of the study included the potential for recall bias (Thompson et al., 2015), 
and the Hawthorne effect (McCarney et al., 2007) in obtaining dietary information much like 
what happens in clinical practice. We used serial 24-hour dietary recalls as the most accurate and 





have a tendency toward random/systematic error, underreporting, and reactivity (Thompson et 
al., 2015). A fundamental limitation was a high attrition rate and poor response rate to the dietary 
recalls. Thereby our results may be skewed toward responders. As previously described in 
Chapter 5, a high drop-out rate is a common event in PCOS lifestyle change research (Hoeger et 
al., 2004; Marsh et al., 2010; Turner-McGrievy et al., 2015). Another limitation is the lack of a 
gold standard for GI values, and associated issues affecting GI, including the ripeness of fruits 
and vegetables, type, processing, and specific combination of foods. We acknowledge that the 
population studied represented ethnicities found in urban prairie cities in Canada. The indigenous 
population was largely underrepresented with respect to the prairie population, possibly due to 
recruitment geographically in an area without a large indigenous population. Therefore results 
cannot be generalized to an indigenous population. 
In a dietary intervention without energy restriction, where aerobic exercise was 
recommended and healthcare counselling was provided, both pulse-based and TLC diet groups 
reduced their energy intake. The pulse-based diet was more efficient than the TLC diet in 
improving the overall diet quality and knowledge about pulses, attributed to a greater awareness 
of pulses through education and receiving pulses as meals over a 16-week multifactorial lifestyle 
changes program. In Chapter 8, a general discussion has been provided based on the results of 












 GENERAL DISCUSSION 
 
The main objective the thesis was to compare the effects of a low-GI pulse-based diet 
with the standard TLC diet on multiple health outcomes of PCOS after a 16-week intervention 
when both groups exercised and received education and healthcare counselling about PCOS and 
lifestyle modification. Insulin resistance and hyperinsulinemia are key pathophysiologic 
contributors to PCOS disruptions which can be aggravated by concomitant obesity. Our findings 
reported in Chapter 3 further support the position that reproductive-age women with PCOS 
exhibit adverse cardio-metabolic and DM2 risk profiles, attributed to inherent IR, impaired 
insulin action, and obesity. These observations align with previous evidence about the substantial 
risk of CVD and DM2 in western populations with PCOS (Apridonidze et al., 2005; Ehrmann et 
al., 2006). Rationalized by the interplay between IR and obesity, work to date has provided 
insights into the short-term benefits of calorie-restricted low-GI diets on improving insulin 
sensitivity, glucoregulation, and weight management in PCOS (Barr et al., 2013; Marsh et al., 
2010; Turner-McGrievy et al., 2014a). However, there is a paucity of evidence surrounding an 
optimal dietary composition to mediate favourable PCOS health outcomes in the long-term 
specifically across various BMI categories. We hypothesized that a nutritionally balanced ad 
libitum low-GI pulse-based diet containing lentils, beans, split peas, and chickpeas would 
increase insulin sensitivity; thereby, improving reproductive and cardio-metabolic sequelae 
associated with PCOS. In Chapter 4, we demonstrated the pulse-based diet was more efficient 
than the TLC diet to increase insulin sensitivity post-intervention, reflected by a reduction in 
total insulin AUC and a tendency toward a lower SHBG. Further, we reported decreased bilateral 
AFC, OV, TT, and increased menstrual regularity in both groups over time. These observations 
inform decreased severity of reproductive disruptions and/or the likelihood of response to 
treatment in PCOS (Jarrett & Lujan, 2017; Lujan et al., 2013), attributed to pre-established 
mechanisms (Bützow et al., 2000; Moran et al., 2011; Moran et al., 2007; Moran et al., 2009; 
Palomba et al., 2008) as discussed in Chapter 4. The most significant finding of the present study 
was that the pulse-based diet was more effective than the diet endorsed to decrease LDL-C,  the 
TLC diet, ("The NCEP ATP III final report," 2002), to reduce LDL-C, TG, TC/HDL-C ratio, 





modifying dietary composition yielded similar improvements in glucoregulation, BMI, WC, 
SBP, and TG in both intervention groups, which can be translated to improved cardio-metabolic 
and DM2 risk profiles in women with PCOS. Hypocholesterolemic and BP lowering effects of 
pulses can be attributed primarily to their low-GI, high fiber content, favourable nutrient and 
antinutrient composition including low sodium content, high potassium content, and in part, 
attibuted to improvements in the renin angiotensin aldosterone system that secondary to 
decreased insulin resistance of our participants (Aburto et al., 2013; Altorf–van der Kuil et al., 
2010; Jayalath et al., 2014; Jee et al., 2002; Kalupahana & Moustaid‐Moussa, 2012; McCrory et 
al., 2010; Mudryj et al., 2014; Sievenpiper et al., 2009; Thorne et al., 1983; Tielemans et al., 
2013) as elaborated in Chapter 5. Although negative impacts of PCOS on HRQoL have been 
documented, surprisingly, few studies have investigated the implications of lifestyle intervention 
for the improvement the HRQoL of women with PCOS. In Chapter 6, we showed women with 
PCOS were highly troubled with the lack of knowledge about PCOS and feasible strategies to 
manage their condition. Following the intervention, women in both groups exhibited 
improvements in all evaluated aspects of quality of life, including health concerns and 
knowledge about PCOS, healthcare satisfaction, active living, healthy dieting, and feelings and 
experiences about participation in the study. Women felt empowered about the management of 
their condition, through information received during education and counselling sessions. The 
positive HRQoL outcomes were attributed to educating women about improving a range of 
healthy eating practices, the favourable nutritional composition of diets, and encouraging aerobic 
exercise via healthcare counselling as described in Chapter 6. We showed that a lifestyle 
intervention comprised of diet, exercise and counselling has had a positive effect on HRQOL 
regardless of the dietary intervention. The outcome of the study revealed the importance for 
women with PCOS to understand the underlying reasons for their condition and ways to improve 
health to make meaningful long-term positive life changes. Analyses of results in women who 
completed the long-term follow up phase of the study showed that women experienced the 
greatest improvements in anthropometric, body composition, physiologic, insulin sensitivity, 
hormonal, and lipid outcomes at 16- weeks post intervention as opposed to 6- or 12-months after 
ithe ntervention. While some of the improvements maintained (HDL-C and TC/HDL-C levels), 
the overall metabolic profile of our participants exacerbated in long-term after the completion of 





may be attributed to decreased levels of physical activity, lower frequency of pulse consumption, 
and less favourable dietary intakes, including decreased consumption of dietary fiber in both 
groups. Our observations highlight the importance of regular follow-up visits with a 
multidisciplinary team to monitor, support, motivate, and encourage women with PCOS to 
increase their adherence to the newly adopted healthy lifestyle practices. In Chapter 7, dietary 
intake and pulse consumption of intervention groups were described during the intervention, 
expressed as changes from baseline. Both groups voluntarily reduced their average daily energy 
intake from baseline. However, an analysis of the overall dietary intake of the pulse-based diet 
group revealed greater improvements in healthy dietary components than observed in the TLC 
diet group; expressed as changes from baseline, the pulse-based diet group had a greater decrease 
in dietary cholesterol intake, a tendency toward a greater decrease of trans-fat intake, and 
increased fiber, folate, magnesium, and iron intakes compared to the TLC diet group. As 
described in Chapter 7, knowledge and attitudes to eating pulses were evaluated in both. Women 
in the pulse-based diet group exhibited higher scores in the domain of knowledge about dietary 
pulses, which was attributed to a greater awareness of pulses through education and receiving 
pulses in their meals over 16 weeks. Both groups exhibited increased scores in the domain of 
attitudes about pulse foods over the 16 weeks.  
A pulse recipe resource guide has been developed during the course of the study. The 
recipe resource guide, being both evidence-based and modified for palatability and acceptability 
for Canadian women, has the potential to be an effective tool both for the clinician as well as for 
the general public. The resource guide can be used for future research studies investigating the 
effects of pulse-based diets in various populations. The booklet can be used as a potential 
resource proactively to encourage beneficial eating habits among healthy populations and 
patients at risk for specific diseases and can be distributed to healthcare practitioners to promote 
pulse utilization and consumption.  
 
8.1. Strengths and Limitations of the Study 
Several RCTs have evaluated the effects of dietary and exercise interventions on various 
health descriptors in women with PCOS. Most studies had small sample sizes and were less 
comprehensive in the measures examined. Our RCT was unique, as it evaluated the effects of a 





women with PCOS. Our study adopted a multi-dimensional approach comprised of dietary, 
exercise, education, and healthcare counselling strategies to evaluate multiple physiologic, 
metabolic, reproductive, HRQoL and dietary factors in response to treatment in women with 
PCOS. The diagnosis of PCOS and polycystic ovaries utilized advanced ultrasound technology 
and analysis methods to determine the effects of treatment on changes in ovarian morphology for 
the first time. Women’s’ medical histories and clinical examinations were completed by very few 
investigators to ensure uniformity and critical appraisal. Biochemical assessments were done at 
standard baseline menstrual cycle timelines to ensure uniformity of sampling. Participant 
education and counselling were likewise uniformly delivered by a small team of knowledgeable 
individuals.  novel PCOS-specific survey was used to examine HRQoL indices before and 
following the intervention as opposed to less inclusive questionnaires such as the health-related 
quality-of-life questionnaire (Cronin et al., 1998). The present study had a diverse sample with 
25.5% of subjects being non-Caucasian. We used ethno-specific adjustments when evaluating for 
hirsutism and abdominal obesity as related to MetS. Two dietitians assisted to improve the 
adherence to dietary interventions during the course of the study. Our first dietitian was blinded 
to group assignments to minimize the bias of dietary education for or against pulse-based diets to 
all women at baseline. Dietary compliance was improved by regular nutritional counselling by a 
second researcher dietitian during the intervention. Long-term follow up of lifestyle changes 
programs have been challenging and neglected in PCOS research. The present study included 
long-term monitoring of participants at 6- and 12-months post-intervention.  
A number of limitations may be included in the interpretation of our results, including the 
potential for recall and/or self-reporting bias in obtaining physical activity, dietary intake and 
menstrual patterns. In our Canadian population, invitations for indigenous participation was 
limited by the geographical location of the study. While a high attrition rate as described in 
Chapter 5 was expected for long-term studies, this factor and economic realities of performing 
studies limited our ability to increase our study sample size. 
 
8.2. Concluding Remarks 
The present study results support the importance of lifestyle modifications in the 
management of PCOS and add another dimension to the existing knowledge concerning the 





women with PCOS. While both ad libitum dietary interventions yielded substantial 
improvements in reproductive, cardio-metabolic, HRQoL outcome measures, the pulse-based 
diet was more effective than the TLC diet in decreasing insulin response to OGTT, decreasing 
risk factors for metabolic syndrome, cardio-metabolic disease and diabetes.in women with PCOS 
following a16-week intervention 
 
8.3. Future Directions 
Motivating women to incorporate beneficial lifestyle changes such as pulse-based diets 
and exercise into daily life needs to be the focus of future large studies to improve overall health 
for women with PCOS. To accomplish this goal, studies are needed to help women to understand 
how to incorporate pulses in their diets, as pulse consumption was foreign to participants with 
PCOS who volunteered for our study. Our attention was directed at providing prepared meals 
containing pulses to evaluate the beneficial effects of pulse-based diets upon women with PCOS. 
Long-term continuation of a pulse diet requires that participants start preparing their meals in 
order to have the skills to continue consuming a healthy diet that is suited to their palate. In 
Canada, although pulses comprise a large agricultural market share, Canadians do not consume 
pulses on a regular basis. Future research is required to address the mechanisms through which 
pulse consumption would mediate health benefits in women with PCOS.  
It has been demonstrated in the past that consumption of a pre-prepared low-calorie food 
substitute is effective at short-term weight loss, only when the food substitute is consumed. 
Weight regain occurs immediately after restricted diets cease because there has been no 
incorporation of healthy eating habits into daily life activities. There is likely to be more long-
term adherence to consumption of pulses and a higher probability for long-term health 
improvements when women are educated to incorporate low-GI nutrient-rich pulse consumption 
into their everyday diet. To address the high attrition rate and poor adherence to lifestyle change 
intervention programs, smaller and more gradual changes are needed over a longer study 
duration to improve long-term compliance. To address ethnic variations, diets need to be 
adjusted to incorporate ethnic palates. A focus towards healthy eating and optimal exercise are 
likely to result in long-term weight loss and thereby address BMI issues and risks for metabolic 





regular counselling with a multidisciplinary healthcare team are warranted for the successful and 
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Appendix A. Characteristics of the health-related quality of life survey and the mean scores of 
groups for each survey item (n=55). 
Quantitative information section 
Domain 1: Health concerns (12-item scores) 
Before/after the lifestyle intervention, I was concerned about: 
Choices: 
1. This is not an issue for me 
2. Not concerned 
3. Indifferent 
4. Somewhat concerned 








(n = 55) 
1. Fertility, and my ability to become pregnant in the 
future 
2. Irregular menstrual bleeding 
3. Unwanted male pattern hair growth (hirsutism) 
4. High male hormone levels (hyperandrogenemia) 
5. Acne 
6. Scalp hair loss (alopecia) 
7. A weight problem 
8. High insulin levels and insulin resistance 
9. My risk of developing cancer of the uterus or breast  
10.  My risk of developing diabetes 
11.  My risk of developing cardiovascular disease 
12.  My risk of developing the metabolic syndrome (a 
group of symptoms, including elevated levels of 
blood triglyceride, glucose, waist circumference, 


































Domain 2: Healthcare satisfaction (5-item scores) 
Before/after the lifestyle intervention: 
Choices: 
1. I did not see a healthcare provider 






4. Yes somewhat 








(n = 55) 
13. I had discussed my symptoms with my primary 
healthcare providers 
14. I felt satisfied with the explanation given to me about 
my symptoms by my healthcare providers 
15. I felt satisfied with the treatment options offered to 
me by my healthcare providers 
16. I felt satisfied with the treatment I was receiving (or 
had received) for my symptoms by my healthcare 
providers 
17. I felt satisfied with the on-going care I was receiving 





















Domain 3: Knowledge about PCOS (23-item scores) 
Before/after the lifestyle intervention I understood [that]: 
Choices: 
1. I do not understand this information 
2. I am unsure 
3. Yes, I somewhat understand 








(n = 55) 
18. A follicle is a small fluid-filled sac with a single egg 
inside and that follicles are often called cysts 
19. How follicle growth and egg release occur 
20. Polycystic ovaries contain more visible follicles than 
the average ovary 
21. Polycystic ovaries tend to ovulate less frequently than 
the average ovary 
22. Ovulating more frequently would improve my 
fertility 
23. After egg release (ovulation), progesterone is 



























to shed and make me have a regular menstrual period 
(if I'm not pregnant) 
24. Having monthly increases in progesterone and 
therefore, menstrual periods would decrease my risk 
of cancer of the uterus 
25. Polycystic ovary tends to make more male hormone 
(like testosterone) than the average ovary 
26. The amount of fat in the body affects the amount of 
free male hormone in my body 
27. More free male hormone promotes unwanted hair 
growth, acne and scalp hair loss (alopecia) 
28. Medications can stop the production of male hormone 
by the ovary (like hormonal contraception) or block 
the effects of male hormone, and would help to 
prevent unwanted hair growth, acne or alopecia (male 
pattern balding) 
29. Insulin helps the ovary make more male hormone 
(like testosterone) 
30. High insulin levels are common in women with 
PCOS 
31. High insulin levels promote weight gain and make it 
harder to lose weight 
32. High insulin levels place individuals at high risk for 
developing diabetes 
33. Lowering insulin levels may help to decrease male 
hormone levels, help with weight loss and help 
trigger ovulation 
34. Insulin levels can be lowered by exercise and by 
certain changes in diet 
35. Insulin levels can be lowered by medications (like 
metformin) that make the body more sensitive to 
insulin 
36. Increasing the amount of muscle in my body will 
increase my body's metabolic rate, that is my body's 
ability to burn calories 
37. The metabolic syndrome increases my risk for 
developing diabetes and cardiovascular disease. 






















































































39. That exercise, appropriate changes in diet, and weight 
loss can decrease the risk of developing the metabolic 
syndrome 
40. Enough about PCOS to explain to another person 






Domain 4: Active living (6-item scores) 








(n = 55) 
41. I led an active lifestyle 
Choices: 




5. Strongly agree 
42. Total number of times I exercised per week  
Choices: 
1. No, I didn't really exercise 
2. 1 to 2 days each week 
3. 3 to 4 days each week 
4. 5 to 6 days each week 
5. Daily 
43. The number of days per week of doing aerobic 
exercise (that is, exercise that increases heart rate and 
makes you warm and sweaty) was 
Choices: 
1. Occasional 
2. 1-2 times per week 
3. 3-4 times per week 
4. 5-6 times per week 
5. Daily 
44. The number of minutes per session of doing aerobic 
exercise was (examples of non-aerobic exercise 
include resistance bands, hand weights, Pilates or 
Yoga but not exercises such as jogging or walking) 
Choices: 































































2. 6-10 minutes 
3. 11-15 minutes 
4. 16-30 minutes 
5. 31-44 minutes 
6. greater than 45 minutes 




2. 1-2 times per week 
3. 3-4 times per week 
4. 5-6 times per week 
5. Daily 
46. The number of minutes per session of non-aerobic 
exercise was 
Choices: 
1. 2-5 minutes 
2. 6-10 minutes 
3. 11-15 minutes 
4. 16-30 minutes 
5. 31-44 minutes 




































Domain 5: Healthy Dieting (8-item scores) 
Before/after the lifestyle intervention: 
Choices: 
1. Never 
2. Hardly ever 
3. Sometimes 














47. I thought about the types of food I was eating when 
planning every meal 
48. I ate three meals per day 
49. I ate protein with every meal 
50. I ate a diet low in fat 
51. I made healthy food choices for snacks 
52. I ate a diet rich in fruits and vegetables 
53. I knew which foods were high in protein 





















Domain 6: Feelings and experiences about PCOS diagnosis (7-item scores) 
           Choose the response that best describes your feelings:   










(n = 55) 
55. I was first diagnosed with PCOS as a result of 
56. I had an ultrasound in the last three years 
57. The type of ultrasound was transvaginal [In case of 









58. I suspect that other women in my family (like mother, 
sisters) or extended family (like aunts, cousins, 
grandmothers) have PCOS 
59. Excess weight (being overweight or obese) runs in 
my family 
60. I feel I need to lose weight for health reasons 
61. I didn't know that I had hirsutism (male pattern hair 



















Domain 7: Feelings and experiences about participating in the lifestyle intervention (13-item 
scores) 










5. Strongly agree 
62. Comfortable about asking questions [from the study 
researchers] 
63. Comfortable about discussing personal or sensitive 
subjects [with the study researchers] 
64. My information would remain confidential (unless I 
agreed to have my information sent to my family 
doctor) 
65. The [study] researchers were knowledgeable about 
PCOS 
66. The [study] researchers would gain helpful 
information about PCOS 
67. The [study] researchers would be able to provide 
answers regarding my concerns about PCOS 
68. It was helpful to look at the ultrasound images of my 
ovaries. Now it is now easier for me to understand 
what it means to have polycystic ovaries 
 
Before/after participating in the study, my level of 
comfort with: 
 
69. The idea of having blood tests was 
Choices: 
1. Painful 
2. Very uncomfortable 
3. Uncomfortable 
4. Slightly uncomfortable 
5. Comfortable 
6. Very comfortable 
70. The idea of having physical examinations, including 
having my height, weight, and waist circumference 
measured, hair growth assessed, and body 











































































2. Very uncomfortable 
3. Uncomfortable 
4. Slightly uncomfortable 
5. Comfortable 
6. Very comfortable 
71. The idea of having a transvaginal ultrasound was 
Choices: 
1. Uncomfortable 
2. Slightly uncomfortable 
3. Neutral 
4. Comfortable 
5. Very comfortable 
72. The experience of doing blood tests was  
Choices: 
1. Too painful 
2. Painful and I wanted to quit but didn't say so 
3. Painful but I didn't want to quit 
4. Not overly painful 
5. Not at all painful/no discomfort 




2. Very uncomfortable 
3. Uncomfortable 
4. Slightly uncomfortable 
5. Comfortable 
6. Very comfortable 
74. The experience of doing transvaginal ultrasound was 
Choices: 
1. Too painful 
2. Painful and I wanted to quit but didn't say so 
3. Painful but I didn't want to quit 
4. Not overly painful 































































Qualitative information section  
Questions asked from participants after completing the lifestyle intervention study 
 





76. We are interested in learning more about how women experience the physical 
examination. Please tell us anything about your experience that you think we should know 
77. We are interested in learning more about how women experience the transvaginal 
ultrasound, which was part of the PCOS study. Please tell us anything about your 
experience that you think we should know 
78. Is there any topic that you think we should have asked you about?  
79. Is there any comment you would like to make about the topic of PCOS or the topic of 
being involved in a study? 
80. Is there anything that you would like to add, ask or comment about? 
81. If you learned something about PCOS during the study, what ONE thing did you learn that 
is most helpful to you? 
82. If you learned something about PCOS over the course of the study, what ONE thing came 
as a surprise to you? 














Appendix B. Pulse Consumption Survey 
Subject ID:  
  








PULSE CONSUMPTION SURVEY 
 
Dear Study Participant, 
 
We are interested in understanding more about why people do or do not eat pulses. This may 
be something you have or have not thought much about but please note, there are no right or 
wrong answers.  Do your best to answer all the questions. 
For your information, the term pulses refer to: 
 
 Beans (i.e. Kidney beans, white beans, black beans, navy beans) 
 Chickpeas 
 Peas (i.e. Split peas) 
 Lentils (i.e. Red, yellow and green) 
 






     PART ONE 








1. I need more information about how to cook 
pulses. 
    
2. Pulse-based meals or snacks are not available 
when I eat out. 
    
3. I’m too busy to prepare a pulse-based meal.     
4. I believe it would be too expensive to eat 
pulses. 
    
5. I believe I would have to go shopping too 
often if I ate pulses. 
    
6. I would buy a prepackaged pulse-based 
snack. 
    
7. I would get indigestion, bloating or gas eating 
pulses. 
    
8. I don’t know how to prepare pulses.     
9. Pulses are not tasty enough.     
10. I believe it takes too long to prepare pulses.     
11. I never think of using pulses when I cook.     
12. I would try a pulse meal in a restaurant.     
13. I would eat pulses if they had a more 
attractive appearance. 
    
14. I would buy a prepackaged pulse-based 
meal. 
    
15. Pulses are expensive to add to meals.     
16. I am motivated to eat pulses.     
17. I know how to cook pulses.     
18. I believe that pulse-based meals can help     
19. Pulses can be a part of a tasty diet.     
20. Pulses are part of my traditional diet.     






The following items are designed to record your usual food habits. 
 
1. How often do you eat pulses? 
□ Never or rarely (Go to question 2) 
□ 1-3 times per month (Go to PART THREE) 
□ 1-2 times per week (Go to PART THREE) 
□ 3-4 times per week (Go to PART THREE) 
□ 5-6 times per week (Go to PART THREE) 
□ Once a day (Go to PART THREE) 
□ Two or more times a day (Go to PART THREE) 
 
2. People have given many reasons for not eating pulses or rarely eating pulses. Of the 
reasons listed at the bottom of the page, indicate which ones are the most important 
regarding why you never or rarely eat pulses?  (Please put letter in box). 
□ Most important reason why I do not or rarely eat pulses. 
□ Second most important reason why I do not or rarely eat pulses. 
□ Third most important reason why I do not or rarely eat pulses. 
    These include: 
A. I believe pulses do not taste good. 
B. I believe pulses take a long time to cook. 
C. I do not know where to find pulses. 
D. I believe my family would not like pulses. 
E. I believe pulses are expensive. 
F. I do not know how to cook pulses. 
G. I do not want to try new foods. 
H. I believe pulses are not very healthy. 
I. Other.  Please explain: 
 
PART THREE 
The following section is regarding your knowledge of pulses and food. If you are unsure, do 
your best in picking what you believe to be the best answer. 
1. According to Canada’s Food Guide, pulses are an example of a food in the (please 
check one): 
□ Vegetable and Fruit Group 
□ Grain Products Group 
□ Milk and Alternatives Group 
□ Meat and Alternatives Group 







3. One serving of cooked pulses according to Canada’s Food Guide equals (please 
check one): 
□ ¼ cup (60 ml) 
  ½ cup (125 ml) 
  ¾ cup (175 ml) 
        1 cup (250 ml)  
4. Pulses are a good source of protein: 
□ True 
□ False 
5. Pulses are a good source of fibre: 
□ True 
□ False 
6. Pulses are a poor source of iron: 
□ True 
□ False 
7. Pulses have too much saturated fat: 
□ True 
□ False 
8. Which of the following does not belong in the Meat and Alternatives Group in 
Canada’s Food Guide (please check one): 
□ Eggs 
□ Kidney Beans 
□ Tofu 
□ Peanut Butter 
□ Cottage Cheese 
9. Pulses are grown in Saskatchewan: 
□ True 
□ False 
10. Where do you access information on healthy 






□ Friends, family, colleagues 











Appendix C. Pulse-Based Diet Recipe Resource Guide. 
To assist with the integration of pulses into the diet, a pulsed-based food recipe booklet 
was developed throughout the course of the study. The booklet has been developed to promote 
pulse consumption and provide general population with an improved insight about preparation 
and consumption of pulse-based meals. The booklet comprised of 59 healthy, easy, and 
affordable recipes in three main categories, entrees, soups, and salads, that featured whole 
pulses and pulse ingredients. The recipes were all tested, evaluated, and modified several times 
to ensure high quality, palatability, profitability, appearance, and nutritional value for 
Canadian consumers. The recipes were modified based on feedback from participants in order 
to make the meals both healthy and tasty. For general educational purposes, the standard 
Nutrition Facts Labels were provided for all recipes, based on the Food and Drug 
Administration Guidelines. The recipes analyses were performed using the Food Processor 
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Introduction 
Welcome to the Pulse-based Recipe Booklet! In this booklet, we will introduce you to 
59 healthy, easy, and affordable recipes that feature whole pulses and pulse 
ingredients. 
Pulses include peas, beans, chickpeas, and lentils. Pulses are super-healthy foods with a 
favorable nutritional composition. Pulses are a rich source of fiber, starch, and vegetable 
protein, and vitamins and minerals, such as iron, zinc, folate, and magnesium. Pulse 
consumption helps to control weight, and fight against diabetes, cardiovascular disease and 
cancer. 
Pulses are surprisingly good when you have the right recipe! Try one of our delicious recipes 
for an easy, healthy meal today. With these recipes, we hope to fight the notion that healthy 
food has to be bland or boring, and to provide you with an improved insight about preparation 
and consumption of pulse-based meals. The recipes offered in the present booklet are full of 
life, colour, and flavour. All of the recipes have been tested, evaluated, and modified several 
times to ensure they are easy to make and taste fantastic. We hope you have fun exploring 
pulsed-based cooking style and share it with your friends and family. 
The Pulse-based Diet Recipe Booklet is organized in two sections. In the first section, The 
Kitchen Companion, you will be introduced to the basic instructions of cooking pulses and 
commonly used grains in the recipes provided. In the second section, pulse-based recipes will 
be introduced in three main categories, entrees, soups, and salads. A note on the times listed to 
complete the recipes: cooking and preparation times are estimates. You can often speed up 
time spent in the kitchen with advanced preparation, or by preparing other ingredients while 
cooking a grain or simmering a soup. 
We like you to enjoy the recipes we’ve provided. In case you have questions or suggestions 
about the recipes, please don’t hesitate to mention it to us, and we will be happy to assist 
you. Please email us at pcos.pulsestudy@usask.ca. 
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• Use a large pot as full of water as possible. For 450 grams dried pasta, place 6 liters 
water in an 8-litre pot. 
• Cover pot, and bring water to a full rolling boil over high heat before adding pasta. 
• Add pasta, and stir with a pasta fork or large tongs to separate strands. 
• Start timing cooking when water returns to a boil. If you use fresh pasta, remember 
that it cooks more quickly than dried. 
• Always cook pasta uncovered, or only partially covered, over high heat. 
• Start testing for doneness a few minutes before indicated cooking time. Pasta that 
offers resistance to the bite, but has no trace of brittleness is al dente. This is how you 
want it. If an undercooked piece of pasta is cut in half, a white dot or line is clearly 
visible in the center. Al dente pasta has only a speck of white remaining, meaning the 
pasta has absorbed just enough water to hydrate it. 
• Set a large colander in the sink so water drains quickly.  Do not rinse the pasta. 
• Return pasta to the warm cooking pot or add to the skillet with sauce, and 
toss immediately with large tongs or a pasta fork. 
 
How to Cook Basic White 
Rice Steps 
• Select a saucepan, deep skillet or sauté pan with a snug-fitting lid. 
• Heat water to boiling. 
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o For soft, tender rice, use 2 cups water per 1 cup rice.
o For dry separate grains, use 1¾ cups water per 1 cup rice.
• Add the rice and salt. Stir once.
• Return to boiling. Stir once.
• Cover and reduce heat to low.
• Cook for 15 minutes or until all the water is absorbed. Don’t lift the lid or stir. Lifting
the lid allows steam to escape, and stirring the rice releases more starch, causing the
grains to stick together in lumps.
• Remove the lid carefully (try not to let the condensation on the lid drip onto the rice).
How to Cook Pearl Barley 
Steps 
• Bring 1 cup barley and 2 ½ cups water or low sodium broth to a boil (Should yield a
generous 3 cups of cooked barley).
• Reduce heat to a simmer. Cook, covered, until tender and most of the liquid has been
absorbed, 40 to 50 minutes.
• Let stand 5 minutes.
How to Cook Chickpeas and Beans 
Steps 
• Place the chickpeas/beans in a bowl and fill with water. Move the chickpeas/beans
around a little with your hand or a spoon to allow any dirt to come loose in the water.
Drain the water. Repeat until the water appears clear. Don't worry too much if you can
never get the water to be perfectly clear. If any chickpeas/beans float to the top, pick
them out and throw them away. These are bad chickpeas/beans. Pick out and throw out





• Soak chickpeas/beans. You will use 3 cups of water for each cup of chickpea/bean. If 
you don't have a large bowl, use a large pot or any other large container that you have. 
* Do not soak chickpeas/beans in the fridge! Soak them at room temperature. 
* Do not add baking soda or salt to the beans. Some advice adding 1/8 teaspoon of 
baking soda if you have particularly hard water, but usually, it is not recommended. 
• Drain the chickpeas/beans and Replace the Water. Drain the water from chickpeas/beans 
and move them to a large pot. Add 3 cups water for each cup of dried beans that you used. 
• Boil the chickpeas/beans. They should take between 2 and 3 hours to cook (excluding the 
time it takes to bring the chickpeas/beans to a simmer). First, bring the water to a boil 
under medium-high heat. Scoop out any froth that forms with a spoon. 
Once the water starts to boil, set the heat to low and cover the pot. Set a timer to 3 hours. I 
keep them in for the full 3 hours to ensure that they are fully cooked, however, cooking 
times vary depending on the amount of beans, the pot, and time spent soaking the beans. 
For your first-time cooking chickpeas/beans, you may want to check after 2 hours and 
keep checking the beans until they are done. Whenever you take the lid off the pot and 
replace it, check to make sure the water is still at a simmer. If it isn't, temporarily bring the 
heat up to medium heat until the water is simmering again, and then set the heat back to 
low. 
* Should I stir the beans? 
Yes. You may want to stir the chickpeas/beans a few times throughout the cooking 
process to ensure that the beans get cooked evenly. 
* How do I know when the chickpeas/beans are done? 
Take a chickpea/bean and bite into it or squeeze it between your fingers. You should 
be able to squeeze it with your fingers, at least. It should have a very soft consistency. 
Note that you can decide how cooked you want the beans to be. If you find that they 
are cooked but you prefer them to be a little softer, go ahead and let them simmer for a 
little while longer. 












• Rinse the lentils under running water and pick through them to remove any bits of soil 
or rocks. You will use 2 cups of water for each cup of lentil. If you don't have a large 
bowl, use a large pot or any other large container that you have. 
• Add lentils and water to a saucepan (with a lid) and bring to a boil. Turn heat down to 
low and cover to let the lentils simmer, but leave the lid ajar a bit so that they don’t 
boil over. Check on them occasionally to make sure the water has not boiled down 
below the level of the lentils and add more as needed. When the lentils are tender and 
can easily be mashed with a fork, they are done. It usually takes about 30-45 minutes 
for them to cook (older lentils take longer to cook, so it’s best to just test them to 
decide when they are ready), or 20 minutes if using the split red lentils. 
• When they are finished cooking, take the saucepan off the heat and cover tightly with 
the lid. Optional: leave the lid to sit for 5-10 minutes. The lentils will absorb more of 
the water making them juicier and tenderer. Makes about 4 cups cooked lentils. 
 






• Pour the split peas into large colander or sieve. Pick out and discard any shriveled or 
broken beans, stones or debris, and rinse under cold water and pick through them to 
remove any bits of soil or rocks. You will use about 1.5 cups of water for each cup of 
split pea. If you don't have a large bowl, use a large pot or any other large container 
that you have. 
• Add the peas and water to a saucepan (with a lid), and allow water to return to 
boiling, reduce heat, partially cover pan, and simmer for 30 to 45 minutes, depending 






the level of the peas and add more as needed. When the peas are tender and can easily be 





















CHICKPEA and CAULIFLOWER CURRY 
Yield: 4 servings 
Preparation time: 30 minutes Cook time: 1 hour 10 minutes Total time: 1 hour 
and 40 minutes 
Ingredients: 
• 900 grams chickpeas, cooked and thawed
• ½ tablespoon madras curry powder
• 1 bay leaf
• 1 teaspoon cinnamon
• 1 teaspoon cardamom
• 2 teaspoons ground cloves
• 2 teaspoons black pepper
• ¼ red onion, quartered
• 2 tablespoons garlic, minced
• 2 teaspoons ginger, minced
• ¼ teaspoon salt
• 2 tablespoons canola oil
• ½ red onion, diced
• 1 tablespoon cumin
• 1 tablespoon coriander
• ½ teaspoon turmeric
• 1 plum tomato, diced
• 3 cups cauliflower florets, frozen
• 2 teaspoons cornstarch
• 2 teaspoons water
• 1 tablespoon lemon juice






1. Cover chickpeas with water. Add curry powder, bay leaf, cinnamon, cardamom, 
cloves, and black pepper. Bring to a boil. Reduce heat and simmer until chickpeas are 
tender. 
2. Pulse quartered onion, garlic, ginger and salt in a food processor to form a paste. 
3. Heat oil in a pot over medium-high heat. Add onion and cook until browned, about 6 
to 7 minutes. 
4. Add onion, garlic and ginger paste. Cook until dry, about 5 to 7 minutes more. 
5. Add cumin, coriander and turmeric. Cook until fragrant, about 1 minute more. 
6. Add chickpeas and cooking liquid, tomatoes, and cauliflower. 
7. Combine cornstarch and water in a small bowl. Add to curry slowly, stirring 
constantly. Allow to sit for thirty minutes. 
8. Add lemon juice and cilantro. Stir to combine. 
















Yield: 5 servings 
Preparation time: 20 minutes Cook time: 20 minutes Total time: 40 
minutes 
Ingredients: 
• 1125 grams chickpeas, cooked and thawed
• 1 tablespoon olive oil
• 1 small onion, chopped
• 1 jalapeno pepper, minced
• 1 teaspoon madras curry powder
• 1 tablespoon garlic, minced
• 1 can light coconut milk
• 1 ¼ cup low-sodium vegetable broth
• ½ teaspoon salt
• 1 bay leaf
• ½ cup brown rice, dry
• 1 cup cold water
Directions: 
1. Heat oil in a pot over medium-high heat. Add onion, jalapeno pepper and curry
powder. Sauté until onion is translucent.
2. Add garlic and sauté for 1 minute more.
3. Add coconut milk, vegetable broth, chickpeas, bay leaves and salt. Stir to
combine. Reduce heat and simmer.
4. Combine brown rice and water in another pot. Bring to a boil. Reduce heat and
simmer until cooked.








































PASTA WITH GINGER AND CORIANDER SAUCE 
Yield: 4 servings 
Preparation time: 20 minutes Cook time: 40 minutes Total time: 1 hour 
Ingredients: 
• 300 grams red lentils, dry
• 3 tablespoons olive oil
• 2 small onions, finely chopped
• 1 tablespoon garlic, minced
• 3 tablespoons ginger, minced
• 1 tablespoon white wine vinegar
• 2 teaspoons coriander
• 2 teaspoons cumin
• 2 cups low-sodium vegetable broth
• ½ teaspoon salt
• 1 tablespoon no-salt seasoning (such as garlic herb)
• black pepper to taste
• 1 ½ cups whole wheat pasta (such as fusilli or macaroni)
• 4 cups cold water
• 1 cup fresh parsley, packed
Directions: 
1. Cook red lentils according to pulse cooking instructions. Add a pinch of
coriander and cumin to cooking water. Drain once cooked.
2. Heat oil in another pot over medium-high heat. Add onion and sauté until
onions begin to wilt.
3. Add garlic and ginger and sauté for 30 seconds more.





5. Add vegetable broth, lentils, coriander and cumin. Stir to combine. Bring to a boil. 
Reduce heat, cover and simmer until lentils are tender and soupy, about 10 to 
15 minutes. 
6. Add salt and no-salt seasoning. Season to taste with pepper. 
7. Bring cold water to a boil in another pot. Cook pasta according to package 
instructions until al dente. Drain. 
























LENTILS WITH BULGUR WHEAT AND CARAMELIZED ONIONS 
Yield: 6 servings 
Preparation time: 30 minutes Cook time: 1 hours Total time: 1 hour and 30 minutes 
Ingredients: 
• 450 grams lentils, dry
• 6 cups water
• 1 cup bulgur wheat, dry
• ½ teaspoon salt
• 2 tablespoons olive oil
• 1 large onion, finely chopped
• 1 tablespoon garlic, minced
• 2 teaspoons cumin
• 1 teaspoon cinnamon
• ½ teaspoon nutmeg
• ½ teaspoon allspice
• ½ teaspoon salt
• ½ teaspoon black pepper
• 1/3 cup walnuts, chopped
• 1 tablespoon olive oil
• 3 large onions, thinly sliced
• 1/3 cup parsley, chopped
Directions: 
1. Cook lentils in water until almost done but still firm, about 15 to 18 minutes.
2. Add bulgur wheat and salt. Remove from heat and cover. Allow to sit until
bulgur wheat is tender and water is absorbed, about 20 to 25 minutes.





3. Heat oil in another pot over medium-high heat. Add onions and sauté until very soft, 
about 5 minutes. 
4. Add garlic, cumin, cinnamon, nutmeg, allspice, salt and black pepper. Cook for 1 
minute. 
5. Add walnuts. Stir to combine. 
6. Add lentil and bulgur wheat mixture. Stir to combine. Remove from heat. 
7. Heat oil in a large skillet over medium heat. Add sliced onions and cook until 
caramelized to very dark brown, about 20 to 25 minutes. Remove from heat. 
8. Portion lentil and bulgur wheat mixture. Portion caramelized onions on top of lentils 



















OAXACAN GREEN MOLE STEW 
Yield: 4 servings 
Preparation time: 30 minutes Cook time: 40 minutes Total time: 1 hour 
and 40 minutes 
Ingredients: 
• 900 grams chickpeas, cooked and thawed
• 3 tablespoons oil
• 2 large onions, chopped
• 1 tablespoon garlic, minced
• 1 tablespoon ground fennel
• 3 medium zucchinis, sliced
• 2 cups corn, frozen
• 1 cup water
• 2 cans salsa verde
• ½ cup fresh parsley, packed
• ½ cup fresh cilantro, packed
• 1 tablespoon garlic, minced
• 2 teaspoons cumin
• 1 teaspoon black pepper
• ½ teaspoon cinnamon
• ½ teaspoons cloves
• 2 whole wheat tortillas
• cinnamon and chili powder
Directions: 
1. Heat oil in a pot over medium-high heat. Add onions and cook until translucent,
about 8 minutes.





3. Add zucchini, corn, and water. Cook until zucchini softens, about 15 minutes. 
4. Combine salsa verde, parsley, cilantro, garlic, cumin, pepper, cinnamon and cloves 
in a food processor. Pulse until sauce consistency is achieved. 
5. Add mole sauce to stew. Stir to combine and cook for 5 more minutes. 





1. Preheat oven to 350°F. 
2. Cut tortillas into eighths. Place in a single layer on an ungreased baking sheet. 
3. Sprinkle with cinnamon and chili powder as desired. 
4. Bake until tortilla chips brown, about 5 to 10 minutes. 
 
 













TOMATO BASIL BOWTIES 
Yield: 6 servings 
Preparation time: 30 minutes Cook time: 30 minutes Total time: 1 hour 
Ingredients: 
• 1350 grams chickpeas, cooked and thawed
• 3 tablespoon olive oil
• 1 small onion, chopped
• 1 ½ cups cherry tomatoes, halved
• 1 369ml can tomato sauce
• 1 tablespoon garlic, minced
• 1 tablespoon lemon juice
• 1 tablespoon white wine vinegar
• 1 ½ cups low-sodium vegetable broth
• 1 teaspoon crushed red pepper flakes
• 1 teaspoon basil, dry
• 1 teaspoon salt
• 1 ½ cups whole wheat bowtie pasta, dry
• 4 ½ cups cold water
• ¼ cup fresh parsley, chopped
Directions: 
1. Heat oil in a pot over medium-high heat. Add onion, garlic, tomatoes, lemon
juice, and parsley. Sauté for 1 minute.
2. Deglaze with vinegar.
3. Add vegetable broth, chickpeas, red pepper flakes and basil. Bring to a boil.
Reduce heat, cover and simmer until chickpeas are soft.





5. Bring cold water to a boil in another pot. Cook pasta according to package 
instructions until al dente. Drain. 
































Yield: 6 servings 
Preparation time: 30 minutes Cook time: 1 hour and 10 minutes Total time: 1 hour 
and 40 minutes 
Ingredients: 
• 1350 grams chickpeas, cooked and thawed
• 1 796ml can diced tomatoes
• 3 tablespoons tomato paste
• 3 tablespoons olive oil
• 2 cups red onion, chopped
• 1 tablespoon garlic, minced
• 2 teaspoons ginger, minced
• 2 tablespoons ground coriander
• 1 tablespoon garam masala
• 1 tablespoon turmeric
• 1 tablespoon paprika
• 2 teaspoons chili powder
• ½ teaspoon salt
• 5 tablespoons nonfat yogurt, plain, beaten until smooth
• 1 tablespoon lemon juice
• 1 cup water
• 3 naan breads, whole wheat
Directions: 
1. Combine diced tomatoes and tomato paste in food processor. Process until smooth.





3. Add garlic and ginger and fry for at least 1 minute. Continue frying until onions are 
as brown as possible without burning. 
4. Add spices and fry for 30 seconds. 
5. Add tomatoes, yogurt and lemon juice and stir to combine. Simmer for 5 to 10 
minutes, or until oil separates. Oil may not separate as little was used. 
6. Add chickpeas. Stir to combine and simmer for five to ten minutes. 
7. Add water. Stir to combine and simmer, covered, for 30 minutes. Stir 
occasionally throughout. 
NOTE: If water is not evaporating to desired consistency fast enough, boil 
vigorously until it does so. If water must be added to achieve desired consistency, 
bring to boil to combine it, then lower heat back to simmer. 















CHICKPEA AND SPINACH CASSEROLE 
Yield: 4 servings 
Preparation time: 30 minutes Cook Time: 1 hour Total Time: 1 hour and 
30 minutes 
Ingredients: 
• 900 grams chickpeas, cooked and thawed
• 5 slices back bacon or ½ package of regular bacon
• 2 tablespoons canola oil
• 1 small onion, thinly sliced
• 1 red bell pepper, chopped
• ¼ teaspoon salt
• 1 teaspoon red pepper flakes
• 2 bay leaves
• 2 tablespoons garlic, minced
• 330 grams spinach, frozen and chopped
• ½ cup dry white wine or cooking wine
Directions: 
1. Preheat oven to 375°F.
2. Cook bacon until crispy in a pot over medium-high heat. Remove and drain on
paper towels. Chop into bite sized pieces.
3. Drain bacon fat from pot. Add canola oil to pot and heat. Add onion, bell pepper, salt,
red pepper flakes, and bay leaves. Cook until onion is soft, about 3 minutes.
4. Add garlic, bacon and chickpeas. Cook, stirring constantly, until chickpeas begin to
turn golden, about 3 minutes.





6. Layer a third of spinach in a casserole dish. Pour half of chickpea mixture on top of 
spinach, and top with another third of spinach. Pour other half of the chickpea mixture on 
top, and top with last third of spinach. 
7. Pour white or cooking wine over the dish. 
8. Cover dish. Bake until chickpeas are tender and spinach is wilted, about 15 minutes. 


























GINGERED VEGETABLE CURRY 
Yield: 6 servings 
Preparation time: 45 minutes Cook time: 45 minutes Total time: 1 hours and 30 
minutes 
Ingredients: 
• 540 grams split peas, dry
• 12 cups water
• 1 small potato, peeled and cubed
• 1 cup cauliflower florets, chopped
• 1 cup green beans, chopped
• 2 carrots, chopped
• 1 teaspoon turmeric
• ½ teaspoon salt
• 1 tablespoon garlic
• 2 teaspoons cumin
• 1 teaspoon curry powder
• 1 tablespoon cornstarch
• 3 tablespoons water
• 3 tablespoons ginger, minced
• 1 tablespoon lime juice
• 1 tablespoon margarine
• 1 cup brown rice, dry
• 2 cups cold water
Directions: 





2. Combine split peas and water in a large pot. Bring to a boil. Skim foam from surface. 
3. Drain potatoes and add to split peas. Bring back to a boil. Reduce heat to medium, and 
simmer uncovered for 5 minutes. 
4. Add cauliflower, green beans, carrots, turmeric and salt. Bring back to a boil again. 
Reduce heat to low, cover, and simmer gently for about 10 minutes more. 
5. Combine brown rice and water in another pot. Bring to a boil. Reduce heat and simmer 
until cooked. 
6. Heat oil in another pot over medium-high heat. Add garlic, cumin and curry powder. 
Cook, stirring constantly, until garlic is lightly browned, about 1 to 2 minutes. 
7. Add garlic mixture, ginger, and cilantro to split pea mixture. Stir to combine. 
8. Whisk cornstarch and water in a small bowl until smooth. Pour slowly into curry, stirring 
constantly. 
9. Turn up heat to medium-high. Simmer uncovered, stirring occasionally, until the curry 
thickens, about 20 minutes. 
10. Add cooked brown rice, lime juice, and margarine. Stir to combine. 








SPAGHETTI WITH MARINARA SAUCE 
Yield: 4 servings 
Preparation time: 30 minutes Cook time: 40 minute Total time: 1 hour and 10 minutes 
Ingredients: 
• 215 grams red lentils, dry
• 150 grams whole wheat spaghetti, dry
• 1 tablespoon canola oil
• 2 tablespoons canola oil
• 1 tablespoon garlic, minced
• 1 cup onion, finely chopped
• 1 cup carrot, finely chopped
• 1 359 ml can tomato sauce
• 1 cup water
• ½ teaspoon tabasco sauce
• 2 teaspoons basil
• 2 teaspoons oregano
• 1 teaspoon thyme
• ½ teaspoon cinnamon
• 1 teaspoon sugar
• ¼ teaspoon salt
Directions: 
1. Cook red lentils according to pulse cooking instructions. Drain.
2. Bring cold water to a boil in another pot. Cook spaghetti according to
package instructions until al dente. Drain. Add oil and toss to coat.
3. Heat oil in another pot over medium-high heat. Add garlic, onions and carrots. Sauté




4. Add tomato sauce, water, basil, oregano, thyme, cinnamon, sugar, salt and tabasco. Stir to 
combine. Simmer until vegetables are tender. 
5. Add red lentils. Stir to combine. 






























SWEET POTATO QUESADILLA 
Yield: 4 servings 
Preparation time: 30 minutes Cook time: 30 minutes Total time: 1 hour 
Ingredients: 
• 300 grams lentils, dry
• 4 tablespoons canola oil
• 1 large sweet potato, peeled and diced
• 1 tablespoon garlic, minced
• 2 tablespoons cumin
• 1 tablespoon chili powder
• ¼ teaspoon salt
• 4 whole wheat tortillas
• 4 tablespoons shredded cheese
• 1 tablespoon canola oil
Directions: 
1. Cook lentils according to pulse cooking instructions. Drain.
2. Heat oil in a pot over medium-high heat. Add sweet potatoes. Cook until they are
tender and can be easily pierced with a fork.
3. Add lentils, garlic, cumin, chili powder, and salt. Stir to combine. Cook for 2
minutes more. Remove from heat.
4. Lay tortillas flat. Sprinkle each tortilla with ¼ of the shredded cheese. Top half of
each tortilla with ¼ of the sweet potato mixture. Fold each tortilla in half into a
quesadilla.
5. Heat oil in a pan over medium heat. Fry each quesadilla, pressing down with a
spatula, until cheese melts and tortilla begins to brown. Flip quesadilla over and
repeat.







Yield: 5 servings 
Preparation time: 30 minutes Cook time: 30 minutes Total time: 1 hour 
Ingredients: 
• 1125 grams chickpeas, cooked and thawed
• 2 tablespoons canola oil
• 2 tablespoons garlic, minced
• 1 onion, chopped
• 2 celery stalks, chopped
• 1 red bell pepper, chopped
• 1 carrot, finely chopped
• 2 cans mushrooms
• ½ cup corn, frozen
• 1 796ml can diced tomatoes
• 1 tablespoon chili powder
• 2 teaspoons paprika
• 2 teaspoons cumin
• 2 bay leaves
• 1 teaspoon oregano
• ¼ teaspoon salt
• black pepper to taste
Directions: 
1. Heat oil in a pot over medium heat. Add garlic, onion, celery, bell pepper, carrot,
mushrooms and corn. Sauté until the vegetables are slightly tender.
2. Add chickpeas, diced tomatoes and spices. Bring to a boil. Reduce heat and simmer for







































ZUCCHINI AND SPLIT PEA SAUTÉE 
Yield: 6 servings 
Preparation time: 30 minutes Cook time: 20 minutes Total time: 50 minutes 
Ingredients: 
• 540 grams split peas, dry
• 3 tablespoons canola oil
• 1 onion, sliced into rings
• 1 tablespoon garlic, minced
• 3 green onions, chopped
• 2 medium zucchinis, sliced
• 1 796ml can diced tomatoes
• 1 cup shredded cheese
• ¼ teaspoon soy sauce, reduced sodium
• ½ teaspoon salt
• ¼ teaspoon black pepper
• 6 whole wheat buns
• 6 teaspoons margarine
Directions: 
1. Cook split peas according to pulse cooking instructions. Drain.
2. Heat oil in a pot over medium-low heat. Add onion rings. Sauté until browned.
Remove from pot and set aside.
3. Add garlic. Sauté until fragrant.
4. Add green onions and zucchini. Sauté until slightly tender, about 5 minutes.
5. Pour diced tomatoes on top of zucchini mixture. Sprinkle two thirds of the cheese on




6. Lay onion rings on top of cheese layer. Sprinkle the rest of the cheese on top of the 
onion layer. 
7. Sprinkle soy sauce, salt and pepper on top of the sautée. 
8. Reduce heat to low, cover, and cook for about 5 minutes, until cheese is melted 
and tomatoes are heated through. 


























Yield: 5 servings 
Preparation time: 30 minutes Cook time: 1 hour Total time: 1 hour and 30 minutes 
Ingredients: 
• 1125 grams chickpeas, cooked
• 3 tablespoons canola oil
• 1 large onion, chopped
• 2 tablespoons garlic, minced
• 2 796ml cans diced tomatoes
• ½ cup dried apricots, chopped
• 2 teaspoons oregano
• 1 teaspoon cumin
• 1 teaspoon coriander
• 1 teaspoon cinnamon
• 1 teaspoon black pepper
• ¼ teaspoon salt
• 1 cup water
Directions: 
1. Heat oil in a pot. Add onion and garlic. Sauté until browned.
2. Add tomatoes, apricots and spices. Stir to combine. Sauté for five minutes.
3. Add chickpeas. Stir to combine.
4. Add water. Reduce heat to low, cover, and simmer until apricots are tender, about 30 to
45 minutes.
5. Add more water if necessary.











































Yield: 4 servings 
Preparation time: 30 minutes Cook time: 30 minutes Total time: 1 hour 
Ingredients: 
• 300 grams red lentils, dry
• 1 cup salsa
• 2 teaspoons chili powder
• 1 bunch green onions, sliced
• 4 whole wheat tortillas
• 90 grams light cheddar cheese, shredded
Directions: 
1. Preheat oven to 350°F.
2. Cook red lentils according to pulse cooking instructions. Drain.
3. Heat a pan over low heat. Add lentils, salsa, and chili powder. Stir to combine. Allow
to warm through.
4. Lay tortillas flat. Portion a quarter of the lentil mixture onto
each tortilla. Sprinkle half of the green onions and cheddar
cheese on top of the lentil mixture.
5. Roll tortillas into burritos. Sprinkle the remaining half of
the green onions and cheddar cheese on top of the
burritos.
6. Place burritos on a baking sheet. Bake until cheese is
melted, about 10 minutes.





BROCCOLI PASTA ITALIANO 
Yield: 4 servings 
 




• 900 grams chickpeas, cooked and thawed 
• 1 ½ cups whole wheat pasta (such as fusilli or macaroni) 
• 2 tablespoons olive oil 
• ¼ cup red onion, minced 
• 2 tablespoons garlic, minced 
• 1 teaspoon oregano 
• 1 teaspoon thyme 
• 1 teaspoon basil 
• 1 796ml can diced tomatoes 
• 2 cups broccoli florets, frozen 
• ½ teaspoon salt 
• black pepper to taste 
 
Directions: 
1. Bring a pot of water to a boil. Cook pasta according to package directions until al 
dente. Drain. 
2. Heat oil in another pot over medium heat. Add onion. Sauté 
until tender. 
3. Add garlic and herbs. Sauté for another 2 minutes. 
4. Add diced tomatoes and broccoli. Bring to a boil. Reduce heat 
to low and simmer until broccoli is tender, about 20 minutes. 
5. Season with salt and pepper. 
6. Add cooked pasta. Stir to combine. Allow to warm through. 
7. Portion out pasta. 
8. Freeze. 
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LENTIL CHILI CON CARNE 
Yield: 5 servings 
Preparation time: 20 minutes Cook time: 1 hour 40 minutes Total time: 2 hours 
Ingredients: 
• 450 grams red lentils, dry
• ¼ pound extra-lean ground beef
• 1 medium onion, chopped
• 1 large carrot, chopped
• 1 tablespoon garlic, minced
• 1 cup water
• ½ cup wild rice, dry
• 1 369ml can tomato sauce
• 2 284ml cans sliced mushrooms
• 2 tablespoon chili powder
• 1 teaspoon black pepper
• ¼ teaspoon salt
• 1 tablespoon white vinegar
Directions: 
1. Cook red lentils according to pulse cooking instructions. Drain.
2. Heat a pot over medium-high heat. Add ground beef, onions, carrots and garlic.
Sauté until beef has browned.
3. Lift beef mixture from pot with slotted spoon and drain fat. Return beef mixture to pot.
4. Add water, wild rice, tomato sauce, mushrooms and spices. Bring to a boil. Reduce
heat to low, cover, and simmer until rice is cooked, about 1 hour.
5. Add vinegar. Simmer for another 15 minutes.








































EAST INDIAN CINNAMON PILAF 
Yield: 6 servings 
Preparation time: 10 minutes Cook time: 1 hour Total time: 1 hour 10 minutes 
Ingredients: 
• 540 grams split peas, dry
• 4 tablespoons canola oil
• 2 bay leaves
• 2 large onions, chopped
• 2 teaspoons cumin
• 1 teaspoon cumin seeds
• 1 teaspoon cinnamon
• 1 teaspoon madras curry powder
• ½ teaspoon turmeric
• ½ teaspoon hot pepper flakes
• black pepper to taste
• 1 cup brown rice, dry
• 2 ½ cups low-sodium vegetable broth
Directions: 
1. Cook split peas according to pulse cooking instructions. Drain and keep warm.
2. Heat oil in a pan over medium-high heat. Add bay leaf. Cook until golden, about 3
minutes.
3. Add onion. Sauté until tender.
4. Add spices. Sauté for 30 seconds.
5. Add rice. Cook, stirring constantly, for 3 minutes.
6. Add broth. Bring to a boil. Reduce heat to low, cover, and simmer until liquid is mostly




7. Add split peas. Stir to combine. Allow to warm through. 






































Yield: 4 servings 
 
 




• 900 grams chickpeas, cooked and thawed 
• 1 bunch green onions, sliced 
• ¼ cup egg whites 
• 3 tablespoons all-purpose flour 
• 2 teaspoons oregano 
• 2 teaspoons cumin 
• ¼ teaspoon salt 
• 1 tablespoon olive oil 
• ¾ cup nonfat yogurt, plain 
• 4 teaspoons tahini 
• 1 ½ tablespoon lemon juice 
• ½ cup fresh parsley, finely chopped 
• 4 whole wheat pita breads, cut in half 
 
Directions: 
1. Place chickpeas, egg whites, flour, green onions and spices in food processor. Pulse 
until a coarse mixture forms which holds together when pressed. 
2. Form chickpea mixture into four patties. 
3. Heat oil in a pan over medium-high heat. Add patties. Fry until golden and beginning 
to crisp, about 4 to 5 minutes. 
4. Flip patties. Fry until other side is also golden and crisp, about 2 to 4 minutes. 




1. Combine yogurt, tahini, lemon juice and parsley in a bowl. Stir to combine.
2. Portion sauce into separate containers.
Serve with 1 container of sauce and 1 pita bread each. 
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SAUSAGE AND SWEET POTATO CHILI 
Yield: 4 servings 
Preparation time: 30 minutes Cook time: 1 hour Total time: 1 hour 30 minutes 
Ingredients: 
• 300 grams red lentils, dry
• 1 teaspoon chili powder
• 1 teaspoon cumin
• 1 teaspoon no-salt seasoning (such as garlic herb)
• 1 teaspoon oregano
• ¼ pound hot italian sausage
• 1 tablespoon canola oil
• 1 small onion, chopped
• 2 tablespoons garlic, minced
• 1 ½ tablespoon. chili powder
• ¼ cup chipotle peppers
• 1 teaspoon cumin
• 1 teaspoon oregano
• black pepper to taste
• 1 796ml can diced tomatoes
• 1 large sweet potato, diced
• ½ cup water
Directions: 
1. Cook red lentils according to pulse cooking instructions. Add chili powder, cumin,
no- salt seasoning, and oregano to cooking water. Drain.
2. Heat a pan over medium heat. Add sausage. Cook until browned. Remove sausage
from pan and slice thinly.
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3. Heat oil in a pot over medium heat. Add onion, garlic and spices. Sauté for 2 minutes,
stirring frequently.
4. Add diced tomatoes, sweet potato and water. Bring to a boil over medium heat. Reduce
heat to low, cover, and simmer until sweet potato is tender, about 25 minutes.
5. Add water and adjust seasoning if necessary.





APPLE CINNAMON OATMEAL 
 
 
Yield: 6 servings 
 
 





• 450 grams red lentils, dry 
• 2 cups water 
• 1 ½ tablespoon vanilla extract 
• 1 cup brown sugar 
• 2 tablespoons cinnamon 
• 1 tablespoon allspice 
• 1 teaspoon ground cloves 
• 1 teaspoon nutmeg 
• 1/8 teaspoon salt 
• 1 cup oats 
• 2 tablespoons skim milk powder 
• 2 cups water 
• 1 ½ tablespoon margarine or unsalted butter 
• 6 medium apples, peeled and chopped 
• ½ cup almonds, slivered 
 
Directions: 
1. Combine red lentils, water, vanilla extract, half of brown sugar and half of spices in a 
pot. Bring to a boil. Reduce heat to low and simmer until lentils are almost done. 
2. Add oats, skim milk powder and water. Cook until oatmeal consistency is achieved. 
3. Heat margarine or butter in pan over medium-low heat. Add apples. Cook until softened. 
4. Add almonds and remaining half of spices to apple mixture. Cook over medium heat 




5. Add remaining half of brown sugar and lemon juice to apple mixture. Cook until sugar 
dissolves. 




































Yield: 5 servings 
 
 




• 1125 grams chickpeas, cooked and thawed 
• 2 cups whole wheat pasta (such as fusilli or macaroni) 
• 1 tablespoon olive oil 
• 1 small onion, chopped 
• 1 bell pepper, chopped 
• 2 tablespoons garlic, minced 
• 1 teaspoon red pepper flakes 
• ½ teaspoon black pepper 
• ½ teaspoon salt 
• 1 cup low-sodium vegetable broth 
• ½ 300 grams package frozen spinach, thawed 
• 1 ½ tablespoon olive oil 
• 2 tablespoons nonfat yogurt, plain 
• 2 tablespoons part-skim mozzarella cheese, shredded 
• 2 tablespoons parmesan cheese, grated 
 
Directions: 
1. Cook pasta according to package instructions until al dente. Drain. 
2. Heat oil in a pot over medium-high heat. Add onions and bell pepper. Sauté 
until softened, about 4 minutes. 
3. Add garlic, red pepper flakes, salt and pepper. Sauté for 1 minute more. 
4. Add chickpeas and vegetable broth. Bring to a boil. Reduce heat to low and simmer 




5. Crush chickpeas against the side of the pot using the back of a spoon. 
6. Add pasta, spinach, olive oil, yogurt, mozzarella and parmesan. Stir to combine. Allow to 
heat through. 



































Yield: 4 servings 
 
 




• 300 grams lentils, dry 
• 2 tablespoons olive oil 
• 1 cup broccoli florets, fresh or frozen and thawed 
• 3 cups baby spinach, fresh or frozen and thawed 
• ¼ cup green onions, finely chopped 
• 1 cup cherry tomatoes, halved 
• ¼ cup fresh basil, finely chopped 
• ¼ cup fresh parsley, finely chopped 
• ¼ cup fresh mint, finely chopped 
• ¼ cup parmesan cheese, grated 
• 2 tablespoons lemon juice 
• ¼ teaspoon black pepper 
• ¼ teaspoon salt 
• 4 whole wheat buns 
• 4 teaspoon margarine 
 
Directions: 
1. Cook lentils according to pulse cooking instructions. Drain. 
2. Heat oil in a pot over medium-high heat. Add broccoli, spinach and green onion. Cook 
until softened and wilted, about 2 minutes. 
3. Add lentils, tomatoes, basil, parsley and mint. Stir to combine. Allow to heat through. 
4. Add parmesan, lemon juice, salt and pepper. Stir to combine. 













































Yield: 3 servings 
 
 




• 450 grams lentils, cooked and thawed 
• 1 teaspoon canola oil 
• 1 small onion, chopped 
• 1 tablespoon garlic, minced 
• 2 teaspoon chili powder 
• 1 teaspoon cumin 
• 1 teaspoon oregano 
• 1 ¼ cup low-sodium vegetable broth 
• ¾ cup lettuce, shredded 
• ¾ cup cherry tomatoes, quartered 
• ½ cup salsa 
• 3 tablespoon low-fat sour cream 
• ¾ cup light cheddar cheese, shredded 
• 6 small or 3 large whole-wheat tortillas 
 
Directions: 
1. Heat oil in a pot over medium-high heat. Add onions and garlic. Sauté until tender. 
2. Add chili powder, cumin and oregano. Sauté for 1 minute more. 
3. Add lentils and vegetable broth. Bring to a boil. Reduce heat to low, cover and 
simmer until lentils are soft, about 20 minutes. 






Serve with ¼ cup lettuce and ¼ cup tomatoes, 1 tablespoon salsa, 1 tablespoon 
sour cream, and ¼ cup cheddar cheese, each in separate containers. 
































MULTIGRAIN LENTIL PILAF 
 
 
Yield: 5 servings 
 
 




• 375 grams lentils, dry 
• 2 ½ tablespoons canola oil 
• 1 medium onion, chopped 
• ½ cup almonds, sliced 
• ¼ cup brown rice, dry 
• ¼ cup barley, dry 
• ¼ cup wild rice, dry 
• 2 ¼ cups low-sodium vegetable broth 
• 1 tablespoon cooking sherry 
• 1 tablespoon no-salt seasoning (such as garlic herb) 
• ½ teaspoon salt 
 
Directions: 
1. Preheat oven to 350°F. 
2. Cook lentils according to pulse cooking instructions. Drain. 
3. Heat oil in a pot over medium-high heat. Add onions. Sauté until onions are translucent. 
4. Add almonds, brown rice and barley. Sauté until rice is slightly browned. 
5. Add lentils, wild rice, vegetable broth, sherry, seasoning and salt. Stir to combine. 
6. Pour mixture into a casserole dish. Loosely cover with tinfoil. Bake for about 1 
hour, stirring every 20 minutes. 












































LENTIL PIZZA WITH HERB PESTO 
 
 
Yield: 4 servings 
 
 




• 300 grams red lentils, dry 
• 4 whole wheat thin buns 
• ¼ cup basil pesto 
• 1 cup artichoke hearts, chopped 
• 1 cup roasted red peppers, chopped 
• ½ cup part-skim mozzarella cheese, shredded 
• fresh ground black pepper to taste 
 
Directions: 
1. Preheat oven to 350°F. 
2. Cook red lentils according to pulse cooking instructions. Drain. 
3. Split thin buns open. Place facing upward on baking sheet. Toast in oven until 
lightly golden. 
4. Mix pesto into lentils. 
5. Spread lentil mixture evenly onto each thin bun. Distribute 
artichoke hearts and roasted red peppers on top of lentil 
mixture. Sprinkle mozzarella cheese over pizzas. 
6. Return pizzas to oven. Toast until cheese melts. 









Yield: 6 servings 
 
 




• 450 grams red lentils, dry 
• 2 tablespoons canola oil 
• 1 small onion, chopped 
• 2 tablespoons garlic powder 
• 1 tablespoon madras curry powder 
• 1 tablespoon ground ginger 
• 1 tablespoon ground thyme 
• 1 teaspoon cinnamon 
• ½ teaspoon salt 
• 1 398ml can light coconut milk 
• 2 cups brown rice, dry 
• 1 cup cauliflower florets, fresh or frozen and thawed, chopped 
• 2 cups green beans, fresh or frozen and thawed, chopped 
 
Directions: 
1. Cook red lentils according to pulse cooking instructions. Drain. 
2. Heat oil in a pot over medium-high heat. Add onions. Sauté until softened. 
3. Add spices. Sauté for 1 minute more. 
4. Add coconut milk, brown rice, cauliflower and green beans. Bring to a boil. Reduce 
heat to low, cover and simmer until rice is cooked, about 30 minutes. 











































Yield: 5 servings 
Preparation time: 30 minutes Cook time: 1 hour Total time: 1 hour 30 minutes 
Ingredients: 
• 375 grams lentils, dry 
• 2 teaspoons vegetable stock powder 
• 2 teaspoons cumin 
• 2 teaspoons oregano 
• 1 large sweet potato, peeled and diced 
• 1 medium russet potato, peeled and diced 
• 2 tablespoons nonfat yogurt, plain 
• 2 tablespoons margarine 
• ½ teaspoon salt 
• black pepper to taste 
• 1 ½ tablespoons olive oil 
• 1 small onion, diced 
• 1 small carrot, diced 
• 1 celery stalk, diced 
• 2 tablespoons garlic, minced 
• 2 teaspoons cumin 
• 2 teaspoons oregano 
• ½ teaspoon black pepper 
• 1 796ml can diced tomatoes 
• 1 medium zucchini, diced 
• ½ cup light cheddar cheese, shredded 
• 2 green onions, thinly sliced 
 
Directions: 




2. Cook lentils according to pulse cooking instructions. Add vegetable broth, cumin and 
oregano to cooking water. Drain and set aside. 
3. Bring a pot of salted water to a boil. Add sweet potatoes and russet potatoes. Cover and 
cook until tender, about 20 minutes. Drain. 
4. Return potatoes to pot. Add yogurt, margarine, salt, pepper and half of the cheese. Mash 
together and set aside. 
5. Heat oil in a pot over medium heat. Add onions, carrot, celery and garlic. Sauté until 
softened, about 6 minutes. 
6. Add cumin, oregano and pepper. Sauté for 2 minutes more. 
7. Add tomatoes, zucchini and lentils. Bring to a boil. Reduce heat to low, cover and 
simmer until thickened, stirring often. 
8. Pour lentil mixture into a casserole dish. Spread mashed potato mixture on top of lentils. 
Sprinkle remaining half of cheese and green onions over potatoes. 
9. Bake in oven until cheese is bubbly, about 30 minutes. 

















SPLIT PEA VEGETABLE SOUP 
 
 
Yield: 6 servings 
 
 
Preparation time: 30 minutes Cook time: 40 minutes Total time: 1 hour 10 minutes 
Ingredients: 
• 3 slices bacon 
• 498 grams split peas, dry 
• 4 tablespoons canola oil 
• 1 onion, chopped (~150g) 
• 6 celery stalks, chopped 
• 2 teaspoons garlic ,minced 
• 185 grams carrots, diced 
• 2 bay leaves 
• 1 teaspoon freshly ground black pepper 
• 1 teaspoon turmeric 
• 28 ounces diced tomatoes, no salt added 
• 1 tablespoon fresh rosemary (or 1 tsp dry) 
• 3 whole wheat pitas ( ½ per serving) 
• 12 teaspoons sour cream, 2 per serving 
 
Directions: 
• Sort and rinse peas. Put in a large pot with 6 cups water, bring to a boil and reduce heat 
to maintain a simmer. 
• While the peas cook, chop bacon into small pieces and brown in a skillet over medium 
heat, stirring occasionally. While the bacon cooks, chop onion, carrots and celery, 
including celery leaves, if available. Add the chopped veggies to bacon and cook, 
stirring occasionally, until onion softens, about 10 minutes. Add rosemary, turmeric, 
bay leaves, and tomatoes and minced or pressed garlic. Stir in well and cook for 




• Add bacon-veggie mix to peas and simmer until peas are soft, 10 to 30 minutes, 
depending on the age of the peas. Taste for seasoning and serve hot. Good with 
crusty wholegrain bread. 
 
TIP: To reduce work time, add all ingredients to the pot with the peas and skip the 




























BARLEY AND LENTIL SOUP 
 
 
Yield: 6 servings 
 
 





• 450 grams lentils, dry 
• 4 cups low-sodium vegetable broth 
• 4 cups cold water 
• ½ cup pearl barley, dry 
• 1 cup cold water 
• 3 tablespoons olive oil 
• 5 large carrots, finely chopped 
• 1 medium red onion, diced 
• ¾ teaspoon salt 
• black pepper to taste 
• 2 tablespoons garlic, minced 
• 2 teaspoons cumin 
• 300 grams spinach, frozen and chopped 
• 3 tablespoons lemon juice 
• 6 whole wheat buns 




1. Heat oil in a pot over medium heat. Add onions, carrots, salt and pepper. Cook 
until vegetables begin to brown, about 15 minutes. 
2. Add garlic and cumin. Cook for 30 seconds more, stirring constantly. 
3. Add lentils, vegetable broth and water. Bring to a boil. Reduce heat, cover 




4. Combine pearl barley and water in another pot. Bring to a boil. Reduce heat 
and simmer until cooked, about 20 minutes. 
5. Add spinach and pearl barley to soup. Stir to combine. Cover and simmer 
until spinach is cooked, about 5 to 10 minutes. 
6. Add lemon juice. Stir to combine. 






























Yield: 6 servings 
 
 




• 450 grams lentils, dry 
• 4 tablespoons olive oil 
• 1 cup carrot, chopped 
• 1 cup celery, chopped 
• 2 tablespoons garlic 
• 2 tablespoons tomato paste 
• 8 cups water 
• 1 796ml can diced tomatoes 
• 2 tablespoons lemon juice 
• ¼ cup fresh parsley, chopped 
• 1 tablespoon oregano 
• 1 teaspoon rosemary 
• 1 teaspoon black pepper 
• ½ teaspoon sugar 
• ½ teaspoon salt 
• 6 whole wheat buns 




1. Heat oil in a pot over medium-high heat. Add carrot and celery. Cook until 
vegetables begin to brown. 




3. Add lentils, water, diced tomatoes, lemon juice, parsley, oregano, rosemary, 
pepper, sugar and salt. Bring to a boil. Reduce heat, cover and simmer until 
vegetables are soft. 
NOTE: Add more water as necessary to maintain soup consistency. 





























HONEY CARAMELIZED CARROT SOUP 
 
 
Yield: 6 servings 
 
 




• 540 grams split peas, dry 
• 1 tablespoon canola oil 
• 1 small onion, chopped 
• 1 medium bell pepper, chopped 
• 1 tablespoon garlic, minced 
• 3 cups low-sodium vegetable broth 
• 1 tablespoon no-salt garlic and herb seasoning 
• ¼ teaspoon salt 
• 1 tablespoon canola oil 
• 2 medium carrots, peeled and sliced into coins 
• 1 tablespoon honey 
• 6 whole wheat buns 
• 6 teaspoons margarine 
 
Directions: 
1. Heat canola oil in a pot over medium heat. Add onion and bell pepper. Cook until 
onions are soft, about 5 minutes. 
2. Add garlic. Cook for 4 minutes more. 
3. Add vegetable broth, split peas, garlic and herb seasoning and salt. Bring to a boil. 
Reduce heat and simmer until split peas are cooked. 




4. Heat canola oil in a pan over medium heat. Add carrots and cook until tender 
enough to pierce with a fork. 
5. Add honey. Stir or toss to combine. Turn heat to high and caramelize for 5 minutes. 






























ROSEMARY INFUSED RED LENTIL SOUP 
 
 
Yield: 5 servings 
 
 




• 375 grams red lentils, dry 
• 2 ½ tablespoons canola oil 
• 1 teaspoon dried rosemary 
• ½ teaspoon dried thyme 
• ½ teaspoon dried basil 
• 1 small onion, chopped 
• 1 tablespoon garlic, minced 
• 1 bay leaf 
• 5 cups water 
• ¼ cup pearl barley 
• ½ teaspoon salt 
• 1 large carrot, chopped 
• 2 celery stalks, chopped 
• 1 small potato, peeled and diced 
• ¼ cup fresh parsley, chopped 
• ½ teaspoon black pepper 
• 5 whole wheat buns 
• 5 teaspoons margarine 
 
Directions: 
1. Heat oil in a pot over medium heat. Add rosemary, thyme and basil. Temper for 1 




2. Add onion, garlic and bay leaf. Turn heat to medium-high. Sauté until onions 
are translucent, about 5 minutes. 
3. Add water, red lentils, barley and salt. Bring to a boil. Reduce heat and simmer for 
20 minutes, stirring occasionally. 
4. Add carrots, celery, potato, parsley and black pepper. Simmer until vegetables 
are tender and lentils and barley are cooked through, about 20 minutes more. 

























SPLIT PEA AND BARLEY SOUP 
 
 
Yield: 7 servings 
 
 





• 630 grams split peas, dry 
• 5 tablespoons canola oil 
• 1 large onion, coarsely chopped 
• 1 large carrot, peeled and coarsely chopped 
• 3 celery stalks, coarsely chopped 
• 1 tablespoon garlic 
• 6 cups low-sodium vegetable broth 
• 1 cup pearl barley, dry 
• 3 cups cold water 
• ¼ teaspoon salt 
• white pepper to taste 
 
Directions: 
1. Heat oil in a pot over medium-high heat. Add onion, carrot, celery and garlic. 
Sauté until onions are translucent. 
2. Add vegetable broth and split peas. Bring to a boil. Reduce heat and 
simmer uncovered for 1 hour. 
3. Combine pearl barley and water in another pot. Bring to a boil. Reduce heat 
and simmer until cooked, about 30 to 40 minutes. 
4. Blend soup with immersion blender until smooth. 
5. Add pearl barley to blended soup. Stir to combine. 
6. Season with salt and white pepper. 










































CURRIED APPLE SOUP 
 
 
Yield: 4 servings 
 
 




• 300 grams red lentils, dry 
• 1 teaspoon minced garlic 
• 1 teaspoon curry powder 
• 1 tablespoon margarine 
• ½ cup chopped onion 
• 2 tablespoons chopped celery leaves and/or celery 
• 1 tablespoon minced garlic 
• 1 teaspoon curry powder 
• 4 cups low-sodium vegetable broth 
• 3 apples, grated 
• ½ cup carrot, grated 
• 4 tablespoons nonfat yogurt, plain 
• 4 whole wheat buns 
• 4 teaspoons margarine 
 
Directions: 
1. Cook red lentils according to pulse cooking instructions. Add garlic and curry powder 
to cooking water. Drain. 
2. Melt margarine in a pot over medium heat. Add garlic, onion and celery. Sauté 
until onion is soft, about 3 minutes. 
3. Add curry powder. Sauté for 1 minute more, stirring constantly. 
4. Add vegetable broth, carrot and apple. Bring to a boil. Reduce heat to low and simmer 




5. Add lentils to soup and stir to combine. 





































Yield: 5 servings 
 
 




• 1125 grams chickpeas, cooked and thawed 
• 2 tablespoons canola oil 
• 1 small onion, chopped 
• 2 tablespoons garlic, minced 
• ¼ cup dried oregano 
• 1 teaspoon salt 
• 2 teaspoons black pepper 
• 1 medium carrot, chopped 
• 2 celery stalks, chopped 
• 5 cups water 
• 1 796ml can diced tomatoes 
• 1 156ml can tomato paste 
 
Directions: 
1. Heat oil in a pot over medium-high heat. Add onions. Sauté until softened. 
2. Add garlic, oregano, salt and pepper. Temper for 30 seconds to 1 minute. 
3. Add carrots and celery. Sauté until lightly browned. 
4. Add water, diced tomatoes, tomato paste and chickpeas. Bring to a boil. Reduce heat to 
low and simmer until vegetables are tender. 










































SOUTHWESTERN CORN SOUP 
Yield: 4 servings 
Preparation time: 15 minutes Cook time: 45 minutes Total time: 1 hours 
Ingredients: 
• 900 grams chickpeas, cooked and thawed
• 2 tablespoons canola oil
• 1 tablespoon garlic, minced
• 1 small onion, diced
• 2 celery stalks, diced
• 1 teaspoon dried thyme
• 2 teaspoons cumin
• 1 teaspoon chili powder
• 1 teaspoon cinnamon
• 4 cups low-sodium vegetable broth
• 1 796ml can diced tomatoes
• 2 cups corn, frozen
• ¼ teaspoon salt
• black pepper to taste
• 4 tablespoons light cheddar cheese, shredded
Directions: 
1. Heat oil in a pot over medium-high heat. Add garlic, onion and celery. Sauté until
onion is translucent.
2. Add thyme, cumin, chili powder and cinnamon. Sauté for 1 minute more.
3. Add vegetable broth, diced tomatoes, corn, salt, and pepper. Bring to a boil. Reduce
heat to low, cover, and simmer until celery is tender, about 30 minutes.








































Yield: 5 servings 
Preparation time: 30 minutes Cook time: 20 minutes Total time: 50 minutes 
Ingredients: 
• 1125 grams chickpeas, cooked and thawed
• 2 tablespoons canola oil
• 1 medium onion, chopped
• 3 medium beets, peeled and chopped
• 1 cup red cabbage, shredded
• 1 cup celery, chopped
• 1 cup green beans, chopped
• 2 ½ cups water
• 1 796ml can diced tomatoes
• 1 teaspoon vegetable stock powder
• 1 teaspoon thyme
• 1 teaspoon dill seeds
• 1 teaspoon no-salt seasoning (such as garlic herb)
• ¼ teaspoon salt
• ¼ teaspoon black pepper
• 1 bay leaf
• 1 tablespoon white vinegar
• 5 whole wheat buns
• 5 teaspoons margarine
Directions: 
1. Heat oil in a pot over medium-high heat. Add onion, beets, cabbage, celery and green




2. Add chickpeas, water, diced tomatoes, vegetable stock, and spices. Bring to a 
boil. Reduce heat to low, cover and simmer until chickpeas and vegetables are 
tender. 
3. Add vinegar. Stir to combine. 































FRENCH CANADIAN SPLIT PEA SOUP 
 
 
Yield: 6 servings 
 
 




• 540 grams split peas, dry 
• 12 cups water 
• 1 bay leaf 
• 5 strips bacon 
• 3 tablespoons canola oil 
• 2 medium onions, chopped 
• 2 medium carrots, chopped 
• 3 celery stalks, chopped 
• 2 tablespoons garlic, minced 
• ½ cup fresh parsley, packed 
• 1 tablespoon dried sage 
• ½ teaspoon salt 
• black pepper to taste 
• 6 whole wheat buns 
• 6 teaspoons margarine 
 
Directions: 
1. Combine split peas, water and bay leaf. Bring to a boil. Reduce heat and simmer until 
split peas puree, about 2 ½ to 3 hours. Add more water as necessary. 
2. Heat pan over medium heat. Add bacon strips and cook bacon strips. Remove from pan 
and chop into pieces. 




until onions are transparent. 
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4. Add bacon, vegetable mixture, parsley, sage, salt and pepper to split peas. Stir
to combine. Simmer for another ½ hour.
5. Remove soup from heat. Allow to cool slightly. Puree with immersion blender
until smooth.
6. Portion out soup.
7. Freeze.
Serving Instructions: 




HEARTY LENTIL SOUP 
 
 
Yield: 5 servings 
 
 




• 375 grams lentils, dry 
• 120 grams back bacon, chopped 
• 1 tablespoon canola oil 
• ½ cup onions, finely chopped 
• ½ cup carrots, finely chopped 
• 1 tablespoon garlic, minced 
• 3 cups low-sodium vegetable broth 
• 1 ½ cups water 
• 1 796ml can diced tomatoes 
• ½ cup fresh parsley, chopped 
• 1 teaspoon oregano 
• fresh ground black pepper to taste 
• ¼ teaspoon salt 
• 5 whole wheat buns 
• 5 teaspoons margarine 
 
Directions: 
1. Cook lentils according to pulse cooking instructions. Drain. 
2. Heat a pot over medium-high heat. Add bacon. Sauté for about 3 minutes, stirring often. 
3. Add oil, onions, carrots and garlic. Sauté until vegetables are tender but not 
browned, about 5 to 8 minutes. 
4. Add lentils, vegetable broth, water, tomatoes, parsley, oregano, salt and pepper. Bring 
to a boil. Reduce heat to low and simmer until heated through. 
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5. Portion out soup.
6. Freeze.
Serving Instructions: 




WINTER VEGETABLE SOUP 
 
 
Yield: 5 servings 
 
 




• 375 grams lentils, dry 
• 2 tablespoons canola oil 
• 1 large onion, sliced thinly 
• 2 large carrots, grated 
• 2 celery stalks, sliced 
• ½ head of cabbage, shredded 
• 2 tablespoons garlic, minced 
• 2 tablespoons tomato paste 
• 2 bay leaves 
• 1 container dill seed 
• black pepper to taste 
• 5 cups low-sodium vegetable broth 
• 3 cups water 
• ¼ cup nonfat yogurt, plain 
• ¼ teaspoon salt 
• 5 whole wheat buns 





1. Heat oil in a pot over medium heat. Add onion, carrots, celery and cabbage. Sauté for 
about 20 minutes, stirring often. 
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2. Raise heat to medium-high. Add garlic, tomato paste, bay leaves and dill seed. Sauté
for another 1 to 2 minutes.
3. Add lentils, vegetable broth and water. Bring to a boil. Reduce heat to low, cover
and simmer until lentils are cooked and vegetables are tender.
4. Add yogurt and salt. Mix well.
5. Portion out soup. Remember to remove bay leaves.
6. Freeze.
Serving Instructions: 








Yield: 6 servings 
 
 
Preparation time: 20 minutes Cook time: 1 hour and 10 minutes Total time: 1 hour 
and 30 minutes 
 
Ingredients: 
• 1350 grams chickpeas, cooked and thawed 
• 2 tablespoons olive oil 
• 1 large onion, diced 
• 3 tablespoons garlic, minced 
• 3 teaspoons paprika 
• 2 teaspoons cumin 
• 2 teaspoons cinnamon 
• ½ teaspoon cayenne pepper 
• 4 cups low-sodium vegetable broth 
• 1 796ml can diced tomatoes 
• 1 tablespoon lemon juice 
• ½ teaspoon salt 
• fresh ground black pepper to taste 
• ½ package spinach, frozen and thawed 
 
Directions: 
1. Heat oil in a pot over medium-high heat. Add onion and garlic. Sauté until onion 
is translucent, reducing heat if browning begins to occur. 
2. Add spices. Sauté for another 1 to 2 minutes. 
3. Add chickpeas, vegetable broth, tomatoes, lemon juice, salt and pepper. Add water 
until chickpeas are just covered with liquid if necessary. 
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4. Bring to a boil. Reduce heat to low and simmer until chickpeas are tender, about 45
minutes. Add more water if necessary.
5. Crush some of the chickpeas against the side of the pot using the back of a spoon.
6. Remove from heat. Stir in spinach. Allow to heat through until wilted, about 2 to 5
minutes.
























LENTIL QUINOA SALAD 
Yield: 1 servings 
Preparation time: 10 minutes Cook time: 20 minutes Total time: 30 minutes 
Ingredients: 
• 150 grams lentils, cooked and thawed
• ¼ cup quinoa, dry
• ½ cup cold water
• ¼ teaspoon Dijon mustard
• ½ tablespoon red wine vinegar
• 1 tablespoon olive oil
• ½ teaspoon garlic powder
• ½ tablespoon lime juice
• ½ teaspoon lime zest
• ¼ teaspoon salt
• black pepper to taste
• 4 green onions, chopped
• 1 tablespoon fresh cilantro, chopped
Directions: 
1. Combine water and quinoa in a pot. Bring to a boil. Reduce heat and simmer until
cooked.
2. Whisk mustard and vinegar together in a small bowl. Drizzle in olive oil and whisk
to emulsify.
3. Add garlic powder, lime juice, lime zest, salt and pepper, and whisk to combine.
4. Combine lentils, quinoa, green onions and cilantro in a large bowl.
5. Pour dressing onto salad and toss to coat.








































ORZO, LENTIL AND FETA SALAD 
Yield: 4 servings 
Preparation time: 20 minutes Cook time: 20 minutes Total time: 40 minutes 
Ingredients: 
• 600 grams lentils, cooked and thawed
• ¾ cup whole wheat orzo pasta, dry
• 1 ½ tablespoon olive oil
• 1 ½ tablespoon canola oil
• 2 tablespoons red wine vinegar
• 1 teaspoon garlic, minced
• 1 cup cherry tomatoes, quartered
• ¼ red onion, diced
• 1/3 cup olives, pitted and chopped
• ¼ cup fresh dill, chopped
• 1/3 cup light feta cheese, crumbled
• 1/8 teaspoon salt
• black pepper to taste
Directions: 
1. Bring a pot of water to the boil. Add orzo. Cook until al dente and drain.
2. Whisk olive oil, canola oil, red wine vinegar, garlic, salt and pepper together in a
small bowl.
3. Combine pasta, tomatoes, red onion, olives, dill and feta cheese in a large bowl.
4. Pour dressing onto salad and toss to coat.












































SANTA FE SALAD 
 
 
Yield: 6 servings 
 
 




• 1350 grams chickpeas, cooked and thawed 
• 1/3 cup olive oil 
• 3 tablespoon lime juice 
• ¼ cup cilantro, chopped 
• 1 teaspoon cumin 
• ¼ teaspoon salt 
• black pepper to taste 
• 1 red bell pepper, diced 
• 1 ½ cup corn, frozen 
• ½ cup red onion, chopped 
• 1 jalapeno pepper, seeded and minced 
• 1 ½ whole wheat pita bread 
 
Directions: 
1. Whisk olive oil and lime juice together in a small bowl. 
2. Add cilantro, cumin, salt and pepper and whisk to combine. 
3. Combine chickpeas, corn, onion, bell pepper and jalapeno in a large bowl. 
4. Pour dressing onto salad and toss to coat. 




















































Yield: 1 serving 
 
 




• 225 grams chickpeas, cooked and thawed 
• 3 spears asparagus 
• 1 cup baby spinach 
• ¼ cup blueberries 
• ½ cup strawberries, halved 
• 2 tablespoons fresh mint, finely chopped 
• 1 tablespoon extra-virgin olive oil 
• 1 tablespoon apple cider vinegar 
• 2 teaspoons honey 
• pinch of salt 
 
Directions: 
1. Bring a pot of water to the boil. Cook asparagus until tender. Drain and chop 
into pieces. Allow to cool. 
2. Combine asparagus, spinach, blueberries, strawberries and mint in a bowl. Mix well. 
3. Whisk olive oil, vinegar, honey and salt together in a small bowl. 




















































Yield: 1 serving 
 
 




• 225 grams chickpeas, cooked and thawed 
• ½ cup cucumber, chopped 
• ½ cup cherry tomatoes, halved 
• 1 tablespoon red onion, finely chopped 
• 1 tablespoon light feta cheese, crumbled 
• 1 ½ tablespoon light balsamic vinaigrette 
• 1 teaspoon lemon juice 
• 1 teaspoon dried oregano 
• ¼ teaspoon salt 
• black pepper, to taste 
 
Directions: 
1. Combine ingredients in a bowl. Mix until coated. 









Yield: 1 serving 
 
 




• 150 grams lentils, cooked and thawed 
• 1 small potato, peeled and diced 
• 2 teaspoons olive oil 
• 1 teaspoon garlic, minced 
• ¼ teaspoon vegetable stock powder 
• ¼ cup fresh parsley, packed 
• ¼ cup fresh dill, packed 
• ¼ cup green onion, chopped 
• ¼ cup bell pepper, chopped 
• 1 teaspoon cumin 
• pinch of salt 
• pinch of black pepper 
 
Directions: 
1. Bring a pot of water to the boil. Add potatoes. Simmer for 7 to 8 minutes. Drain. 
2. Add olive oil, garlic, vegetable stock, parsley and dill to a food processor. Blend until 
a paste forms. 
3. Combine lentils, potatoes, herb paste, green onion, bell pepper, cumin, salt and pepper 
in a bowl. Mix well. 












































LENTIL AND VEGGIE STUFFED PITA 
 
 
Yield: 1 serving 
 
 




• 150 grams lentils, cooked and thawed 
• ¼ cup bell pepper, chopped 
• ¼ cup cucumber, chopped 
• 1 ½ tablespoon light feta cheese, crumbled 
• ¾ cup salad greens, chopped 
• 1 tablespoon light balsamic vinaigrette 
• 1 whole wheat pita bread, cut in half and opened 
 
Directions: 
1. Combine lentils, bell pepper, cucumber, and feta cheese in a bowl. Mix well. 









ORIENTAL PEA SALAD 
 
 
Yield: 1 serving 
 
 




• 183 grams split peas, cooked and thawed 
• ⅛ cup brown rice, dry 
• ¼ cup water 
• 1 small carrot, grated 
• 1 stalk celery, sliced 
• ¼ cup red bell pepper, diced 
• 1 tablespoon green onion, sliced 
• 1 teaspoon garlic, minced 
• 1 teaspoon ginger, minced 
• 2 tablespoons light Italian salad dressing 
• ½ teaspoon sesame oil 
• pinch of salt 
• 1 ½ tablespoon. chow mein noodles, dry 
 
Directions: 
1. Combine brown rice and water in a pot. Bring to a boil. Reduce heat and simmer 
until cooked. 
2. Combine carrot, celery, bell pepper, green onion, garlic and ginger in a bowl. Mix well. 
3. Whisk salad dressing, sesame oil and salt together in another bowl. 














































TOMATO AND SWEET CORN SALAD 
 
 
Yield: 1 serving 
 
 





• 150 grams lentils, cooked and thawed 
• ½ cup tomato, chopped 
• ¼ cup cucumber, chopped 
• ⅓ cup corn, frozen 
• 1 tablespoon red onion, diced 
• ¼ cup fresh parsley, finely chopped 
• 2 tablespoons light cheddar cheese, shredded 
• 2 tablespoons light balsamic vinaigrette 
• 1 cup salad greens 
 
Directions: 
1. Combine lentils tomato, cucumber, corn, red onion, parsley and cheddar cheese 
in a bowl. Mix well. 
2. Portion out salad. Top with salad greens. Portion out 














CARROT RAISIN SALAD 
 
Yield: 5 servings 
 
 





• 750 grams lentils, cooked and thawed 
• 2 tablespoons olive oil 
• 1 medium onion, sliced thinly 
• 5 large carrots, peeled and sliced into coins 
• 1 teaspoon cumin 
• 1 teaspoon chili powder 
• 1 teaspoon paprika 
• 1 teaspoon red chili pepper flakes 
• 1 teaspoon caraway seeds 
• 1 teaspoon ground thyme 
• ½ teaspoon salt 
• ¾ cup raisins 
• ½ cup part-skim mozzarella cheese, shredded 
• 5 whole wheat buns 
• 5 teaspoons margarine 
 
Directions: 
1. Heat oil in a pan over medium heat. Add carrots. Cook until softened, about 30 minutes. 
2. Add onions and raisins to the pan for the last 10 minutes. 
3. Add spices. Cook for 1 minute more. 
4. Portion out lentils. Portion out carrot mixture on top of lentils. Stir to combine. 

















Cho leste rol 5mg 
















     















GRAPE WALNUT SALAD 
 
 
Yield: 1 servings 
 
 




• 150 grams lentils, cooked and thawed 
• ½ cup green grapes, halved 
• ¼ cup cucumber, chopped 
• ¼ cup bell pepper, chopped 
• 2 green onions, chopped 
• 1 tablespoon walnuts, chopped 
• 1 teaspoon extra-virgin olive oil 
• 2 teaspoons fresh lemon juice 
• ¼ teaspoon lemon zest 
• pinch of salt 
• black pepper to taste 
 
Directions: 
1. Combine lentils, grapes, cucumber, bell pepper and green onions in a large bowl. 
2. Whisk olive oil into lemon juice in a small bowl. Add lemon zest, salt and pepper. 





















































Cho leste rol 0mg 













Vitam in C 70 % 
Iron 35 % 
    














HONEY BROWN RICE SALAD 
 
 
Yield: 1 servings 
 
 




• 150 grams lentils, cooked and thawed 
• ¼ cup brown rice, dry 
• ½ cup cold water 
• ½ cup cherry tomatoes, halved 
• ½ bunch green onions, chopped 
• 1 tablespoon canola oil 
• 1 tablespoon cider vinegar 
• 1 ½ teaspoon honey 
• ¼ teaspoon cinnamon 
• pinch of salt 
 
Directions: 
1. Combine brown rice and water in a pot. Bring to a boil. 
Reduce heat and simmer 
until cooked. 
2. Combine lentils, brown rice, tomatoes, and green onions 
in a bowl. Mix well. 
3. Add oil, vinegar, honey, cinnamon and salt. Toss to coat. 





HUMMUS AND CRUDITÉS 
 
 
Yield: 2 servings 
 




• 450 grams chickpeas, cooked and thawed 
• ½ cup fresh parsley, packed 
• 2 tablespoons garlic, minced 
• 2 tablespoons olive oil 
• 2 tablespoons fresh lemon juice 
• ¼ cup water 
• 2 teaspoons cumin 
• ½ teaspoon red pepper flakes 
• pinch of salt 
• black pepper to taste 
• ½ cup cherry tomatoes, whole 
• ½ cup carrots, julienned 
• ½ cup bell peppers, julienned 
• ½ cup celery, julienned 
• 1 whole wheat pita bread, halved 
 
Directions: 
1. Combine chickpeas, garlic, parsley, lemon juice, olive oil, 
water and spices in food processor. Process until smooth. Add 
water if necessary. 












LENTIL CONFETTI SALAD 
 
 
Yield: 1 servings 
 
 




• 750 grams lentils, cooked and thawed 
• 2 tablespoons brown rice, dry 
• ¼ cup cold water 
• ¼ cup cherry tomatoes, halved 
• ¼ cup cucumber, diced 
• ¼ bell pepper, diced 
• ½ bunch green onions, diced 
• 2 tablespoons fresh parsley, finely chopped 
• 2 tablespoons Italian salad dressing 
• ½ teaspoon extra-virgin olive oil 
• pinch of salt 
• ½ cup romaine lettuce 
• 1 whole wheat buns 
• 1 teaspoon margarine 
 
Directions: 
1. Combine brown rice and water in a small pot. Bring to a boil. Reduce heat and 
simmer until cooked. 
2. Combine lentils, rice, tomatoes, cucumber, bell pepper, green onions and parsley in 
a large bowl. Mix well. 
3. Whisk salad dressing, olive oil and salt in a small bowl. 













































Yield: 2 servings 
 
 





• 450 grams chickpeas, cooked and thawed 
• 2 shallots, thinly sliced 
• 1 teaspoon garlic, minced 
• 1 tablespoon extra-virgin olive oil 
• 2 tablespoons red wine vinegar 
• pinch of salt 
• 100 grams carrot, grated 
• 100 grams beet, peeled and grated 
• ¼ cup dried cranberries 
• 1 tablespoon extra-virgin olive oil 
• ¼ cup fresh parsley, chopped 
• fresh ground black pepper to taste 
 
Directions: 
1. Preheat oven to 450°F. 
2. Combine shallot, garlic, olive oil, vinegar and salt in a large bowl. Set aside to mellow. 
3. Combine chickpeas, carrot, beet, cranberries and olive oil on a baking sheet. Stir to 
coat. Roast in oven until vegetables are lightly browned. 
4. Pour chickpea mixture into shallot mixture. Add parsley and pepper. Toss to coat. 








































LEMONY LENTIL SALAD 
Yield: 1 servings 
Preparation time: 20 minutes Cook time: - Total time: 20 
minutes 
Ingredients: 
• 75 grams lentils, cooked and thawed
• 1 tablespoon fresh dill, chopped
• ¼ teaspoon Dijon mustard
• 1 tablespoon fresh lemon juice
• pinch of salt
• fresh ground black pepper to taste
• ½ tablespoon olive oil
• ¼ cup red bell pepper, diced
• ¼ cup cucumber, diced
• 1 tablespoon red onion, minced
• 1 ½ tablespoon feta cheese, crumbled
• 1 cup romaine lettuce, shredded
• 1 whole wheat pita bread
Directions: 
1. Combine dill, mustard, lemon juice, salt and pepper in a large bowl. Gradually whisk
in olive oil.
2. Add lentils, bell pepper, cucumber, onion, and feta cheese. Toss to coat.










































TOASTED CHICKPEA SALAD 
Yield: 2 servings 
Preparation time: 15 minutes Cook time: 15 minutes Total time: 30 minutes 
Ingredients: 
• 450 grams chickpeas, cooked and thawed
• 2 tablespoons ground cardamom
• ¼ cup green olives, drained
• 1 tablespoon red wine vinegar
• 2 tablespoons extra-virgin olive oil
• ½ cup grapes, halved or quartered
• pinch of salt
• fresh ground black pepper to taste
• 4 cups lettuce, chopped
Directions: 
1. Heat a large pan over medium heat. Add chickpeas. Cook until toasted, about 12 to
15 minutes. Add ground cardamom while cooking.
2. Combine olives and vinegar in food processor. Process
until smooth. Stream in olive oil while processing.
3. Combine chickpeas, olive dressing, grapes, salt and pepper
in a large bowl. Toss to coat.
4. Portion out salad. Portion out lettuce on top of salad.
5. Refrigerate.
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